Skip to content
Federal Criminal TrialtranscripttranscriptLisa Peterson — Direct/Cross (Continued) - Day 24 - Federal Criminal TrialLisa Peterson completed direct testimony about Holmes's media statements and an April 2016 meeting before cross-examination turned to RDV's due diligence, reliance on Theranos, and the investment approval timeline.
Robert S. LeachKatherine TrefzLance A. WadeEdward J. DavilaLisa PetersonMr. LeachLisa PetersonJudge DavilaMr. WadeCourt ClerkMs. Trefzdirectproceduralcross
5 pages·1 witness·3,140 lines
Lisa Peterson completed direct testimony about Holmes's media statements and an April 2016 meeting before cross-examination turned to RDV's due diligence, reliance on Theranos, and the investment approval timeline.
Proceedings
Direct 1Lisa Peterson — Direct (Resumed)Line 4
ProceduralHearing and Ruling on Today Show VideoLine 15
Direct 2Lisa Peterson — Direct (Resumed)Line 22
CrossLisa Peterson — CrossLine 19

MR. LEACH: MS. PETERSON, I WANT TO MOVE FORWARD IN TIME TO APRIL OF 2016. DO YOU HAVE THAT TIME PERIOD IN MIND?

MR. LEACH: AT OR AROUND THAT TIME, DID YOU REVIEW A SEGMENT ON THE "TODAY SHOW" FEATURING MS. HOLMES?

MR. LEACH: AND DID YOU OBSERVE MS. HOLMES MAKING STATEMENTS ABOUT HER LEVEL OF INVOLVEMENT IN HER COMPANY?

MR. LEACH: AND THIS WAS IN APPROXIMATELY APRIL OF 2016?

MR. LEACH: IT WAS THE "TODAY SHOW"?

LISA PETERSON: I DON'T REMEMBER WHICH ONE. ONE OF THOSE MORNING SHOWS.

MR. LEACH: PRIOR TO TESTIFYING TODAY, DID YOU HAVE AN OPPORTUNITY TO REVIEW SEGMENTS OF A NEWS STORY IN APRIL OF 2016?

MR. LEACH: OKAY. YOUR HONOR, I WOULD LIKE TO OFFER THE INTERVIEW SEGMENT FROM THE "TODAY SHOW." IT'S EXHIBIT 3152, AND I'LL OFFER THE EXHIBIT IN ITS ENTIRETY.

JUDGE DAVILA: ALL RIGHT. THANK YOU. DID YOU -- BEFORE WE DO THAT, I'M NOT SURE THAT THIS WITNESS TESTIFIED THAT WHAT WE JUST SAW, THE THREE CLIPS, WERE THE ONES THAT SHE SAW.

MR. LEACH: I CAN ASK THAT, YOUR HONOR. I'M CONSCIOUSLY NOT GETTING INTO REACTION OR STATE OF MIND ON THAT, BUT --

JUDGE DAVILA: CORRECT. FOUNDATIONALLY -- I THINK YOU ASKED HER IF SHE SAW THEM, BUT I'M NOT CERTAIN THAT SHE TESTIFIED THAT WHAT WE SAW WAS WHAT SHE WAS REFERENCING.

MR. LEACH: I'LL ASK THE FOLLOWUP.

MR. LEACH: WE LOOKED AT THREE SEGMENTS FROM "MAD MONEY," MS. PETERSON, CLIPS 2851-1, -2, AND -3. ARE THOSE PORTIONS OF THE "MAD MONEY" CLIPS THAT YOU VIEWED?

ProceduralProc.Hearing and Ruling on Today Show Video

JUDGE DAVILA: ALL RIGHT. THANK YOU. MR. WADE?

MR. WADE: JUST THE SAME.

JUDGE DAVILA: SAME OBJECTIONS? ALL RIGHT. THANK YOU. WE'LL NOTE THAT, AND THE OBJECTIONS ARE OVERRULED, AND YOU CAN PLAY THE CLIP.

MR. LEACH: ALL RIGHT. THANK YOU. AND I'M GOING TO PLAY THE ENTIRETY OF THE CLIP.

MR. LEACH: THANK YOU.

(GOVERNMENT'S EXHIBIT 3152 WAS RECEIVED IN EVIDENCE.)

JUDGE DAVILA: EXCUSE ME. COULD WE STOP THIS FOR JUST A SECOND? MS. HOLLIMAN, CAN WE STOP THERE FOR JUST A SECOND? I'M SORRY. AND I NEED TO TALK TO COUNSEL FOR A MOMENT. WHY DON'T WE DO THAT? LET'S GO IN CHAMBERS RATHER THAN CLEAR EVERYONE.

COURT CLERK: LET ME TAKE THIS DOWN, YOUR HONOR.

JUDGE DAVILA: YES, GO AHEAD AND TAKE THAT DOWN. I JUST NEED CLARIFICATION ON SOMETHING. I'M SORRY. SO LET'S SEE -- I THINK THIS WILL JUST TAKE A SECOND. SO WE CAN DO THAT IN THE LITTLE ROOM BACK HERE, MR. WADE.

JUDGE DAVILA: FOLKS, THIS WILL TAKE JUST A COUPLE OF MINUTES, BUT YOU CAN STAND AND STRETCH. DON'T LEAVE THE ROOM, PLEASE.

(CONFERENCE ON THE RECORD IN THE JURY ROOM WITH COUNSEL.)

JUDGE DAVILA: WE'RE ON THE RECORD. WE'RE IN -- OUTSIDE OF THE PRESENCE OF THE JURY. MR. LEACH IS HERE AND MR. WADE IS HERE. I STOPPED THIS, AND WE CAN REWIND IT ACCORDINGLY. BUT THIS WAS GOING TO BE A VIDEO OF HER MAKING HER -- MS. HOLMES, PARDON ME, MAKING STATEMENTS. MY CONCERN IS THAT THERE'S COMMENTARY FROM THE REPORTERS TALKING ABOUT REPORTING AND GETTING THAT INFORMATION IN, WHICH I THINK IS ADDITIONAL TO THOSE STATEMENTS. THAT'S MY CONCERN, AND I HAVE SOME CONCERN ABOUT THE INTRODUCTION, MS. SHRIVER, THE REPORTER TALKING AND OFFERING THAT COMMENTARY. I DON'T THINK YOU MENTIONED THIS, MR. WADE, IN YOUR COMMENTS EARLIER, BUT I GUESS I'M CONCERNED ABOUT WHAT I SHOULD TELL THE JURY ABOUT THAT OR WHETHER OR NOT -- I THOUGHT HONESTLY THIS WAS GOING TO BE A -- THE SAME THING AS THE "MAD MONEY," QUESTION, ANSWER, QUESTION, ANSWER.

MR. LEACH: FIRST, YOUR HONOR, LET ME APOLOGIZE.

JUDGE DAVILA: I SHOULD HAVE READ THE TRANSCRIPT A LITTLE CLOSER.

MR. LEACH: THE GOVERNMENT ONLY PROPOSED THE PORTIONS WHERE MS. HOLMES IS SPEAKING, AND AS I UNDERSTAND THE DEFENSE'S OBJECTION, IF THAT WAS GOING TO COME IN, THEY WANTED THE ENTIRETY OF THE INTERVIEW.

MR. WADE: (NODS HEAD UP AND DOWN.)

MR. LEACH: SO AFTER OUR COLLOQUY, LISTENING TO THE DEFENSE OBJECTION THAT THEY WANTED THE ENTIRE VIDEO IN, TO AVOID THE OBJECTION, I OFFERED THE ENTIRE VIDEO.

MR. LEACH: I DON'T KNOW WHAT THEIR POSITION ON THE COMMENTARY IS, BUT WE WANTED MS. HOLMES'S STATEMENTS IN. WE STILL WANT MS. HOLMES'S STATEMENTS IN.

MR. LEACH: AND IF THE OBJECTION IS A RULE 106 OBJECTION FOR COMPLETENESS AND PLAY THE WHOLE THING, WE'RE FINE WITH THAT, TOO. IT'S INITIALLY NOT WHAT WE WANTED TO OFFER, BUT IN RESPONSE TO THE DEFENSE'S OBJECTION, I UNDERSTOOD THE WHOLE THING COULD COME IN.

MR. WADE: BUT I DON'T THINK WE'RE PLAYING ALL OF THE STATEMENTS, RIGHT? WE'RE ONLY PLAYING SELECTIVE STATEMENTS?

JUDGE DAVILA: OF THIS, OF THIS "TODAY" INTERVIEW?

MR. WADE: YEAH, YEAH.

JUDGE DAVILA: IT SOUNDS LIKE IT'S THE WHOLE TAPE.

MR. WADE: YOUR INITIAL PROPOSAL.

MR. LEACH: OUR INITIAL PROPOSAL WAS SOME OF MS. HOLMES'S STATEMENTS IN THE INTERVIEW. THE DEFENSE OBJECTED THAT THEY WANTED THE ENTIRETY OF THE CLIP IN.

MR. LEACH: IN RESPONSE TO THAT OBJECTION, I'M FINE WITH THE ENTIRE CLIP COMING IN --

MR. LEACH: -- INCLUDING STATEMENTS BY MS. HOLMES THAT THE GOVERNMENT HAD NOT INITIALLY OFFERED.

JUDGE DAVILA: OKAY. ALL RIGHT. YOU'RE GOOD WITH THAT?

MR. WADE: I'M FINE WITH THAT.

JUDGE DAVILA: OKAY. THANK YOU. I WAS -- I LOOKED AT IT, AND JUST FOR THE RECORD, THE REASON I STOPPED THE PROCEEDING -- AND WE'LL PLAY THIS AGAIN AND START IT BECAUSE I SAW THAT THERE WAS COMMENTARY AND I DIDN'T -- I KNOW THAT YOU DIDN'T OBJECT. I JUST WANTED TO BE CLEAR AND MAKE SURE THAT I HAVE THAT NOW, THAT'S ON THE RECORD NOW, THAT THE ENTIRETY OF THIS CAN BE PLAYED. YOU'VE HEARD MY REASON I STOPPED THIS WAS --

MR. WADE: NO, I APPRECIATE THE CAUTION, YOUR HONOR. BECAUSE IT WAS A LITTLE -- I THINK IT WAS A LAST MINUTE ADJUSTMENT BY MR. LEACH, WHICH WE UNDERSTAND AND --

JUDGE DAVILA: AND I'M NOT POINTING --

MR. WADE: SO I'M GLAD WE'RE CLEAR ON THAT.

JUDGE DAVILA: THANK YOU FOR THAT. I'M SORRY FOR THE DISRUPTION. I'M NOT POINTING FINGERS. I JUST WANTED CLARITY.

MR. WADE: NO. THAT'S ALWAYS BETTER SAFE THAN SORRY. THANK YOU, YOUR HONOR.

JUDGE DAVILA: SO LET'S -- WE'RE STILL ON THE RECORD HERE. SHOULD WE START THE TAPE AGAIN? I CAN'T RECALL WHERE I STOPPED IT. I THINK IT WAS JUST AFTER MS. SHRIVER, THE REPORTER, WAS INTRODUCED. SHOULD WE START IT THERE?

MR. LEACH: I'M FINE STARTING IT WHERE WE STOPPED.

MR. WADE: THAT'S FINE. WE CAN START WHERE IT IS.

JUDGE DAVILA: WELL, I WAS TALKING AND IT WAS RUNNING.

MR. WADE: MAYBE BACK IT UP 15 SECONDS OR SO.

JUDGE DAVILA: WHY DON'T WE START WHEN THE REPORTER, MS. SHRIVER, IS INTRODUCED, AND THEN IT BREAKS AWAY INTO THE INTERVIEW. IS THAT ALL RIGHT WITH YOU?

MR. LEACH: THAT'S FINE.

MR. WADE: THAT'S FINE. SURE.

JUDGE DAVILA: THANK YOU. SORRY FOR THE DISRUPTION.

MR. WADE: NO. NO PROBLEM AT ALL, YOUR HONOR.

(END OF CONFERENCE ON THE RECORD IN THE JURY ROOM WITH COUNSEL.)

JUDGE DAVILA: ALL RIGHT. THANK YOU, COUNSEL. THANK YOU. AND I APOLOGIZE FOR THE INTERRUPTION. WE'RE BACK ON THE RECORD. ALL PARTIES PREVIOUSLY PRESENT ARE PRESENT ONCE AGAIN. OUR WITNESS IS STILL ON THE STAND. MR. LEACH, IF YOU COULD QUEUE UP THE RECORDING AGAIN. PERHAPS WE CAN START IT JUST AS THE REPORTER, MS. SHRIVER, WAS BEING INTRODUCED. WOULD THAT BE ALL RIGHT TO START THERE?

MR. LEACH: YES, YOUR HONOR.

JUDGE DAVILA: WOULD THAT BE ALL RIGHT TO START THERE?

MR. WADE: YES, YOUR HONOR.

(VIDEO PLAYING OFF THE RECORD.)

MR. LEACH: THAT COMPLETES THE VIDEO CLIP, YOUR HONOR, EXHIBIT 3152.

MR. LEACH: MS. PETERSON, DID YOU VIEW THAT SEGMENT IN OR AROUND APRIL OF 2016?

MR. LEACH: AND SHORTLY AFTER THAT VIDEO SEGMENT, DID YOU MEET WITH MS. HOLMES PERSONALLY IN PALO ALTO?

LISA PETERSON: YES, JERRY AND I DID.

MR. LEACH: AND WHO ELSE WAS AT THIS MEETING IN PALO ALTO?

LISA PETERSON: DAN MOSLEY -- IT WAS DAN MOSLEY, JERRY TUBERGEN AND MYSELF, AS WELL AS PEOPLE FROM THE OTHER SIDE, TOO.

MR. LEACH: AND DID MS. HOLMES DISCUSS THE CMS INSPECTION?

LISA PETERSON: THERE WAS A NUMBER OF THINGS DISCUSSED. WE ASKED ABOUT EVERYTHING -- THIS WAS THE FIRST TIME THAT WE HAD A CHANCE TO ACTUALLY TALK TO HER IN PERSON SINCE WE MADE THE INVESTMENT, AND A LOT HAD HAPPENED SINCE, SO WE WERE ASKING REALLY WHAT WAS GOING ON. AND THERE WAS A LOT OF CONVERSATION BY HER AROUND THE LAB AND THINGS THAT WERE GOING ON, AND IT WAS MORE ALONG THE LINES OF THE PROCESS WASN'T -- CMS WAS QUESTIONING THE PROCESS, NOT THE ACCURACY OF THE TESTS.

MR. LEACH: AND DID MS. HOLMES SAY, IN SUBSTANCE, THERANOS CAN'T TRIVIALIZE THE ISSUES IN THE PRESS?

MR. LEACH: AND DID SHE SAY, IN SUBSTANCE, THAT IN REALITY THERANOS DOESN'T FEEL THE ISSUES ARE MAJOR?

LISA PETERSON: CORRECT. VERY MUCH DOWNPLAYED WHAT HAD BEEN HAPPENING IN THE PRESS, AND MUCH OF THE CORRESPONDENCE THAT WE HAD RECEIVED FROM THE COMPANY SINCE THE INVESTMENT WAS DOWNPLAYING WHAT HAD BEEN SAID IN THE NEWS.

MR. LEACH: MAY I HAVE A MOMENT, YOUR HONOR?

(DISCUSSION AMONGST GOVERNMENT COUNSEL OFF THE RECORD.)

MR. LEACH: NO FURTHER QUESTIONS, YOUR HONOR. THANK YOU. THANK YOU, MS. PETERSON.

JUDGE DAVILA: ANY CROSS-EXAMINATION?

MR. WADE: I DO, YOUR HONOR. MAYBE A STANDING BREAK AS I TRANSITION?

JUDGE DAVILA: SURE. FOLKS, FEEL FREE TO STAND AND STRETCH AS YOU WOULD LIKE DURING THE TRANSITION HERE. I THINK WE'RE GOING TO TAKE A BREAK AT 1:30, LADIES AND GENTLEMEN, RIGHT AROUND 1:30. YOU CAN STAND AS WELL, MS. PETERSON, IF YOU WOULD LIKE TO STRETCH.

(STRETCHING.)

MR. WADE: MAY I APPROACH, YOUR HONOR?

MR. WADE: (HANDING.)

CROSS-EXAMINATION BY MR. WADE:

MR. WADE: GOOD AFTERNOON, MS. PETERSON.

MR. WADE: MY NAME IS LANCE WADE. I REPRESENT MS. HOLMES. I'LL ASK YOU A FEW QUESTIONS HERE THIS AFTERNOON. DO YOU RECALL BEING ASKED SOME QUESTIONS ABOUT A PFIZER REPORT THAT YOU REVIEWED IN CONNECTION --

LISA PETERSON: DO I RECALL?

MR. WADE: TELL US WHAT YOU REMEMBER ABOUT THAT REPORT.

LISA PETERSON: THERE WERE A LOT OF PAGES IN THE DUE DILIGENCE BINDER AROUND THAT, AND I JUST RECALL READING IT, AND THE TAKE AWAY FOR ME WAS THE ACCURACY OF THE TESTING THAT THEY HAD DONE.

MR. WADE: WHAT WAS THE KIND OF STUDY THAT WAS DONE BY PFIZER?

LISA PETERSON: I DON'T RECALL.

MR. WADE: WHERE WAS IT DONE?

LISA PETERSON: I DON'T RECALL THAT.

MR. WADE: WHAT WAS THE DRUG INVOLVED?

LISA PETERSON: I DON'T RECALL THE SPECIFICS.

MR. WADE: DO YOU RECALL ANYTHING ABOUT THAT STUDY?

LISA PETERSON: NOT TODAY, NO.

MR. WADE: JUST THE LOGO? JUST THE LOGO, THAT'S ALL YOU RECALL?

LISA PETERSON: NO. I RECALL READING THEM AT THE TIME AND UNDERSTANDING -- THE TAKE AWAY FOR ME IN LOOKING AT IT WAS THAT IT WAS LENDING CREDIBILITY TO THE ACCURACY OF THE ANALYZERS AND THAT IT HAD DONE WORK AND, AS ELIZABETH HAD SAID, THEY HAD DONE WORK FOR THE PHARMACEUTICAL COMPANIES FOR THE LAST FIVE TO SEVEN YEARS. SO, YES, I WAS LOOKING AT -- THAT THAT WAS TRUE, AND EVERYTHING I WAS READING, THE TAKE AWAY WAS ACCURACY OF THE TESTS THAT WAS DONE.

MR. WADE: BUT YOU DON'T RECALL THE ACTUAL WORK THAT WAS DONE WITH PFIZER BY THE COMPANY?

LISA PETERSON: NO, NOT THE SPECIFIC TESTS THAT WERE RUN, NO.

MR. WADE: OKAY. WE'LL COME BACK TO THE PFIZER REPORT IN A MINUTE. LET ME START WITH YOUR EMPLOYER. YOU WORK FOR RDV; IS THAT RIGHT? RDV CORPORATION?

MR. WADE: AND WHAT DOES RDV STAND FOR?

LISA PETERSON: RICHARD DEVOS.

MR. WADE: AND HE'S THE FOUNDER OF AMWAY; IS THAT RIGHT?

LISA PETERSON: HE'S A COFOUNDER, THE PATRIARCH OF THE FAMILY THAT I WORK FOR, YES.

MR. WADE: AND JUST FOR THE BENEFIT OF THE JURY, BECAUSE SOME OF US MAY NOT UNDERSTAND WHAT AN ENTITY LIKE THAT IS, THAT'S SOMETIMES REFERRED TO AS A FAMILY OFFICE; IS THAT RIGHT?

MR. WADE: AND COULD YOU EXPLAIN TO US WHAT A FAMILY OFFICE IS, OR WHAT THIS FAMILY OFFICE IS? HOW'S THAT?

LISA PETERSON: THIS FAMILY OFFICE IS VERY MUCH A FAMILY -- THERE'S A FAMILY SERVICES PART OF THE OFFICE THAT DOES A LOT OF SERVICES DIRECTLY FOR THE FAMILY, LIKE MANAGING THEIR I.T. AND THEIR PHONES AND CUTTING THEIR CHECKS AND DOING ALL OF THE STUFF THAT YOU DO FOR A FAMILY, FOR A LARGE FAMILY LIKE THIS, HIRING THEIR STAFF. AND THEN THERE'S THE INVESTMENT SIDE, WHICH IS WHERE I WAS.

MR. WADE: OKAY. AND ABOUT HOW MANY PEOPLE ARE THERE ON THE INVESTMENT SIDE?

LISA PETERSON: ON THE INVESTMENT SIDE AT THE TIME?

MR. WADE: (NODS HEAD UP AND DOWN.)

LISA PETERSON: ABOUT 12 TO 15.

MR. WADE: ABOUT 12 TO 15. AND TO WHOM DID YOU REPORT AT THE TIME THE INVESTMENT?

LISA PETERSON: DIRECTLY TO RANDY DAMSTRA.

MR. WADE: TO RANDY DAMSTRA. AND WHAT WAS HIS TITLE?

LISA PETERSON: SENIOR MANAGING DIRECTOR OF PRIVATE EQUITY.

MR. WADE: AND TO WHOM DID MR. DAMSTRA REPORT?

LISA PETERSON: DIRECTLY TO JERRY TUBERGEN.

MR. WADE: AND TO WHOM DID MR. TUBERGEN REPORT?

LISA PETERSON: TO THE FAMILY.

MR. WADE: WHAT DOES THAT MEAN IN PRACTICE?

LISA PETERSON: THE FAMILY MEMBERS, AND IT ROTATED, MADE UP THE INVESTMENT COMMITTEE. SO JERRY REPORTED TO THE FAMILY DIRECTLY AND TO THE INVESTMENT COMMITTEE, AND THEY HAVE A BOARD, RDV HAS A BOARD OF DIRECTORS WHICH IS MADE UP OF FAMILY MEMBERS, AND JERRY REPORTED TO THEM.

MR. WADE: OKAY. SO -- AND AS PART OF THE INVESTMENT PORTFOLIO, IT'S THE JOB OF RDV PEOPLE TO MANAGE THE ASSETS OF THE DEVOS FAMILY? IS THAT A FAIR HIGH LEVEL SUMMARY?

MR. WADE: AND OBVIOUSLY TO TRY AND GET GAINS TO THE EXTENT POSSIBLE; RIGHT?

MR. WADE: AND HOW MANY -- YOU HAD TESTIFIED THAT I THINK YOU HAD BEEN THERE HOW MANY YEARS AGAIN? I'M SORRY.

LISA PETERSON: TODAY? GOING ON 17. I STARTED IN 2005.

MR. WADE: OKAY. SO FROM 2005 TO 2014, HOW MANY OTHER DIRECT INVESTMENTS IN PRIVATE COMPANIES DID YOU DO THAT WERE NOT AFFILIATED WITH PRIVATE EQUITY INVESTMENTS?

MR. WADE: NONE? THIS WAS THE FIRST ONE?

MR. WADE: AND THIS WAS SOMEWHAT UNIQUE?

MR. WADE: AND THIS WAS AN INVESTMENT THAT HAD TO BE APPROVED BEFORE IT COULD BE FUNDED; RIGHT?

MR. WADE: AND WHO, WHO HAD AUTHORITY -- DID YOU HAVE AUTHORITY TO APPROVE THE INVESTMENT?

MR. WADE: WHO HAD AUTHORITY TO MAKE THE INVESTMENT DECISION?

LISA PETERSON: THE MEMBERS OF THE INVESTMENT COMMITTEE.

MR. WADE: OKAY. SO THAT'S A -- MEMBERS OF THE DEVOS FAMILY?

MR. WADE: AND HOW FREQUENTLY DID YOU COMMUNICATE DIRECTLY WITH THE MEMBERS OF THE DEVOS FAMILY ABOUT THE THERANOS INVESTMENT?

LISA PETERSON: WE HAD A LOT OF CONVERSATION, I DID DIRECTLY WITH THE INVESTMENT -- THE TWO INVESTMENT COMMITTEE MEMBERS THAT WERE ON THE AIRPLANE ON THE RIDE TO THE DILIGENCE MEETING THAT WE HAD. AND THEN EVERYTHING FROM THERE WENT THROUGH JERRY TUBERGEN.

MR. WADE: OKAY. SO YOU TALKED TO -- I'M SORRY, WERE YOU DONE? I DIDN'T MEAN TO INTERRUPT.

MR. WADE: OKAY. YOU TALKED ON THE PLANE RIDE OUT TO THE COMPANY?

MR. WADE: AND IS THAT IT?

LISA PETERSON: DIRECTLY WITH THE FAMILY MEMBERS?

LISA PETERSON: THERE MIGHT HAVE BEEN ONE OR TWO EMAIL EXCHANGES WITH RICK DEVOS AND THAT WAS ABOUT IT.

MR. WADE: AND IS RICK DEVOS WHAT THEY CALL A GENERATION THREE FAMILY MEMBER? IS THAT RIGHT?

MR. WADE: SO THAT MEANS THAT HE'S --

LISA PETERSON: THE OLDEST OF THE GRANDCHILDREN OF THE PATRIARCH.

MR. WADE: SO THAT'S KIND OF TWO LEVELS DOWN FROM THE PATRIARCH; IS THAT RIGHT?

MR. WADE: AND HE WAS ON THE INVESTMENT COMMITTEE?

LISA PETERSON: AT THE TIME, YES.

MR. WADE: AND HE TOOK THE TRIP OUT TO THERANOS?

MR. WADE: OKAY. AND JUST SO WE HAVE A SENSE OF WHERE THE OTHER FOLKS FALL, WHERE IN THE GENERATIONS DO THE OTHER INVESTMENT COMMITTEE MEMBERS FALL?

LISA PETERSON: DOUG DEVOS WAS THE CHAIRMAN OF THE INVESTMENT COMMITTEE AT THE TIME AND HE'S ONE OF THE SONS OF THE PATRIARCH; AND THEN THERE'S CHERI DEVOS WHO WENT ON THE TRIP, AND SHE WAS NOT ON THE INVESTMENT COMMITTEE, BUT SHE'S A FAMILY MEMBER AND THEY OFTEN -- FAMILY MEMBERS KIND OF CAME IN AND OUT OF THE INVESTMENT COMMITTEE. SO IT WASN'T UNUSUAL FOR HER TO GO. AND THEN THE OTHER TWO MEMBERS OF THE INVESTMENT COMMITTEE FROM THE GENERATION TWO WAS DOUG DEVOS -- OR I'M SORRY -- DAN DEVOS AND I BELIEVE DICK DEVOS.

MR. WADE: OKAY. SO IS IT DAN DEVOS, DOUG DEVOS, AND DICK DEVOS REPRESENTED GENERATION TWO?

MR. WADE: AND RICK DEVOS REPRESENTED GENERATION ONE ON THE INVESTMENT COMMITTEE?

LISA PETERSON: GENERATION THREE.

MR. WADE: GENERATION THREE, I APOLOGIZE.

LISA PETERSON: AND THEN THERE WERE TWO OTHER GENERATION THREE MEMBERS ON THE INVESTMENT COMMITTEE AT THE TIME.

MR. WADE: AND MR. TUBERGEN REPORTS DIRECTLY TO THE INVESTMENT COMMITTEE AND TO THE DEVOS FAMILY; IS THAT RIGHT?

MR. WADE: OKAY. AND THE ENTITY THAT ACTUALLY INVESTED IN THIS COMPANY WAS CALLED DYNASTY FINANCIAL II LLC; CORRECT?

MR. WADE: AND DO YOU KNOW WHO OWNS THAT?

LISA PETERSON: I DON'T KNOW THE BENEFICIAL OWNERS OF THE ENTITY, NO.

MR. WADE: DO YOU KNOW -- WHAT DO YOU KNOW ABOUT THE ENTITY? DOES THE ENTITY HAVE A BOARD?

MR. WADE: IT DOESN'T?

LISA PETERSON: NO. WE USUALLY CREATE A NEW ENTITY FOR ALL OF OUR INVESTMENTS. THIS PARTICULAR ONE I KNOW HAD MULTIPLE ASSETS IN IT, BUT I'M NOT PRIVY TO ALL OF THE OWNERS OF THAT ENTITY.

MR. WADE: OKAY. THE INVESTMENT IN TOTAL WAS $100 MILLION; IS THAT RIGHT?

LISA PETERSON: 99 SOMETHING RATHER, YES.

MR. WADE: OKAY. AND THERE ARE DOCUMENTS WITHIN THE RDV THAT SUGGEST 80 MILLION OF THAT IS ATTRIBUTED TO RDV. ARE YOU FAMILIAR WITH THAT?

MR. WADE: DO YOU KNOW -- DO YOU KNOW WHETHER THERE WAS ANOTHER ENTITY THAT HELD 20 MILLION?

LISA PETERSON: THE ONLY OTHER INDIVIDUALS OUTSIDE OF THE FAMILY THAT WOULD HAVE BEEN INVESTING AT THAT POINT IN TIME WAS THE EXECUTIVE STAFF.

MR. WADE: SO SENIOR LEADERSHIP COULD CHOOSE TO PARTICIPATE IN THAT, TOO?

MR. WADE: AND YOU DON'T KNOW WHETHER THEY DID OR NOT?

MR. WADE: OKAY. THERE ARE DOCUMENTS THAT REFER TO WINDQUEST.

MR. WADE: AND WHAT IS WINDQUEST?

LISA PETERSON: WINDQUEST IS DICK AND BETSY'S FAMILY OFFICE. IT'S THE NAME OF THEIR FAMILY OFFICE. SO THERE ARE THE C-2 GENERATION, THE FOUR SIBLINGS EACH HAVE THEIR OWN OUTSIDE INTERESTS OUTSIDE OF RDV CORPORATION, IN WHICH THEY HAVE -- SOME OF THEM HAVE FAMILY OFFICES, NAMES OF THEIR FAMILY OFFICES, AND THAT WOULD BE ONE OF THEM.

MR. WADE: DID YOU SAY THERE WERE FOUR GENERATION TWO DEVOS MEMBERS?

MR. WADE: AND THEY HAVE INDIVIDUAL FAMILY OFFICES IN ADDITION TO THE RDV FAMILY OFFICE?

MR. WADE: AND DO YOU KNOW WHETHER WINDQUEST INVESTED IN THE THERANOS TRANSACTION?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. DOUG DEVOS WHO, YOU MENTIONED, HE'S ALSO THE CEO OF AMWAY; IS THAT RIGHT?

LISA PETERSON: HE WAS. HE'S NO LONGER.

MR. WADE: OKAY. CAN I DRAW YOUR ATTENTION TO 2170 IN YOUR BINDER.

COURT CLERK: 2107?

MR. WADE: NO. IT'S A NEW EXHIBIT.

BY MR. WADE:

MR. WADE: LET ME KNOW WHEN YOU HAVE THAT IN FRONT OF YOU.

MR. WADE: DO YOU RECOGNIZE THAT TO BE AN EMAIL RELATING TO THE CLOSING OF THE THERANOS INVESTMENT THAT YOU'RE ON?

LISA PETERSON: I'M SORRY, SAY THE QUESTION AGAIN.

MR. WADE: DO YOU RECOGNIZE THAT THIS IS AN EMAIL THAT RELATES TO THE CLOSING OF THE THERANOS INVESTMENT?

MR. WADE: AND DO YOU SEE YOUR NAME IS ON THE EMAIL?

MR. WADE: OKAY. MOVE THE ADMISSION OF 2170.

MR. LEACH: NO OBJECTION.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 2170 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: AND WE CAN JUST LOOK AT THE TOP. DO YOU SEE THAT THIS INDICATES THAT THE INVESTMENT, THE SIGNED INVESTMENT DOCUMENTATION WAS SENT BY MR. TUBERGEN TO MR. BALWANI ON 10-31-2014? DO YOU SEE THAT?

MR. WADE: AND IF WE GO TO THE SECOND PAGE, THIS IS THE, THIS IS THE EXECUTED MASTER SIGNATURE PAGE?

MR. WADE: AND ON YOUR DIRECT TESTIMONY, MR. LEACH SHOWED YOU SOME ELECTRONIC FILES WITH ALL OF THE PAPERWORK FOR THE INVESTMENT. DO YOU RECALL THAT?

MR. WADE: AND THIS IS THE EXECUTED VERSION OF IT; CORRECT?

LISA PETERSON: IT'S THE SIGNATURE PAGE FOR THOSE DOCUMENTS, YES.

MR. WADE: OKAY. AND WHO IS THE PERSON WHO IS SIGNING HERE? WHO IS THAT PERSON?

LISA PETERSON: ROBERT SCHIERBEEK.

MR. WADE: AND WHO IS HE?

LISA PETERSON: HE RUNS THE FAMILY SIDE OF THE OFFICE, AND HE WAS THE COO OF RDV CORPORATION WHICH OWNED DYNASTY FINANCIAL, AND HE'S THE SIGNOR FOR THE ENTITY.

MR. WADE: OKAY. SO IS THAT THE NUMBER 2 -- IS HE THE NUMBER 2 PERSON WITHIN THE FAMILY OFFICE?

LISA PETERSON: MR. SCHIERBEEK AND -- MR. DAMSTRA WOULD BE ON THE INVESTMENT SIDE, AND MR. SCHIERBEEK WAS RUNNING THE FAMILY SERVICES SIDE.

LISA PETERSON: THE FAMILY SIDE CONTROLS THE BANK, THE MONEY, AND THAT'S WHY HE'S THE SIGNER.

MR. WADE: OKAY. SO ONCE THERE'S, THERE'S APPROVAL OF THE INVESTMENT, THEN MR. -- IS IT SCHIERBEEK?

LISA PETERSON: SCHIERBEEK.

MR. WADE: -- SCHIERBEEK HAS THE AUTHORITY TO DISBURSE THE FUNDS TO FUND THE INVESTMENT?

MR. WADE: OKAY. LET ME BACK UP TO THE START OF THE RELATIONSHIP WITH THERANOS. IS IT YOUR UNDERSTANDING THAT MR. DAN MOSLEY INTRODUCED RDV TO THE THERANOS INVESTMENT?

LISA PETERSON: THAT'S MY UNDERSTANDING, YES.

MR. WADE: AND MR. MOSLEY WAS A PARTNER AT THE LAW FIRM OF CRAVATH, SWAINE & MOORE IN NEW YORK CITY?

MR. WADE: AND HE HAD PREVIOUSLY DONE SOME WORK FOR THE DEVOS FAMILY?

MR. WADE: AND CRAVATH IS ONE OF THE MOST REPUTABLE CORPORATE LAW FIRMS IN THE WORLD; CORRECT?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. DO YOU KNOW IT TO BE A HIGHLY REPUTABLE CORPORATE LAW FIRM?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. DO YOU KNOW THAT MR. MOSLEY ALSO HAD CLOSE TIES WITH BDT CAPITAL?

LISA PETERSON: NOT AT THE TIME, NO.

MR. WADE: BUT YOU KNOW THAT NOW?

MR. WADE: OKAY. HE NOW WORKS AT BDT CAPITAL; RIGHT?

LISA PETERSON: YES, I KNOW THAT.

MR. WADE: AND THE MEETING THAT WAS SCHEDULED -- THAT YOU TESTIFIED TO ON DIRECT WHERE MR. TUBERGEN AND MS. HOLMES MET INITIALLY, THAT WAS AT THE BDT CAPITAL CONFERENCE; CORRECT?

MR. WADE: OKAY. AND THAT'S A MEETING IN CHICAGO; RIGHT?

MR. WADE: AND THAT'S HOSTED BY THAT INVESTMENT FIRM; CORRECT?

MR. WADE: AND BDT CAPITAL IS A FIRM THAT WAS FOUNDED BY MR. BYRON TROTT?

MR. WADE: AND MR. TROTT IS A FORMER SENIOR BANKER AT GOLDMAN SACHS; CORRECT?

MR. WADE: AND HE STARTED THIS FIRM FOCUSSING ON A NICHE RELATED TO PRIVATE FAMILY INVESTMENT; IS THAT RIGHT?

MR. WADE: AND IS IT FAIR TO SAY, IF YOU KNOW, THAT MR. TROTT IS REPUTED TO BE ONE OF THE WISEST INVESTMENT BANKERS AROUND IN THIS SPACE?

MR. WADE: AND, IN FACT, THE DEVOS FAMILY INVESTS MONEY NOW WITH MR. TROTT; CORRECT?

LISA PETERSON: WE DID IN THEIR FUND 2, AND WE DID NOT IN THEIR FUND 3.

MR. WADE: OKAY. AND MR. TUBERGEN WAS IN CHICAGO TO ATTEND THE CONFERENCE THAT BDT HOSTS EVERY YEAR; RIGHT?

MR. WADE: AND HE WAS ACTUALLY THERE TO SPEAK AT THE CONFERENCE; RIGHT?

LISA PETERSON: MR. TUBERGEN?

LISA PETERSON: NOT MY RECOLLECTION.

MR. WADE: DO YOU RECALL THAT MR. TUBERGEN SPOKE AT THE CONFERENCE AND GAVE A PRESENTATION ON HOW TO HAVE INVESTMENT SUCCESS?

LISA PETERSON: I WAS NOT TOLD THAT. I DON'T KNOW.

MR. WADE: LET'S TAKE A LOOK AT 1938 TO SEE IF THAT REFRESHES YOUR RECOLLECTION.

COURT CLERK: WHAT EXHIBIT NUMBER, COUNSEL?

COURT CLERK: THANK YOU.

BY MR. WADE:

MR. WADE: DO YOU RECOGNIZE THAT TO BE AN AGENDA FOR THAT BDT CAPITAL CONFERENCE?

LISA PETERSON: NO. I WAS NOT THERE. I WAS AT A DIFFERENT MEETING. WE ONLY FLEW HOME TOGETHER.

MR. WADE: RIGHT. DO YOU RECOGNIZE THAT IT IS CAPTIONED AS A --

LISA PETERSON: I'VE NEVER SEEN THIS BEFORE.

MR. WADE: OKAY. TAKE A LOOK AT THE FOURTH PAGE -- OR, I'M SORRY, THE LAST PAGE, THE EIGHTH PAGE IN THE DOCUMENT.

LISA PETERSON: THE EIGHTH PAGE?

MR. WADE: THE LAST PAGE IN THE DOCUMENT.

MR. WADE: DO YOU SEE THAT?

MR. WADE: DOES THAT REFRESH YOUR RECOLLECTION THAT MR. TUBERGEN SPOKE ON A PANEL WHERE HE PROVIDED EXPERT ADVICE ON INVESTMENT SUCCESS?

LISA PETERSON: I DID NOT KNOW THAT.

MR. WADE: DID YOU CONSIDER HIM TO BE AN EXPERT ON INVESTMENTS, MR. TUBERGEN?

MR. WADE: WERE YOU AWARE THAT -- WERE YOU GIVEN A BRIEFING OF EVERYTHING THAT HAPPENED AT THE BDT CONFERENCE BY MR. TUBERGEN?

LISA PETERSON: AT THE CONFERENCE, NO.

MR. WADE: WERE YOU GIVEN A DEBRIEFING ON ALL OF HIS INTERACTIONS WITH DAN MOSLEY?

MR. WADE: WERE YOU GIVEN A BRIEFING ON ALL OF HIS INTERACTIONS WITH BYRON TROTT?

MR. WADE: AND WERE YOU GIVEN A DEBRIEFING ON ALL OF HIS INTERACTIONS WITH THE WALTON FAMILY?

MR. WADE: AND DO YOU KNOW WHO THE WALTON FAMILY IS?

MR. WADE: AND THAT'S THE WAL-MART HEIRS?

MR. WADE: AND YOU UNDERSTOOD THAT THEY LATER INVESTED IN THERANOS?

LISA PETERSON: YES, I KNOW THAT.

MR. WADE: AND WERE YOU AWARE THAT THEY ATTENDED THE BDT CONFERENCE?

MR. WADE: WERE YOU AWARE THAT THEY WERE CLIENTS OF DAN MOSLEY?

LISA PETERSON: NO. AND AT THE TIME WE WEREN'T AWARE THAT THEY WERE AN INVESTOR.

MR. WADE: OKAY. WE'LL GET TO THAT. BUT COMING OUT OF THIS CONFERENCE, YOU DIDN'T GET A DEBRIEFING FROM MR. TUBERGEN ABOUT THE INTERACTIONS THAT HE HAD WITH RESPECT TO THOSE INDIVIDUALS?

MR. WADE: AND DID YOU GET A DEBRIEFING WITH RESPECT TO ALL OF THE INTERACTIONS AND DISCUSSIONS THAT HE MAY HAVE HAD WITH -- ABOUT THERANOS?

LISA PETERSON: WE TALKED ABOUT THERANOS. WE TALKED A LOT ABOUT THE, THE MEETING THAT JERRY HAD DIRECTLY WITH CHRISTIAN AND ELIZABETH HOLMES.

MR. WADE: ALL RIGHT. SO YOU TALKED ABOUT THE MEETING, AND I'LL ASK YOU SOME QUESTIONS ABOUT THAT IN A SECOND.

MR. WADE: DID YOU TALK -- DID YOU TALK AT ALL WITH MR. TUBERGEN ABOUT ANY OTHER INTERACTIONS THAT HE HAD AT THE BDT CAPITAL CONFERENCE WITH RESPECT TO THERANOS?

MR. WADE: OKAY. ARE YOU AWARE THAT, ARE YOU AWARE THAT MS. HOLMES SPOKE ON A PANEL AT THE BDT CONFERENCE?

MR. WADE: OKAY. ARE YOU AWARE THAT MS. HOLMES HOSTED A DINNER WITH TOBY COSGROVE FROM THE CLEVELAND CLINIC AT THE BDT CONFERENCE?

MR. WADE: AND YOU DIDN'T HAVE ANY DISCUSSIONS WITH MR. TUBERGEN ABOUT ANY OF THOSE KINDS OF TOPICS?

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: NOW, YOU TALKED ABOUT THE MEETING THAT MR. TUBERGEN HAD WITH ELIZABETH HOLMES, CHRISTIAN HOLMES, AND DAN MOSLEY. DO YOU RECALL THAT?

MR. WADE: AND THAT HAPPENED AT THAT CONFERENCE; CORRECT?

MR. WADE: AND THAT WAS A MEETING THAT WAS BROKERED BY MR. MOSLEY; CORRECT?

LISA PETERSON: THAT'S MY UNDERSTANDING.

MR. WADE: AND, AGAIN, YOU DON'T KNOW WHAT INFORMATION MR. MOSLEY IMPARTED TO MR. TUBERGEN IN ADVANCE OF THAT MEETING; CORRECT?

LISA PETERSON: NO. ONLY THAT HE WAS EXCITED ABOUT THE OPPORTUNITY.

MR. WADE: OKAY. AND ARE YOU AWARE IF MR. MOSLEY PROVIDED MR. TUBERGEN WITH ANY MATERIALS IN ADVANCE OF THAT MEETING?

MR. WADE: TAKE A LOOK AT 12571.

MR. WADE: 12571.

MR. WADE: YES, YOUR HONOR, 12751. MY APOLOGIES.

BY MR. WADE:

MR. WADE: AND DO YOU SEE THIS IS AN EMAIL ON SEPTEMBER 17TH, 2014 FROM DAN MOSLEY TO JERRY TUBERGEN?

LISA PETERSON: YES, I SEE THAT.

MR. WADE: ATTACHING THE "FORTUNE" ARTICLE THAT YOU LOOKED AT EARLIER; CORRECT?

MR. WADE: OKAY. AND DO YOU RECALL THAT WHEN YOU WERE RIDING BACK TO MICHIGAN FROM CHICAGO THAT MR. MOSLEY PULLED UP ON HIS COMPUTER THE ARTICLE AND SHOWED IT TO YOU?

LISA PETERSON: NO. NO, I DON'T RECALL THAT.

MR. WADE: DO YOU RECALL MAKING PRIOR STATEMENTS IN CONNECTION WITH PROCEEDINGS AND RELATING TO THERANOS THAT THAT'S WHAT HAPPENED?

LISA PETERSON: I THINK HE HAD IT IN -- ON PAPER.

MR. WADE: OKAY. DID -- IS THIS THE VERSION THAT HE SHOWED YOU?

MR. WADE: OKAY. MOVE THE ADMISSION OF 12751.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 12751 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: OKAY. YOU SEE 12751 AND YOU SEE THE ATTACHMENT THAT'S SEPTEMBER 17TH, 2014? DO YOU SEE THAT?

MR. WADE: AND THAT'S THE DATE OF THE MEETING THAT HAPPENED WITH MS. HOLMES; CORRECT?

MR. WADE: AND YOU WROTE BACK THE NEXT DAY AFTER THAT MEETING ON THE 18TH; CORRECT?

MR. WADE: OKAY. AND I THINK -- DO YOU SEE THERE THAT THE ATTACHMENT SAYS THERANOS.PDF? DO YOU SEE THAT?

MR. WADE: AND DO YOU RECOGNIZE THAT AS THE SAME FILE NAME AS THE ATTACHMENT OF THE DOCUMENT THAT MR. LEACH SHOWED YOU PREVIOUSLY WHERE MR. TUBERGEN SENT THE DOCUMENT TO THE DEVOS FAMILY?

LISA PETERSON: I'M SORRY, WHAT IS THE QUESTION? IS THIS THE SAME ONE THAT MR. LEACH SHOWED ME? YES.

MR. WADE: ALL RIGHT. WE'LL TAKE THEM ONE AT A TIME TO MAKE SURE THE RECORD IS CLEAR.

MR. WADE: YOU SEE IT'S THERANOS.PDF SENT 9-17-2014?

MR. WADE: AND THAT'S FROM DAN MOSLEY TO JERRY TUBERGEN; CORRECT?

MR. WADE: YOUR BOSS'S BOSS?

MR. WADE: LET'S PULL UP 1944.

COURT CLERK: IS THAT IN EVIDENCE, COUNSEL?

MR. WADE: WHICH IS IN EVIDENCE.

MR. WADE: AND DO YOU SEE THE ATTACHMENT THERE IS THERANOS.PDF? DO YOU SEE THAT?

MR. WADE: AND THAT'S THE SAME, THAT'S THE SAME "FORTUNE" ARTICLE THAT MR. TUBERGEN HAD SENT ON TO MEMBERS OF THE DEVOS FAMILY? DO YOU SEE THAT?

MR. WADE: AND THOSE COMMUNICATIONS HAPPENED THE DAY AFTER THE MEETING THAT MS. HOLMES HAD WITH MR. TUBERGEN; CORRECT?

MR. WADE: OKAY. AND DO YOU SEE IN THIS DOCUMENT, IF YOU LOOK ON THE THIRD LINE, IT SAYS, "I'D LIKE TO SEE IF WE CAN FIND 15 MINUTES TOMORROW TO SHARE WITH YOU AND DISCUSS A VERY UNIQUE INVESTMENT OPPORTUNITY WE MAY HAVE WITH HER COMPANY." DO YOU SEE THAT?

MR. WADE: AND DO YOU KNOW WHETHER THAT MEETING HAPPENED?

LISA PETERSON: I DON'T KNOW.

MR. WADE: DO YOU KNOW WHETHER A CALL HAPPENED? WHETHER A CALL HAPPENED?

LISA PETERSON: NO, I DON'T KNOW SPECIFICALLY. I WAS NOT ON IT.

MR. WADE: OKAY. DO YOU KNOW WHETHER -- DO YOU KNOW WHETHER, AROUND THIS TIME, MR. TUBERGEN WAS HAVING ANY COMMUNICATIONS WITH THE MEMBERS OF THE DEVOS FAMILY?

LISA PETERSON: YES, HE WAS.

MR. WADE: HE WAS.

MR. WADE: BUT YOU DON'T KNOW WHAT THE SUBSTANCE WAS?

MR. WADE: YOU WEREN'T INVOLVED IN THOSE COMMUNICATIONS?

LISA PETERSON: I WASN'T INVOLVED IN THE COMMUNICATIONS, BUT I WAS ASKED TO WORK ON IT, SO I KNOW THERE WAS COMMUNICATION GOING ON.

MR. WADE: AND YOU SAY -- AND YOU WANTED TO WORK ON IT; CORRECT?

MR. WADE: AND YOU HAD A CONVERSATION ON THE PLANE ON THE 18TH WITH MR. TUBERGEN AND MR. DAMSTRA; CORRECT?

MR. WADE: AND THEN ABOUT 12 DAYS WENT BY AND YOU HADN'T HEARD ANYTHING, SO YOU ACTUALLY FOLLOWED UP WITH MR. DAMSTRA AND SAID, IF THERE'S AN OPPORTUNITY, I'D LIKE TO, I'D LIKE TO WORK ON THIS. DO YOU RECALL THAT?

LISA PETERSON: I WAS ENTHUSED FROM THE VERY BEGINNING, AND I'M NOT ON THE BDT RELATIONSHIP, SO I THOUGHT THAT THIS MIGHT GO TO THE PERSON THAT WAS IN CHARGE OF BDT.

MR. WADE: OKAY. SO UNDER MR. DAMSTRA THERE'S A PERSON KIND OF AT YOUR LEVEL, IF YOU WILL?

MR. WADE: I MEAN NO OFFENSE WHEN I SAY THAT, BUT A SIMILAR POSITION WITHIN THE FAMILY OFFICE?

MR. WADE: AND THEY WERE RESPONSIBLE FOR BDT?

MR. WADE: AND COMING OUT OF THIS, COMING OUT OF THIS MEETING, BETWEEN THE TIME THAT YOU HAD THOSE INTERACTIONS WITH MR. TUBERGEN AND THE TIME THAT YOU GOT ON THE PLANE TO GO TO CALIFORNIA, YOU DIDN'T HAVE ANY INTERACTIONS WITH THE DEVOS FAMILY MEMBERS ABOUT THIS?

LISA PETERSON: OTHER THAN SHARING MY MEMOS, NO.

MR. WADE: WELL, YOU DON'T ACTUALLY KNOW WHETHER THEY GOT YOUR MEMOS, DO YOU?

LISA PETERSON: YES, BECAUSE WE TALKED ABOUT IT ON THE PLANE.

MR. WADE: DO YOU RECALL --

LISA PETERSON: WE WENT THROUGH THE MEMO ON THE PLANE.

MR. WADE: OKAY. DO YOU RECALL GIVING TESTIMONY IN THIS CASE IN CONNECTION WITH THERANOS MATTERS PREVIOUSLY?

MR. WADE: OKAY. DO YOU RECALL YOU WERE DEPOSED? DO YOU REMEMBER THAT?

MR. WADE: IN MICHIGAN?

MR. WADE: DO YOU RECALL THAT? AND THERE WAS A COURT REPORTER LIKE OUR COURT REPORTER HERE TAKING DOWN EVERYTHING THAT YOU SAID? DO YOU RECALL THAT?

MR. WADE: OKAY. AND YOU WERE UNDER OATH; RIGHT?

MR. WADE: AND YOU TOLD THE TRUTH IN THAT TESTIMONY, DID YOU NOT?

LISA PETERSON: IF YOU CAN SHOW ME WHAT YOU'RE REFERRING TO, MAYBE IT WILL REFRESH MY MEMORY.

MR. WADE: MY QUESTION IS JUST WHETHER YOU TOLD THE TRUTH.

MR. WADE: AND DID YOU TESTIFY IN THAT DEPOSITION THAT YOU DON'T KNOW WHETHER THE DEVOS FAMILY MEMBERS REVIEWED ANY OF YOUR MEMOS?

LISA PETERSON: I KNOW THAT WE TALKED ABOUT ALL OF THE WORK THAT I HAD DONE ON THE AIRPLANE ON THE WAY HERE, SO YES.

LISA PETERSON: I DON'T KNOW IF THEY HAD ACTUALLY PHYSICALLY PUT THEIR EYES ON THE MEMO, BUT WE DEFINITELY TALKED ABOUT THE SUBSTANCE OF MY MEMO ON THE PLANE.

MR. WADE: OKAY. OKAY. I JUST WANT TO MAKE SURE OUR RECORD IS CLEAR. YOU DON'T KNOW WHETHER THEY READ YOUR MEMO; CORRECT?

MR. WADE: BUT YOU DID HAVE DISCUSSIONS WITH THEM ON THE PLANE RIDE ON THE WAY?

LISA PETERSON: YES, LOTS OF THEM.

MR. WADE: OKAY. DO YOU HAVE NOTES OF THOSE CONVERSATIONS?

MR. WADE: OKAY. THE NEXT INTERACTION THAT YOU HAD WITH THERANOS -- WELL, LET ME STEP BACK. LET ME ASK YOU ANOTHER QUESTION ABOUT MR. MOSLEY. ARE YOU AWARE THAT -- I WANT TO SHOW YOU A DOCUMENT. IF YOU LOOK AT 4197.

MR. WADE: AND THIS IS A DOCUMENT THAT YOU'VE SEEN BEFORE; CORRECT?

LISA PETERSON: I DON'T RECALL. DEFINITELY NOT PRIOR TO OUR MAKING THE INVESTMENT.

MR. WADE: OKAY. DO YOU RECALL -- LET'S TAKE IT ONE PIECE AT A TIME. DO YOU RECALL WHETHER YOU'VE SEEN THIS DOCUMENT BEFORE?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. LET'S LOOK AT 10587. ACTUALLY, BEFORE I DO THAT, LET ME JUST ASK A QUESTION ABOUT DO YOU KNOW WHETHER -- LET'S GO TO 10587.

MR. WADE: DO YOU SEE THAT THIS IS AN EMAIL THAT WAS SENT TO YOU BY HUGH FREUND IN 2017? I'M LOOKING AT THE COVER EMAIL RIGHT NOW.

MR. WADE: OKAY. AND DO YOU SEE THAT HE ATTACHES THE DOCUMENT THAT I WAS REFERRING TO AS EXHIBIT 4197?

LISA PETERSON: OKAY, YES.

MR. WADE: OKAY. MOVE THE ADMISSION OF -- AND THIS IS AN INVESTMENT ANALYSIS THAT MR. MOSLEY DID IN CONNECTION WITH THERANOS; CORRECT?

MR. WADE: OKAY. MOVE THE ADMISSION OF 10587.

MR. LEACH: HEARSAY ON 10587, YOUR HONOR. I HAVE NO OBJECTION TO THE PRIOR EXHIBIT THAT WE WERE LOOKING AT.

JUDGE DAVILA: WILL THAT WORK FOR YOU, MR. WADE?

MR. WADE: WHY DON'T WE TRY IT?

MR. WADE: IF THE GOVERNMENT IS OKAY WITH ME ASKING QUESTIONS OF 4197, MAYBE I'LL JUST ASK THE QUESTION.

MR. WADE: I MOVE THE ADMISSION OF 4197.

MR. LEACH: NO OBJECTION.

JUDGE DAVILA: THAT'S ADMITTED, AND IT MAY BE PUBLISHED.

(GOVERNMENT'S EXHIBIT 4197 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: OKAY. DO YOU SEE HERE THIS IS A DAY -- THIS IS A DAY -- OR A DOCUMENT FROM MR. MOSLEY. DO YOU SEE THAT?

MR. WADE: AND THIS ONE IS ADDRESSED TO DR. KISSINGER?

MR. WADE: DO YOU RECOGNIZE THAT TO BE HENRY KISSINGER?

MR. WADE: OKAY. AND ATTACHED TO THIS, IF YOU GO TO THE SECOND PAGE, AND IT'S SEPTEMBER 2ND -- I'M SORRY. IT'S SEPTEMBER 2ND, 2014; RIGHT?

LISA PETERSON: BUT I DIDN'T SEE THIS UNTIL THREE YEARS LATER.

MR. WADE: THAT'S NOT MY QUESTION, BUT WE'LL GET TO THAT.

LISA PETERSON: OKAY. OKAY.

MR. WADE: YOU SEE THAT IT'S DATED SEPTEMBER 2ND, 2014?

MR. WADE: OKAY. AND THAT IS A COUPLE OF WEEKS BEFORE THE MEETING THAT MR. MOSLEY AND MR. TUBERGEN AND MS. HOLMES HAD IN CHICAGO AT THE BDT CONFERENCE; CORRECT?

MR. WADE: OKAY. LET'S GO TO THE SECOND PAGE. AND IF YOU LOOK, AND I WON'T GO THROUGH THE DETAILS OF IT NOW, BUT IF WE JUST SCROLL THROUGH THE PAGES, THERE'S A PRETTY DETAILED ANALYSIS THAT MR. MOSLEY HAD DONE WITH RESPECT TO THERANOS; CORRECT?

LISA PETERSON: IT APPEARS THAT WAY, YES.

MR. WADE: OKAY. OKAY. AND DO YOU KNOW WHETHER THIS DOCUMENT WAS COMMUNICATED TO MR. TUBERGEN BEFORE HIS MEETING WITH MS. HOLMES?

LISA PETERSON: NOT TO MY KNOWLEDGE.

MR. WADE: OKAY. BUT YOU DON'T KNOW; CORRECT?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. AND DO YOU KNOW WHETHER THE SUBSTANCE OF THIS ANALYSIS WAS COMMUNICATED ORALLY BY MR. MOSLEY TO MR. TUBERGEN IN PART OR IN WHOLE?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. THIS DOCUMENT, DO YOU RECALL THAT THIS DOCUMENT WAS LATER COMMUNICATED TO YOU IN YOUR GMAIL ACCOUNT?

MR. WADE: AND DO YOU ORDINARILY USE YOUR GMAIL ACCOUNT FOR BUSINESS MATTERS?

LISA PETERSON: NOT REGULARLY, NO.

MR. WADE: OKAY. AND DO YOU RECALL THEN THAT YOU FORWARDED THIS DOCUMENT FROM YOUR GMAIL ACCOUNT TO A GMAIL ACCOUNT AND A HOME ACCOUNT RELATING TO MR. TUBERGEN?

MR. WADE: OKAY. DO YOU NORMALLY COMMUNICATE WITH MR. TUBERGEN ABOUT MATTERS WITH WORK EMAIL?

LISA PETERSON: I NORMALLY COMMUNICATE WITH MR. TUBERGEN WITH MY WORK EMAIL, YES.

MR. WADE: YOU DO?

MR. WADE: SO NORMALLY YOU SEND IT FROM YOUR WORK EMAIL TO HIS WORK EMAIL; RIGHT?

MR. WADE: OKAY. AND WERE -- IS THE FACT THAT IT WAS BEING COMMUNICATED BY GMAIL SOME INDICATION THAT YOU WERE TRYING TO HIDE THE DOCUMENT?

LISA PETERSON: EVERYTHING AROUND THIS, WE WERE TRYING TO UNDERSTAND MR. MOSLEY'S ROLE IN THE THERANOS INVESTMENT, AND WE COULDN'T FIGURE IT OUT, AND WE HAD NOT SEEN THIS. AND ONE OF THE OTHER -- ONCE WE UNDERSTOOD WHO THE OTHER INVESTORS WERE, ONE OF THE OTHER INVESTORS GAVE US THIS.

LISA PETERSON: AND UNTIL WE UNDERSTOOD WHAT HIS ROLE WAS IN ALL OF THIS.

MR. WADE: NO, I UNDERSTAND THAT. FAIR ENOUGH.

MR. WADE: YOU WERE DOING SOME WORK TO FIGURE OUT -- THIS IS YEARS LATER; RIGHT?

MR. WADE: AND YOU WERE DOING SOME WORK TO FIGURE OUT WHAT MR. MOSLEY'S ROLE IN THE INVESTMENTS WAS; RIGHT?

LISA PETERSON: CORRECT, AND WHETHER HE WAS COMPENSATED.

MR. WADE: AND HE HAD ACTUALLY -- PRIOR TO THE INVESTMENT, HE HAD DONE LEGAL WORK FOR THE DEVOS FAMILY; CORRECT?

MR. WADE: OKAY. MY QUESTION IS, AS YOU'RE TRYING TO FIGURE THIS OUT, IS THERE A REASON THAT THESE DOCUMENTS ARE BEING COMMUNICATED IN GMAIL AS OPPOSED TO WORK EMAIL?

LISA PETERSON: BECAUSE AT THIS TIME THERE WAS ALL KINDS OF ISSUES GOING ON AROUND THE COMPANY, AND WE DIDN'T KNOW WHETHER MR. MOSLEY -- WHAT HIS ROLE WAS IN ALL OF THIS AND, FRANKLY, WE DID NOT WANT TO GET HIM IN TROUBLE.

MR. WADE: OKAY. SO YOU WANTED TO KEEP IT UNDER YOUR HAT?

MR. WADE: SO YOU KIND OF HID THE DOCUMENT? IS THAT FAIR?

LISA PETERSON: SOMEWHAT, YES.

MR. WADE: DO YOU KNOW -- YOU TESTIFIED THAT MR. MOSLEY WORKED AT THE LAW FIRM OF CRAVATH, SWAINE & MOORE. DO YOU RECALL THAT?

MR. WADE: AND DO YOU RECALL THAT LEARNING, DURING YOUR WORK RELATING TO THERANOS, THAT HE USED -- THAT THERANOS HAD A LAWYER BY THE NAME OF MR. DAVID BOIES?

LISA PETERSON: YES, I KNEW THAT.

MR. WADE: AND WERE YOU AWARE THAT MR. DAVID BOIES USED TO BE LAW PARTNERS WITH MR. MOSLEY AT CRAVATH, SWAINE & MOORE?

MR. WADE: WERE YOU AWARE AT ANY TIME THAT MR. MOSLEY WAS DOING DUE DILIGENCE AND OBTAINING INFORMATION FROM DAVID BOIES IN CONNECTION WITH THERANOS?

MR. LEACH: FOUNDATION. RELEVANCE.

JUDGE DAVILA: I'LL ALLOW IT. YOU CAN --

BY MR. WADE:

MR. WADE: ARE YOU -- DO YOU KNOW WHETHER MR. TUBERGEN LEARNED OF ANY OF THOSE FACTS IN CONNECTION WITH THE INVESTMENT?

LISA PETERSON: NOT TO MY KNOWLEDGE.

MR. WADE: OKAY. MR. TUBERGEN CAME OUT OF THE MEETING WITH MS. HOLMES VERY EXCITED ABOUT THE POTENTIAL INVESTMENT; CORRECT?

MR. WADE: HE -- THIS WAS BEFORE -- THIS WAS BASED ON THE INITIAL INTERACTION; RIGHT?

MR. WADE: AND WHATEVER OTHER INTERACTIONS HE HAD IN ADVANCE OF THAT; CORRECT?

LISA PETERSON: I DON'T KNOW WHAT OTHER INTERACTIONS HE HAD, BUT HE WAS VERY EXCITED ABOUT THE MEETING THAT HE HAD WITH CHRISTIAN AND ELIZABETH.

MR. WADE: RIGHT. AND HE CAME, HE CAME BACK HIGHLY INTERESTED IN DOING THE INVESTMENT; CORRECT?

LISA PETERSON: HE CAME BACK HIGHLY INTERESTED AND LOOKING AT THE OPPORTUNITY AND TAKING IT TO THE FAMILY.

MR. WADE: AND DO YOU RECALL THAT HE REALLY WANTED TO MAKE IT HAPPEN? DO YOU RECALL THAT?

LISA PETERSON: I DON'T SEE HIS BEHAVIOR ANY DIFFERENT THAN NORMAL. HE WAS, HE WAS EXCITED ABOUT AN OPPORTUNITY THAT WE HAD A CHANCE TO LOOK AT, AND WE LOOKED AT IT, AND IT WENT THROUGH THE PROPER PROCESS OF GOING THROUGH THE INVESTMENT COMMITTEE.

MR. WADE: DO YOU RECALL, DO YOU RECALL WHAT DROVE THE INVESTMENT WAS MR. TUBERGEN'S BELIEF THAT THERANOS WAS A UNICORN?

LISA PETERSON: I DON'T RECALL THAT.

MR. WADE: OKAY. DO YOU KNOW WHAT A UNICORN IS?

LISA PETERSON: CAN YOU EXPLAIN IT?

MR. WADE: I'M ASKING YOU. YOU'RE THE INVESTMENT PROFESSIONAL. I'M WONDERING IF YOU KNOW WHAT A UNICORN IS.

LISA PETERSON: (LAUGHTER.) IT'S NOT SOMETHING THAT WE NORMALLY INVEST WITH. HIGH GROWTH INVESTMENTS LIKE THAT, WE DON'T AT ALL INVEST WITH THOSE.

MR. WADE: AND WHEN YOU SAY "HIGH GROWTH INVESTMENTS," UNICORNS ARE USUALLY INVESTMENTS THAT CAN REALLY POP; CORRECT?

LISA PETERSON: THAT'S YOUR DEFINITION, YES. THAT'S YOUR DEFINITION, OKAY?

MR. WADE: WHAT IS YOUR DEFINITION?

LISA PETERSON: I DON'T DEAL IN INVESTING IN UNICORNS, SO --

MR. WADE: OKAY. AND YOU DON'T RECALL THAT WHAT DROVE THE INVESTMENT IN THE CASE OF THERANOS WAS MR. TUBERGEN'S BELIEF THAT THERANOS WAS A UNICORN?

LISA PETERSON: I DON'T BELIEVE THAT WAS THE CASE. WE WERE RELYING ON FOUR KEY ELEMENTS OF THIS, WHICH WERE THE FINANCIALS THAT WERE SOLID, THE CONTRACTS THAT WERE IN PLACE, THE FACT THAT THEY HAD DONE WORK FOR THE LAST FIVE TO SEVEN YEARS WITH PHARMACEUTICAL COMPANIES THAT, THAT SUBSTANTIATED THE ACCURACY OF IT. THOSE ARE WHAT WE BASED OUR INVESTMENT DECISION ON.

MR. WADE: WELL, YOU DIDN'T MAKE THE INVESTMENT DECISION; RIGHT?

LISA PETERSON: I INFORMED THE INVESTMENT COMMITTEE THAT MADE THE INVESTMENT DECISION, YES, AS WELL AS THEM GOING IN THE MEETING.

MR. WADE: JUST TO BE CLEAR, YOU DID NOT ATTEND THE INVESTMENT COMMITTEE MEETING; CORRECT?

MR. WADE: AND YOU DON'T KNOW WHETHER ANY OF YOUR MEMOS WERE EVER READ BY THE INVESTMENT COMMITTEE; RIGHT?

MR. WADE: OKAY. AND, IN FACT, THE INVESTMENT IN THERANOS WAS COMMITTED TO BEFORE YOU EVEN PREPARED THAT MEMO, THE SECOND MEMO; CORRECT?

LISA PETERSON: THAT'S NOT CORRECT.

MR. WADE: OKAY. WE'LL GET TO THAT. BUT STICKING WITH THE UNICORN, DO YOU RECALL THAT YOU GAVE AN INTERVIEW WITH THE S.E.C. AND THE DEPARTMENT OF JUSTICE IN APRIL OF 2017?

MR. WADE: AND DO YOU RECALL THAT WAS, THAT WAS A MEETING WHERE, WHERE MANY OF THE -- A COUPLE OF THE PROSECUTORS MAYBE HERE ATTENDED. DO YOU RECALL THAT?

LISA PETERSON: I DON'T RECALL WHO WAS IN THE ROOM EXACTLY, BUT I REMEMBER THE INTERVIEW.

MR. WADE: AND THERE WERE SOME S.E.C. ATTORNEYS. DO YOU RECALL THAT?

MR. WADE: AND IT WAS IN SAN FRANCISCO, I THINK.

MR. WADE: OKAY. AND YOU WERE REPRESENTED BY COUNSEL; RIGHT?

MR. WADE: OKAY. AND DO YOU RECALL, IN CONNECTION WITH THAT, THAT YOUR ATTORNEYS HAD MEETINGS IN ADVANCE WITH THE S.E.C.?

LISA PETERSON: I DON'T RECALL ANY OF THAT, NO.

MR. WADE: OKAY. DO YOU RECALL IN ADVANCE THAT YOUR ATTORNEYS TOLD THE S.E.C. AND DOJ THAT WHAT DROVE THE INVESTMENT WAS A UNICORN?

MR. LEACH: OBJECTION.

JUDGE DAVILA: SUSTAINED.

LISA PETERSON: I DON'T RECALL THAT.

JUDGE DAVILA: SUSTAINED. SUSTAINED. THE ANSWER IS STRICKEN. YOU CAN ASK ANOTHER QUESTION.

BY MR. WADE:

MR. WADE: I'M TRYING TO REFRESH YOUR RECOLLECTION. IF YOU CAN LOOK AT EXHIBIT 11453.

LISA PETERSON: CAN YOU DIRECT ME TO WHAT YOU'RE REFERRING TO?

MR. WADE: YEAH, I WILL. AND JUST SO WE'RE CLEAR, READ IT TO YOURSELF. PLEASE DON'T SPEAK UNTIL AFTER I ASK YOU A QUESTION JUST SO NEITHER ONE OF US GET IN TROUBLE, OKAY? THE -- IF YOU CAN LOOK ABOUT TWO-THIRDS OF THE WAY DOWN THE PAGE, MAYBE THREE QUARTERS OF THE WAY, DO YOU SEE WHAT DROVE INVESTMENT? DO YOU SEE THAT LANGUAGE? IF I COULD APPROACH, I CAN POINT IT OUT, YOUR HONOR.

JUDGE DAVILA: SURE. GO RIGHT AHEAD. GO RIGHT AHEAD. YES.

LISA PETERSON: I DON'T RECALL EVER SAYING THAT WORD. I SEE THAT. I DO NOT EVER RECALL SAYING THAT WORD. IT'S NOT SOMETHING I WOULD EVER USE. I DO RECALL IT SAYS RELIED ON LONG-TERM CONTRACTS WITH WALGREENS AND SAFEWAY.

BY MR. WADE:

MR. WADE: SO DO YOU THINK YOUR ATTORNEYS GOT THOSE FACTS RIGHT WHEN THEY GAVE THE PROFFER?

MR. LEACH: OBJECTION.

JUDGE DAVILA: SUSTAINED. WHY DON'T WE MOVE ON?

LISA PETERSON: I WOULD NEVER USE THE WORD "UNICORN."

BY MR. WADE:

MR. WADE: JUST TO BE CLEAR, JUST SO THE RECORD IS CLEAR, I WAS NEVER SUGGESTING THAT YOU WERE. DO YOU RECALL THAT YOUR LAWYERS ON YOUR BEHALF PROFFERED THOSE FACTS?

MR. LEACH: OBJECTION. FOUNDATION.

JUDGE DAVILA: DO YOU HAVE ANOTHER QUESTION?

BY MR. WADE:

MR. WADE: AFTER YOUR MEETING WITH MR. TUBERGEN ON THE AIRPLANE, WHEN DID YOU NEXT MEET WITH HIM IN CONNECTION WITH THE THERANOS INVESTMENT?

LISA PETERSON: I BELIEVE HE -- WE TALKED THE DAY OF THE CALL WITH ELIZABETH HOLMES.

MR. WADE: DID -- WHEN YOU DID THE CALL, WERE YOU IN THE SAME PHYSICAL SPACE?

MR. WADE: OKAY. IN HIS OFFICE?

MR. WADE: OKAY. AND SO YOU MET THAT DAY AND MADE THE CALL TO MS. HOLMES?

MR. WADE: AND THAT WAS THE CALL THAT YOU REFERRED TO, THE OCTOBER 3RD CALL?

LISA PETERSON: WE TALKED AHEAD OF THE CALL AND AFTER THE CALL.

MR. WADE: OKAY. AND THAT WAS THE POINT AT WHICH MR. TUBERGEN GAVE YOU THE BINDERS; IS THAT RIGHT?

MR. WADE: AND THERE WERE TWO -- I BELIEVE YOU'VE SAID PREVIOUSLY THAT THERE WERE TWO BINDERS; IS THAT RIGHT?

LISA PETERSON: THERE WERE TWO BINDERS. I WENT UP AND GOT THE BINDERS EARLY THAT MORNING AND STARTED GOING THROUGH THEM AND DEVELOPING QUESTIONS FOR THE CALL LATER THAT DAY.

MR. WADE: I THOUGHT YOU SAID IT WAS IN THE MEETING THAT HE GAVE YOU THE BINDERS.

LISA PETERSON: NO. HE EMAILED ME AND SAID THAT THERE WAS GOING TO BE A CALL THAT DAY AND COULD I ATTEND, AND I SAID YES. AND THEN HE SAID THAT THE BINDERS HAD ARRIVED AND THEY WERE ON HIS DESK, AND SO I WENT AND GOT THEM AND MADE A COPY.

LISA PETERSON: AND I BEGAN LOOKING AT THEM AHEAD OF THE CALL THAT WAS LATER THAT AFTERNOON.

MR. WADE: OKAY. AND WITH RESPECT TO THAT CALL, DO YOU RECALL THAT THAT WAS ABOUT LESS THAN HALF AN HOUR?

LISA PETERSON: IT WAS PROBABLY HALF AN HOUR.

MR. WADE: OKAY. THE MINUTES -- YOU TOOK NOTES OF THE CALL; CORRECT?

MR. WADE: AND YOU WERE LOOKING AT THOSE NOTES EARLIER; CORRECT?

MR. WADE: AND I THINK THAT'S 2015, WHICH IS PROBABLY IN BOTH BINDERS. DO YOU HAVE THAT IN FRONT OF YOU?

MR. WADE: OKAY. AND DO YOU SEE AT THE TOP THE FIRST HEADING IS "WHAT IS THE LONG-TERM VISION OF THERANOS?"

MR. WADE: AND THAT WAS SOMETHING THAT MR. TUBERGEN WAS VERY FOCUSSED ON; CORRECT?

LISA PETERSON: NO. IT'S JUST A QUESTION THAT WE HAD.

MR. WADE: OKAY. DO YOU RECALL HIM, WHEN HE CAME BACK WITH THE FAMILY AND WITH YOU, HE WAS SPEAKING ABOUT THE LONG-TERM VISION THAT THE COMPANY HAD?

LISA PETERSON: WELL, I THINK IT'S ONE OF MANY ASPECTS IN UNDERWRITING THAT WE UNDERTAKE WHAT IS THE LONG-TERM VISION AND GROWTH OF THE COMPANY.

MR. WADE: RIGHT. I WAS ASKING SPECIFICALLY WITH RESPECT TO MR. TUBERGEN. DO YOU RECALL HIM SPEAKING ABOUT THE VISION OF THE COMPANY, HIS INTEREST IN THE LONG-TERM VISION OF THE COMPANY?

LISA PETERSON: YEAH, BUT IT WASN'T THE ONLY THING THAT HE WAS FOCUSSED ON.

MR. WADE: OKAY. IT WAS THE FIRST QUESTION THAT HE ASKED MS. HOLMES; CORRECT?

LISA PETERSON: IT WAS THE FIRST QUESTION ON MY LIST OF QUESTIONS.

COURT CLERK: ZOOM JUST WENT DOWN.

JUDGE DAVILA: OKAY. EXCUSE ME JUST A SECOND. WHY DON'T WE TAKE OUR BREAK NOW? I UNDERSTAND THAT THEY'RE HAVING PROBLEMS WITH THE ZOOM FEED.

MR. WADE: DOWNSTAIRS? OKAY.

JUDGE DAVILA: SO LET'S TAKE A BREAK NOW. 30 MINUTES, 30 MINUTE BREAK, PLEASE.

(PAUSE IN PROCEEDINGS.)

(RECESS FROM 1:32 P.M. UNTIL 2:02 P.M.)

JUDGE DAVILA: THANK YOU. PLEASE BE SEATED. THANK YOU. WE'RE BACK ON THE RECORD. ALL PARTIES PREVIOUSLY PRESENT ARE PRESENT ONCE AGAIN. MS. HOLMES IS PRESENT. MR. WADE, YOU HAVE ADDITIONAL QUESTIONS?

MR. WADE: I DO, YOUR HONOR. THANK YOU.

MR. WADE: MS. PETERSON, I THINK WE WERE ABOUT TO TALK A LITTLE BIT ABOUT THE CALL THAT YOU HAD WITH MS. HOLMES. DO YOU RECALL THAT THE PURPOSE OF THE CALL WAS TO GET A BETTER SENSE OF HER VISION?

LISA PETERSON: THE PURPOSE OF THE CALL WAS TO BE ASKING SOME QUESTIONS.

MR. WADE: OKAY. DO YOU RECALL IN ONE OF YOUR EARLIER MEETINGS WITH THE GOVERNMENT IN THIS CASE THAT YOU TOLD THEM THE PURPOSE OF THE CALL WAS TO GET A BETTER SENSE OF THE VISION?

LISA PETERSON: I DON'T RECALL THAT, BUT I -- WE HAD LISTED OUT THESE QUESTIONS. THESE ARE THE KIND OF THINGS THAT WE WERE -- THE DARKER, THE DARKER WORDS IN HERE ARE THE QUESTIONS THAT WE HAD GOING INTO THE CALL.

MR. WADE: MY QUESTION WAS DID, DID -- DO YOU RECALL TELLING THE GOVERNMENT THAT THE PURPOSE OF THE CALL WAS TO GET A BETTER SENSE OF HER VISION?

LISA PETERSON: I MAY HAVE. I DON'T RECALL EXACTLY.

MR. WADE: OKAY. LET'S TAKE A LOOK. IF YOU WOULD LOOK IN YOUR BINDER AT EXHIBIT 11249. TELL ME WHEN YOU HAVE THAT IN FRONT OF YOU. AGAIN, PLEASE READ THIS TO YOURSELF AND WAIT FOR MY QUESTION AFTER I DIRECT YOU TO THE SPOT. DO YOU HAVE THAT IN FRONT OF YOU?

MR. WADE: OKAY. AND DO YOU RECALL THAT YOU MET WITH PEOPLE IN THE U.S. ATTORNEY'S OFFICE IN APRIL OF 2017?

MR. WADE: OKAY. I WANT YOU TO LOOK IN THE ONE, TWO -- IN THE FOURTH PARAGRAPH, I THINK ABOUT FOUR SENTENCES IN THE SENTENCE THAT STARTS WITH "PETERSON HAD."

LISA PETERSON: I'M SORRY, WHICH PARAGRAPH?

MR. WADE: THE FOURTH PARAGRAPH ON THE FIRST PAGE.

MR. WADE: DO YOU SEE THE SENTENCE "PETERSON HAD" MIDWAY THROUGH THAT PARAGRAPH?

MR. WADE: READ THAT TO YOURSELF. HAVE YOU READ THAT TO YOURSELF?

MR. WADE: AND DOES THAT REFRESH YOUR RECOLLECTION THAT YOU TOLD THE GOVERNMENT THAT THE PURPOSE OF THE CALL WAS TO GET A BETTER SENSE OF HER VISION?

LISA PETERSON: THAT'S NOT MY RECOLLECTION EXACTLY.

LISA PETERSON: THE CALL WAS TO BEGIN DOING DILIGENCE.

MR. WADE: DID YOU DO A FULL DUE DILIGENCE ON THIS INVESTMENT?

LISA PETERSON: THIS WAS THE START OF QUESTIONS. THAT'S DILIGENCE FOR US.

MR. WADE: OKAY. YOU DID A FULL, FULL -- EXHAUSTIVE DUE DILIGENCE ON THE INVESTMENT?

LISA PETERSON: THAT'S NOT WHAT I SAID.

MR. WADE: WELL, THAT'S MY QUESTION.

LISA PETERSON: WE DID ALL, WE DID -- YES, ALL OF THE DILIGENCE THAT WE WERE GOING TO DO ON THIS INVESTMENT AT THE TIME.

MR. WADE: WHEN YOU SAY "ALL OF THE DILIGENCE THAT YOU WERE GOING TO DO ON THE INVESTMENT," WHAT DOES THAT MEAN?

LISA PETERSON: WE DID -- WE DID THE CALL AND WE WENT ON SITE AND WE DID -- THAT WAS OUR DILIGENCE.

MR. WADE: OKAY. DO YOU BELIEVE THAT YOU DID APPROPRIATE DUE DILIGENCE IN CONNECTION WITH THIS INVESTMENT?

MR. WADE: AND DO YOU BELIEVE THAT YOU DID THOROUGH DUE DILIGENCE IN CONNECTION WITH THIS INVESTMENT?

LISA PETERSON: I THINK WE DID APPROPRIATE DUE DILIGENCE FOR WHAT WE WERE DOING, YES.

MR. WADE: OKAY. THE, THE -- IF YOU CAN BRING BACK IN FRONT OF YOU THE DOCUMENT THAT WE LEFT OFF WITH IN 2015. DO YOU HAVE THAT IN FRONT OF YOU?

MR. WADE: OKAY. CAN WE BRING THAT UP? IT'S IN EVIDENCE. OKAY. YOU WERE ASKED SOME QUESTIONS ABOUT THIS ON DIRECT; DO YOU RECALL?

MR. WADE: AND THE FIRST QUESTION IS ABOUT THE LONG-TERM VISION OF THERANOS. DO YOU SEE THAT?

MR. WADE: AND THEN -- AND IT GIVES SOME DETAILS. WAS THIS INFORMATION IN RESPONSE TO QUESTIONS THAT YOU HAD ASKED?

MR. WADE: OKAY. LET'S GO TO WALGREENS. DO YOU SEE THAT?

MR. WADE: NOW, THIS WAS, THIS WAS -- YOU'RE AWARE THAT THEY HAD A WALGREENS ROLLOUT; CORRECT?

MR. WADE: AND DID YOU GO AND VISIT A WALGREENS LOCATION?

MR. WADE: DID YOU PULL THE PUBLIC ANNOUNCEMENTS OF --

LISA PETERSON: WE ACTUALLY DID PULL THE 10K FROM THE -- FROM 2013.

MR. WADE: AND THE PRESS RELEASE ANNOUNCING THE --

LISA PETERSON: IT SAID THAT THEY WERE GOING TO GO AND BEGIN LAUNCHING THEIR -- WITH THERANOS. IT WAS TWO OR THREE SENTENCES IN THE 10K.

MR. WADE: OKAY. DID YOU LOOK AT THE PRESS RELEASE THAT ANNOUNCED THE PARTNERSHIP?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. LET'S LOOK AT 1113. IT'S IN EVIDENCE. IT'S UP ON YOUR SCREEN IF YOU'D LIKE AND IF IT'S EASIER.

MR. WADE: DO YOU SEE IT?

MR. WADE: OKAY. AND IN LOOKING AT 1113, DO YOU RECOGNIZE THAT AS THE JOINT PRESS RELEASE BETWEEN WALGREENS AND THERANOS? DO YOU SEE THAT?

MR. WADE: AND THAT WAS OUT ON THE INTERNET. DO YOU KNOW IF YOU FOUND THIS AS PART OF YOUR INTERNET RESEARCH?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. IF YOU, IF YOU -- DO YOU RECALL YOUR TESTIMONY ON DIRECT THAT YOU WEREN'T AWARE OF ANY VENOUS DRAWS BEING DONE AT THERANOS?

MR. WADE: OKAY. AND YOU DIDN'T GO TO A WALGREENS LOCATION AT THE TIME AND SEE WHAT KIND OF DRAWS THEY USED; CORRECT?

MR. WADE: AND IF YOU LOOK AT THE LAST SENTENCE IN THIS PRESS RELEASE, IF WE CAN JUST HIGHLIGHT THAT, DO YOU SEE IT SAYS, "THE SAMPLES ARE EITHER TAKEN FROM A TINY FINGERSTICK OR A MICRO-SAMPLE TAKEN FROM TRADITIONAL METHODS." DO YOU SEE THAT?

LISA PETERSON: I SEE THAT.

MR. WADE: AND DO YOU KNOW WHAT "TRADITIONAL METHODS" MEANS?

LISA PETERSON: I DON'T RECALL LOOKING AT THIS.

MR. WADE: OKAY. WOULD YOU UNDERSTAND TRADITIONAL METHODS TO MEAN VENOUS DRAW?

MR. WADE: AND DO YOU KNOW WHETHER YOU WENT AND LOOKED AT -- YOU SAID YOU DID INTERNET RESEARCH; CORRECT?

LISA PETERSON: SOME, YES.

MR. WADE: WELL, I THOUGHT YOU SAID YOU DID THOROUGH DUE DILIGENCE, DID YOU NOT?

LISA PETERSON: WE DID ADEQUATE DILIGENCE FOR THIS DEAL, YES.

MR. WADE: OKAY. AND IN CONNECTION WITH THAT, DID YOU GO INTO THE COMPANY THERANOS'S WEBSITE?

MR. WADE: OKAY. DID YOU GO TO THE WALGREENS WEBSITE?

LISA PETERSON: I DON'T RECALL. I REMEMBER GOING ON THERANOS'S WEBSITE AND LOOKING AT THE PRICE LISTINGS AND EVERYTHING ELSE THAT SHE HAD TALKED ABOUT.

LISA PETERSON: TRYING TO VERIFY THAT THAT WAS TRUE.

MR. WADE: OKAY. SO YOU WENT THERE TO LOOK AT THE TEST MENU?

MR. WADE: AND HOW MANY? DO YOU RECALL?

LISA PETERSON: IT WAS A LOT. I DIDN'T COUNT THEM.

MR. WADE: IT WAS A LOT. OKAY. AND WHEN YOU WERE THERE, YOU DON'T RECALL WHETHER YOU LOOKED AT THIS PRESS RELEASE ON EITHER OF THE COMPANIES' WEBSITES?

MR. WADE: OKAY. DID YOU LOOK -- DO YOU RECALL ASKING ANY FOLLOW-UP QUESTIONS ABOUT WALGREENS AND HOW THE RELATIONSHIP WORKED OF THERANOS?

LISA PETERSON: WE ASKED A LOT OF QUESTIONS ABOUT WALGREENS AND SPECIFICALLY WHAT THE ROLLOUT PLAN WAS AND WHERE WERE THEY AT THE MOMENT, IN 42 OR -- 40 OR 42 LOCATIONS IN ARIZONA, AND WE ASKED SPECIFICALLY ABOUT WHAT THE ROLLOUT PLAN WAS. THEY WERE ALREADY OPERATING IN WALGREENS STORES, SO THE PRESS RELEASE WASN'T THAT RELEVANT TO US.

MR. WADE: OKAY. AND --

LISA PETERSON: WE WANTED TO KNOW WHAT LOCATIONS WERE THEY GOING TO OPEN IN AND WHEN, AND WE WENT THROUGH THAT.

MR. WADE: OKAY. DID YOU LEARN HOW THE WALGREENS -- HOW IT WORKED AT WALGREENS WITH THERANOS, I MEAN, WHAT THE EXPERIENCE WAS LIKE?

LISA PETERSON: WELL, CHERI WAS TESTED, SO IT WAS SIMILAR TO WHAT WE WERE TOLD. CHERI WAS TESTED AT THEIR LOCATION AND, LIKE I SAID, THEY HAD PUT SOME TINY CLINIC INSIDE OF THEIR BUILDING AND THEY SAID THIS WAS VERY MUCH THE LOOK AND FEEL OF THE CLINIC INSIDE OF A WALGREENS.

MR. WADE: OKAY. THAT WASN'T MY QUESTION. MY QUESTION WAS, DID YOU LEARN ABOUT WHAT IT WAS LIKE, HOW THEY WERE OPERATING WITHIN THE WALGREENS AND WITH DIFFERENT WALGREENS LOCATIONS?

LISA PETERSON: LEARN HOW THEY WERE OPERATING?

MR. WADE: YES, HOW IT WORKED.

LISA PETERSON: EVERYTHING THAT SHE HAD TOLD US WAS THAT THEY WERE DOING FINGERSTICK AT WALGREENS.

MR. WADE: OH, I UNDERSTAND THAT. YOU'VE SAID THAT. BUT EXPLAIN TO ME WHAT HAPPENED WHEN A PATIENT GOES INTO A WALGREENS AT THERANOS IN THIS PERIOD BEFORE YOU ARE MAKING THE INVESTMENT.

LISA PETERSON: IT WAS OUR UNDERSTANDING THAT THEY WOULD GO IN, EXACTLY LIKE CHERI DID, INTO A CLINIC AND HAVE A FINGERSTICK DRAW.

MR. WADE: AND THEN WHAT HAPPENS?

LISA PETERSON: AND THEN IT WAS TESTED RIGHT THERE.

MR. WADE: IT WAS TESTED RIGHT THERE? THAT'S YOUR TESTIMONY?

LISA PETERSON: IN THE MACHINES, YEAH.

MR. WADE: AND IT WAS YOUR TESTIMONY THAT THEY TESTED IT IN THE MACHINES IN THE WALGREENS STORE?

MR. WADE: AND THAT THEY WEREN'T RUNNING OUT OF A CENTRAL LAB?

LISA PETERSON: THEY, THEY SAID THEY HAD A LAB THAT WAS RUNNING SOME OF THE TESTS, BUT EVERYTHING WAS FINGERSTICK. BUT EVERYTHING THAT WAS GOING ON IN THE 42 WALGREENS STORES, IT WAS OUR IMPRESSIONS THAT THIS WAS DONE AT WALGREENS.

MR. WADE: WAS IT YOUR IMPRESSION OR DID THEY TELL YOU THAT?

LISA PETERSON: THEY TOLD US THAT.

MR. WADE: OKAY. YOU'RE SURE ABOUT THAT?

MR. WADE: OKAY. AND --

LISA PETERSON: THERE WERE OTHER TESTS THAT THEY WERE DOING AND THEY SAID THAT THEY WERE DOING WORK FOR THESE PHARMACEUTICAL COMPANIES AND EVERYTHING ELSE, WHICH IS WHAT WE THOUGHT THEY WERE DOING AT THEIR LAB.

MR. WADE: AND WHY DID THEY HAVE -- SO THEY HAD A CLIA LAB JUST FOR THE PHARMACIES?

LISA PETERSON: FOR OTHER THINGS BESIDES WALGREENS.

MR. WADE: DID YOU EVER TAKE THE TIME IN ANY OF THESE MEETINGS TO CLARIFY ANY OF THESE ISSUES AND ASK QUESTIONS?

LISA PETERSON: WE ASKED QUESTIONS AND WE GOT ANSWERS THAT WE WERE SATISFIED WITH THAT ARE DIFFERENT THAN WHAT CAME OUT LATER.

MR. WADE: UNDERSTOOD. YOU WENT UNDER THE -- BUT YOU NEVER ACTUALLY WENT TO ONE OF THOSE WALGREENS LOCATIONS AND FIGURED OUT WHAT HAPPENED ONCE THE BLOOD WAS GIVEN?

LISA PETERSON: BECAUSE THEY SAID IT WAS VERY MUCH LIKE THE EXPERIENCE THAT CHERI HAD AT THE OFFICE, THE CLINIC.

MR. WADE: OKAY. I THINK YOU TESTIFIED IN YOUR INTERNET RESEARCH THAT YOU WENT ONTO THE WEBSITES OF BOTH COMPANIES.

LISA PETERSON: BOTH COMPANIES?

MR. WADE: WALGREENS AND THERANOS?

LISA PETERSON: I WENT AND PULLED THE 10K, YES --

MR. WADE: DID YOU GO --

LISA PETERSON: -- FROM WALGREENS.

MR. WADE: BUT --

LISA PETERSON: BUT I DID NOT GO ON THE WEBSITE OF WALGREENS.

MR. WADE: DID YOU GO ON THE WEBSITE OF THERANOS?

MR. WADE: AND DID YOU READ THE LANGUAGE WHERE THEY TALKED ABOUT USING VENOUS DRAWS ON THE WEBSITE OF THERANOS?

LISA PETERSON: I DON'T RECALL EVER SEEING THAT, NO.

MR. WADE: DID YOU JUST LOOK AT THE TEST MENUS, OR DID YOU LOOK AROUND AT OTHER SITES?

LISA PETERSON: I DON'T RECALL WHAT I LOOKED AT THERE EXACTLY.

MR. WADE: BUT YOU DIDN'T SEE THE WEB PAGE THAT TALKS ABOUT THE FACT THAT THEY USE VENOUS TESTS?

LISA PETERSON: NO. THAT WAS NOT MADE AWARE TO US UNTIL AFTER "THE WALL STREET JOURNAL" ARTICLE.

MR. WADE: WELL, THEY DIDN'T PREVENT YOU FROM REVIEWING THE WEBSITE?

LISA PETERSON: NO, BUT WE DID NOT DO THAT.

MR. WADE: THEY DIDN'T TELL YOU YOU COULD NOT REVIEW THE WEBSITE; RIGHT?

MR. WADE: OKAY. DID YOU EVER ASK FOR ANY OF THE DETAILED INFORMATION ABOUT HOW IT -- HOW THE EXPERIENCE WORKED AT WALGREENS? DID YOU ASK FOR DOCUMENTS OR ANYTHING LIKE THAT?

LISA PETERSON: YES. WE ASKED HOW IT WORKED AND WE WERE SHOWN HOW IT WORKED WITH CHERI.

MR. WADE: OKAY. ISN'T IT THE CASE THAT YOU ACTUALLY WANTED TO CALL YOUR CONTACT AT WALGREENS?

LISA PETERSON: I HAD SUGGESTED IT BECAUSE I DID KNOW THE CIO OF WALGREENS AT THE TIME, YES.

MR. WADE: SO THE ANSWER IS YES?

MR. WADE: OKAY. AND MR. TUBERGEN TOLD YOU NOT TO DO THAT; CORRECT?

LISA PETERSON: HE SAID -- YES, HE ADVISED NOT TO DO THAT. THE KEY THING THERE WAS, YOU KNOW, THIS WAS LARGELY AN INVITATION ONLY, AND WE FELT THAT IF WE HAD CIRCUMVENTED SOME OF THE PROCESS THAT WE FELT THAT WE WERE IN, THAT WE WOULD BE UNINVITED TO PARTICIPATE IN THIS OPPORTUNITY. SO WE WERE VERY CAREFUL NOT TO CIRCUMVENT THINGS AND UPSET ELIZABETH.

MR. WADE: SO THE ANSWER TO THE QUESTION ABOUT -- MR. TUBERGEN TOLD YOU NOT TO CONTACT WALGREENS; CORRECT?

MR. WADE: OKAY. DID HE TELL YOU NOT TO LOOK AT THE WALGREENS WEBSITE?

MR. WADE: OKAY. THERE WAS NOTHING THAT PREVENTED YOU FROM DOING THAT?

MR. WADE: OKAY. DID HE TELL YOU NOT TO GO TO WALGREENS?

LISA PETERSON: THE WALGREENS WAS IN ARIZONA. NO, I DID NOT GO TO ARIZONA.

MR. WADE: WELL, THE FAMILY HAS PLANES THAT THEY CAN USE; CORRECT?

LISA PETERSON: THAT IS NOT PART OF WHAT WE WOULD HAVE DONE.

LISA PETERSON: WE WERE RELYING ON WHAT WE WERE TOLD.

MR. WADE: I APOLOGIZE. YOU'VE DONE A LOT OF INVESTMENTS IN YOUR CAREER; CORRECT?

MR. WADE: AND YOU'RE FAMILIAR WITH THE CONCEPT CALLED DUE DILIGENCE; CORRECT?

MR. WADE: AND DUE DILIGENCE IS A PROCESS WHERE PEOPLE, BEFORE THEY MAKE AN INVESTMENT, DO RESEARCH SO THAT THEY FULLY UNDERSTAND THE INVESTMENT; RIGHT?

MR. WADE: OKAY. AND YOU SAW WITHIN THE AGREEMENT MR. LEACH SHOWED YOU THAT YOU HAD THE ABILITY TO DO DUE DILIGENCE; CORRECT?

MR. WADE: THERE WAS CONTRACTUALLY NOTHING THAT PROHIBITED YOUR ABILITY TO DO DUE DILIGENCE; RIGHT?

LISA PETERSON: WE DID DO DUE DILIGENCE.

MR. WADE: AND THERE WAS --

LISA PETERSON: WE WERE ON SITE FOR FIVE HOURS. THAT WAS A LOT OF DUE DILIGENCE FOR US.

MR. WADE: THAT WASN'T MY QUESTION. MY QUESTION WAS, THERE WAS NOTHING IN THE CONTRACT THAT PREVENTED YOU FROM DOING DUE DILIGENCE; CORRECT?

MR. WADE: OKAY. SO YOU WERE FREE TO DO WHATEVER INVESTIGATION YOU WANTED TO MAKE SURE THAT YOU HAD A FULL AND ACCURATE UNDERSTANDING OF HOW THE COMPANY WAS OPERATING AT THE TIME; CORRECT?

LISA PETERSON: IT WAS CHARACTERIZED TO US. WE THOUGHT THAT IF WE DID MORE THAN WHAT -- IF WE DID TOO MUCH, WE WOULDN'T BE INVITED BACK TO INVEST. THAT WAS THE ISSUE.

MR. WADE: I UNDERSTAND HOW YOU -- HOW SOME PEOPLE AT RDV MAY HAVE FELT, BUT THAT WASN'T MY QUESTION. MY QUESTION WAS, THERE WASN'T NOTHING THAT PREVENTED YOU FROM --

MR. WADE: -- DOING ALL OF THAT RESEARCH; RIGHT?

LISA PETERSON: OTHER THAN THE FEAR OF BEING UNINVITED TO INVEST.

MR. WADE: RIGHT. BUT GOING ON A WEBSITE ISN'T GOING TO PROMPT THAT, IS IT?

MR. WADE: AND GOING ON A VISIT TO A LOCATION ISN'T GOING TO PROMPT THAT, IS IT?

MR. WADE: AND YOU COULD PROBABLY CALL OTHER PEOPLE AND THERANOS WOULD NEVER KNOW ABOUT IT; RIGHT? YOU DO THAT ALL OF THE TIME IN INVESTMENTS, DON'T YOU?

LISA PETERSON: YES, BUT THAT'S NOT WHAT WE DID HERE.

MR. WADE: OKAY. BUT YOU COULD? YOU'VE DONE IT IN OTHER CASES THOUGH; CORRECT?

LISA PETERSON: CORRECT, BUT THAT'S NOT WHAT WE DID HERE.

MR. WADE: BACK TO 2015. MR. LEACH FOCUSSED YOU ON THE DISCUSSION OF THE WALGREENS AND THE ROLLOUT. DO YOU SEE THAT? AND THAT SAYS THE PROJECTIONS WERE BASED ON 900 STORES. DO YOU SEE THAT?

MR. WADE: AND THAT'S THE PROJECTIONS THAT WERE IN THE BINDER; RIGHT?

LISA PETERSON: YES, FOR 2015.

MR. WADE: WE'LL ASK SOME QUESTIONS ABOUT THAT IN A SECOND. YOU UNDERSTOOD THOSE WERE PROJECTIONS; RIGHT?

LISA PETERSON: YES, AND FOR CONTRACTS, WE WERE TOLD THAT THERE WERE CONTRACTS THAT SUBSTANTIATED WHAT THE PROJECTION SAID.

MR. WADE: I UNDERSTAND. MY QUESTION IS, YOU UNDERSTOOD THOSE WERE PROJECTIONS; CORRECT?

MR. WADE: OKAY. AND YOU KNEW HOW MANY STORES THEY HAD AT THE TIME; RIGHT?

MR. WADE: HOW MANY?

LISA PETERSON: FORTY OR FORTY-TWO.

MR. WADE: OKAY. AND UNDER THE RISKS, DO YOU SEE THE RISK THAT IS FOCUSSED ON THERE IS THE RISK OF AN EXECUTION; RIGHT?

MR. WADE: AND FOR A YOUNG COMPANY, THAT'S ALWAYS A RISK; RIGHT?

MR. WADE: AND TO GO FROM, WHATEVER, 42 STORES YOU SAID, TO 900 STORES IN A YEAR IS A LOT; CORRECT?

MR. WADE: OKAY. AND SO THE PRIMARY RISK THAT MS. HOLMES ALERTED YOU TO WAS THE RISK OF BEING ABLE TO EXECUTE ON THAT AND GROW AT THAT RATE; CORRECT?

MR. WADE: OKAY. LET'S GO TO THE SECOND PAGE. THIS SETS FORTH THE GOALS FOR OCTOBER 14TH. DO YOU SEE THAT?

MR. WADE: AND THAT WAS THE VISIT THAT THE FAMILY WAS GOING TO TAKE OUT TO THE COMPANY; RIGHT?

MR. WADE: AND SO THE GOAL WAS REALLY SORT OF A RELATIONSHIP GET-TO-KNOW-YOU GOAL?

LISA PETERSON: PART OF IT.

MR. WADE: WELL --

LISA PETERSON: THIS WAS OUR GOALS FOR THE OCTOBER 14TH. AND IN HERS, SHE MADE IT VERY SPECIFIC THAT SHE WANTED TO GET TO KNOW THE PEOPLE WHO ARE MAKING THE INVESTMENT.

MR. WADE: WELL, IN FACT, MR. TUBERGEN SAID THAT THAT WAS ONE OF THE PRINCIPLES OF --

MR. WADE: RIGHT? BECAUSE THE DEVOS FAMILY WANTED A LONG-TERM INVESTMENT; RIGHT?

MR. WADE: AND THEY WANTED TO BE A COMMITTED PARTNER IN THE INVESTMENT; RIGHT?

MR. WADE: AND BEFORE THEY DID THAT, THEY WANTED TO GET TO KNOW ELIZABETH AND OTHER PEOPLE AT THERANOS; RIGHT?

MR. WADE: AND SO ONE OF THE CORE PRINCIPLES IN GOING OUT THERE WAS SO THAT THERE COULD BE INTERACTION THAT WOULD ALLOW PEOPLE TO GET COMFORTABLE WITH ONE ANOTHER; RIGHT?

LISA PETERSON: ON BOTH SIDES, CORRECT.

MR. WADE: RIGHT. ON BOTH SIDES?

MR. WADE: AND THAT WAS DISCUSSED IN ADVANCE; RIGHT?

MR. WADE: AND, IN FACT, ULTIMATELY LATER WHEN, WHEN YOU WENT OUT THERE, THERE WAS A LOT OF DISCUSSION GOING BOTH WAYS ABOUT THE PHILOSOPHIES OF BOTH SIDES; RIGHT?

MR. WADE: AND THERE WAS DISCUSSION FROM MR. DEVOS, ONE OF THE MR. DEVOS'S ABOUT --

MR. WADE: DOUG, ABOUT THE BUSINESS RELATIONSHIPS THAT THE COMPANY HAD HAD AND ITS PHILOSOPHY AND APPROACH TO MAKING INVESTMENTS; RIGHT?

MR. WADE: AND HOW HE GREW THE AMWAY BUSINESS AND HIS BUSINESS PHILOSOPHY FROM A MANAGEMENT PERSPECTIVE; RIGHT?

LISA PETERSON: YES, THAT WAS DISCUSSED.

MR. WADE: RIGHT. AND THERE WERE SIMILAR DISCUSSIONS ABOUT MS. HOLMES'S VISION, AND SHE HAD A LONG-TERM VIEW OF THE BUSINESS; CORRECT?

MR. WADE: AND HOW SHE WANTED TO SEE THIS OVER THE LONG TERM IN ORDER TO HAVE THE TYPE OF IMPACT IN HEALTH CARE THAT SHE WANTED TO HAVE; RIGHT?

MR. WADE: AND MR. TUBERGEN ACTUALLY SPECIFICALLY SAID IN THIS PRE-CALL THAT IT NEEDED TO BE -- IT NEEDED TO BE UNDERSTOOD THAT THESE WEREN'T HIGHLY SCIENTIFIC PEOPLE, RIGHT, THE DEVOS FAMILY, AND THIS NEEDED TO BE KEPT AT A LEVEL THAT WAS NOT A TECHNICAL MEETING, BUT MORE OF A RELATIONSHIP MEETING; RIGHT?

LISA PETERSON: I DON'T RECALL HIM SAYING THAT, BUT, YES, I CAN -- NONE OF US WERE SCIENTISTS, SO KEEPING IT AT A LEVEL THAT WE ALL COULD UNDERSTAND WAS IMPORTANT.

MR. WADE: RIGHT. AND YOU WEREN'T SEEKING OR YOU DIDN'T ASK FOR ANY TESTING DATA; CORRECT?

LISA PETERSON: WE DID NOT ASK FOR THAT, NO.

MR. WADE: OKAY. AND YOU DIDN'T BRING IN A CONSULTANT WHO HAS GREATER EXPERTISE IN THIS AREA TO LOOK AT THE TECHNOLOGY OR THE DATA, DID YOU?

MR. WADE: AND YOU DIDN'T BRING IN A REGULATORY EXPERT TO LOOK AT THE REGULATORY ISSUES THAT WERE PRESENT IN CONNECTION WITH THIS INVESTMENT; RIGHT?

MR. WADE: OKAY. YOU DIDN'T BRING IN A LAWYER WHO IS WITH EXPERTISE WHO COULD MAKE THOSE KINDS OF JUDGMENTS; RIGHT?

LISA PETERSON: NO. WE WERE RELYING ON WHAT WE WERE TOLD BY THEM ON THE ACCURACY OF THE ANALYZER.

MR. WADE: YOU'RE NOT AN EXPERT IN THE -- IN FDA OR CMS RELATED ISSUES, ARE YOU?

MR. WADE: AND NO ONE IN THE FAMILY IS EITHER; RIGHT?

MR. WADE: AND NO ONE IN THE COMPANY SAID YOU COULDN'T HIRE ANY OF THOSE PEOPLE; RIGHT?

LISA PETERSON: NO. BUT THEY ALSO SAID THAT THEY DIDN'T NEED FDA REGULATORY APPROVAL FROM THE FDA TO DO IT.

MR. WADE: I UNDERSTAND. THAT WASN'T MY QUESTION. MY QUESTION WAS, NO ONE SAID THAT YOU, YOU COULDN'T HIRE ANY OF THOSE EXPERTS TO COME IN AND HELP YOU UNDERSTAND THE TECHNICAL ISSUES; RIGHT?

LISA PETERSON: NO ONE DID, BUT WE DIDN'T KNOW WHY WE WOULD NEED THAT.

MR. WADE: OKAY. WELL, YOU'RE NOT A TECHNICAL EXPERT IN THIS CASE; CORRECT?

LISA PETERSON: NO, BUT THEY WERE TELLING US THAT IT WORKED.

MR. WADE: THAT WASN'T MY QUESTION. MY QUESTION WAS WHETHER YOU UNDERSTOOD THE FDA AND CMS TECHNICAL ISSUES. DID YOU?

LISA PETERSON: WE UNDERSTOOD WHAT THEY TOLD US.

MR. WADE: OKAY. AND DID YOU -- AND NO ONE PREVENTED YOU --

MR. WADE: -- FROM BRINGING IN SOMEONE WHO HAS EXPERTISE TO GIVE ADDITIONAL PERSPECTIVE ON THAT; CORRECT?

LISA PETERSON: WE DIDN'T THINK THAT WE NEEDED IT.

MR. WADE: OKAY. YOU THEN TALKED ABOUT THE RDV INVESTMENT PHILOSOPHY THERE AND HOW IT WAS A GOAL IN THE MEETING. THIS IS KIND OF ONE OF THE ISSUES THAT YOU WERE TALKING ABOUT; RIGHT?

MR. WADE: AND THAT WAS ONE OF THE THINGS THAT THERANOS WANTED TO LEARN FROM THE FAMILY?

MR. WADE: AND, IN FACT, IT WASN'T USUAL FOR THE DEVOS FAMILY TO GO OUT ON AN INVESTMENT; RIGHT?

LISA PETERSON: THEY'VE NEVER GONE ON AN INVESTMENT WITH ME.

MR. WADE: OKAY. SO THIS WAS SORT OF A UNIQUE SITUATION; RIGHT?

MR. WADE: AND IT WAS MORE OF A RELATIONSHIP SITUATION; RIGHT?

LISA PETERSON: NO. NO. THIS WAS AN INVESTMENT AND ONE THAT CAME WITH IT, WE WANTED TO MAKE SURE -- WITH ANYONE WE INVEST WITH, WE WANT TO HAVE A GOOD PARTNERSHIP, LONG-TERM PARTNERSHIP WITH ANYONE WE INVEST WITH. THIS WASN'T ANY DIFFERENT THAN ANYTHING ELSE.

MR. WADE: UNDERSTOOD. YOU SEE THE REFERENCE THERE TO THE IMPORTANCE OF THE RELATIONSHIP GOING FORWARD. DO YOU SEE THAT?

MR. WADE: THAT WAS IMPORTANT TO BOTH SIDES; RIGHT?

LISA PETERSON: IT IS. BUT THAT WASN'T UNIQUE TO THIS DEAL.

MR. WADE: OKAY. I WAS JUST ASKING WHETHER THAT WAS PART OF THE DISCUSSION GOING INTO THE MEETING.

LISA PETERSON: CORRECT. IT JUST WASN'T UNIQUE TO THIS DEAL.

MR. WADE: OKAY. LET'S GO TO THE NEXT PAGE, OR THE NEXT PIECE. YEAH, LET'S GET THE REST OF IT. OKAY. AND THIS IS THE BALANCE OF THE DISCUSSION THERE; RIGHT?

MR. WADE: YOU DISCUSSED WHAT THE EXPECTATION WAS ON SOME OF THE NUMBERS; RIGHT?

LISA PETERSON: WE TALKED ABOUT WHAT THEY MIGHT RAISE IN THIS FUND RAISING, YES.

MR. WADE: RIGHT. THAT THEY MIGHT RAISE 500 MILLION. DO YOU SEE THAT?

MR. WADE: AND 50 MILLION WAS A GOOD NUMBER TO START; RIGHT?

LISA PETERSON: WE ALWAYS KIND OF ASKED SIZING, WHAT MAKES THE MOST SENSE, AND SO JERRY HAD BROUGHT UP 50 MILLION. IS THAT A GOOD NUMBER FOR US TO CONSIDER? WE ALWAYS WANT TO KNOW WHAT WE'RE TO CONSIDER IN AN INVESTMENT.

MR. WADE: UNDERSTOOD. AND A LOT OF THE ISSUES THAT YOU TALKED ABOUT IN YOUR MEMO, WHICH WE'RE GOING TO TALK ABOUT IN A LITTLE BIT ABOUT THE PARTICULARS, AREN'T REFERENCED IN YOUR NOTES ANYWHERE; RIGHT?

LISA PETERSON: THIS WAS JUST MY SHORTHAND FROM THE CALL. EVERYTHING ELSE THAT WE TALKED ABOUT IS REFERENCED IN THE MEMO THAT WENT TO THE FAMILY.

MR. WADE: OKAY. SO, SO THERE WAS A LOT OF STUFF THAT HAPPENED ON THIS CALL THAT YOU DIDN'T WRITE DOWN IN YOUR NOTES; IS THAT YOUR --

LISA PETERSON: YES, THIS WAS SHORTHAND OF ALL OF THE POINTS, THE QUESTIONS THAT WE HAD AND THE ANSWERS, AND THEN THERE'S -- THERE WAS MORE. AND ALSO I INCORPORATED IN SOME OF THE STUFF THAT I READ FROM THE DUE DILIGENCE BINDERS.

MR. WADE: NO. I UNDERSTAND THAT. WE'LL TALK ABOUT THE INCORPORATION OF THE DUE DILIGENCE BINDERS. BUT WE'RE TALKING ABOUT A 30 MINUTE CALL HERE; RIGHT?

MR. WADE: AND YOU WENT THROUGH THESE TWO -- YOU COVERED EVERYTHING IN THESE PAGES; RIGHT?

LISA PETERSON: YEAH, BUT THIS IS FAIRLY SHORTHAND FOR -- THIS ISN'T EXACTLY WHAT WAS SAID.

MR. WADE: OKAY. AND ALL OF THE TECHNICAL STUFF THAT RELATES TO YOUR MEMO, YOU DIDN'T PUT THAT IN THE NOTES; IS THAT RIGHT?

MR. WADE: OKAY. LET'S TAKE A LOOK AT YOUR MEMO. I BELIEVE IT'S IN YOUR -- THE GOVERNMENT BINDER AT 2073.

LISA PETERSON: YOUR BINDER OR THIS BINDER?

MR. WADE: YOU CAN STAY IN THAT BINDER. I THINK IT'S IN THE NEXT BINDER, THE WHITE BINDER.

LISA PETERSON: I'M IN THE BLACK BINDER.

MR. WADE: I THINK IT'S IN BOTH, BUT I HAPPEN TO BE LOOKING AT THE GOVERNMENT VERSION 2073, WHICH I THINK IS IN EVIDENCE. DO YOU HAVE THAT? DO YOU SEE THAT IN FRONT OF YOU?

JUDGE DAVILA: THAT'S ALSO IN YOUR BINDER AS WELL, 2073.

MR. WADE: SURE, LET'S STAY IN OUR BINDER. WE'LL LOOK AT 2073.

LISA PETERSON: OKAY. YES.

BY MR. WADE:

MR. WADE: AND I JUST WANT TO MAKE SURE. THERE'S A REFERENCE HERE TO -- THIS IS AN OVERVIEW FOR THE MEMO -- FOR THE MEETING IN ADVANCE; CORRECT?

MR. WADE: OKAY. AND THIS WAS PREPARED AFTER THAT CALL?

MR. WADE: AND THEN THE MATERIALS THAT YOU REFERENCED IN THERE, IT'S YOUR TESTIMONY THAT ALL OF THOSE MATERIALS WERE PRINCIPALLY FROM THE 30 MINUTE CONVERSATION WITH MS. HOLMES AND THE BINDERS THAT YOU WERE SENT?

LISA PETERSON: AND THE BINDERS, YES.

LISA PETERSON: OTHER THAN THE SKEPTIC PARTS THAT I PUT IN THE BACK OF THIS --

LISA PETERSON: -- WHICH I READ ONLINE.

MR. WADE: OKAY. ISN'T IT, ISN'T IT ACTUALLY THE CASE THAT A LOT OF THE MATERIAL IN THERE CAME DIRECTLY OUT OF THE "FORTUNE" ARTICLE?

LISA PETERSON: NO. A LOT OF THIS CAME OUT OF THE BINDERS, AND SOME OF IT COULD HAVE COME OUT OF WHAT I READ, YES.

MR. WADE: OKAY. YOU RECEIVED THAT "FORTUNE" ARTICLE THAT WAS SENT FROM MR. MOSLEY TO MR. TUBERGEN; CORRECT?

MR. WADE: OKAY. AND YOU HAD THAT ARTICLE; CORRECT?

MR. WADE: OKAY. AND I KNOW YOU'VE TESTIFIED THAT YOU -- I KNOW THAT YOU'VE TESTIFIED THAT YOU RELIED ON THE BINDER MATERIALS, BUT ISN'T IT TRUE THAT A LOT OF THE ITEMS IN YOUR MEMO ACTUALLY CAME ALMOST DIRECTLY FROM THE "FORTUNE" ARTICLE?

LISA PETERSON: THAT'S NOT MY RECOLLECTION.

MR. WADE: OKAY. LET'S TAKE A LOOK. WHY DON'T -- I'LL -- LET'S START WITH PAGE 6 OF YOUR MEMO. DO YOU SEE THAT? THAT'S THE APPENDIX?

MR. WADE: AND DO YOU SEE THAT THERE ARE A LOT OF BULLET POINTS THERE?

LISA PETERSON: A LOT OF THE APPENDIX -- THAT'S WHY IT SAYS STATISTICS AND NOTEWORTHY ITEMS. A LOT OF THAT WAS WHATEVER I COULD FIND.

MR. WADE: YEAH. DO YOU RECALL IN YOUR TESTIMONY WHERE YOU WERE GOING THROUGH AND MR. LEACH WAS ASKING YOU, WAS THAT BASED UPON THE BINDER AND THE MATERIALS THAT MS. HOLMES GAVE YOU? AND YOU SAID YES, YES, YES, YES, EXCEPT FOR THE LAST ONE. DO YOU RECALL THAT?

LISA PETERSON: MUCH OF THIS WAS IN THE BINDER, YES.

MR. WADE: YES. BUT MUCH OF IT WAS IN OTHER ITEMS; RIGHT?

LISA PETERSON: IT WAS IN MULTIPLE PLACES, YES.

MR. WADE: OKAY. WELL, DID YOU TAKE THINGS RIGHT OUT OF THE "FORTUNE" ARTICLE AND PUT THEM INTO THE MEMO? DO YOU REMEMBER?

LISA PETERSON: I MIGHT HAVE, YES.

MR. WADE: OKAY. LET'S TAKE A LOOK AT THE 11TH PARAGRAPH, OKAY? OR THE 11TH NUMBER WHICH STARTS, "THERANOS USES THEIR OWN ANALYZER EQUIPMENT." DO YOU SEE THAT?

MR. WADE: OKAY. AND IF -- CAN WE DO A SPLIT SCREEN? LET'S DO A SPLIT SCREEN AND PULL UP THE "FORTUNE" ARTICLE. I'LL DO IT ON THE SCREEN, BUT YOU'RE WELCOME TO REFERENCE THIS AT ANY TIME. THE "FORTUNE" ARTICLE IS 1944, OKAY? OKAY. LET'S LOOK AT PAGE -- LET'S LOOK AT PAGE 4, AND LET'S BLOW UP THE PARAGRAPH WITH THE P. I'M GOING TO GIVE YOU A MINUTE TO LOOK AT THAT. THAT BULLET IS LIFTED RIGHT FROM THE "FORTUNE" ARTICLE, CORRECT, THAT YOU GOT FROM MR. MOSLEY?

LISA PETERSON: YES, UH-HUH.

MR. WADE: ALL RIGHT.

LISA PETERSON: BUT WE ALSO DISCUSSED THIS WITH ELIZABETH.

MR. WADE: LET'S GO TO, LET'S GO TO PAGE 5 OF THE ARTICLE. LET'S LOOK AT THE PARAGRAPH -- THE TWO PARAGRAPHS ON THE RIGHT COLUMN, "IMPORTANTLY" AND "IT TAKES." LET'S BLOW THOSE UP. AND LET'S GO TO THE MEMO AND BLOW UP THE NEXT BULLET THERE, 12. OKAY. TAKE A MINUTE TO REVIEW THOSE.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: DO YOU SEE THAT YOU'RE LIFTING THAT ALMOST DIRECTLY FROM THE "FORTUNE" ARTICLE?

LISA PETERSON: NOT EXACTLY. AND WE TALKED ABOUT -- WE TALKED ABOUT HER USING THE MACHINE IN THE MILITARY AND USING IT -- THEY WERE WORKING ON EBOLA AT THE TIME. THERE WAS A LOT OF DISCUSSION AROUND WHAT THEY WERE DOING WITH THE GOVERNMENT.

MR. WADE: AND, AND IN THE 30 MINUTE CALL?

LISA PETERSON: YES. THERE WAS, THERE WAS -- WE WERE TALKING ABOUT WHERE THEY WERE USING IT AND IS IT ACCURATE.

MR. WADE: IN THE 30 MINUTE CALL? I'M JUST TRYING TO UNDERSTAND WHERE YOU'RE GETTING THIS KNOWLEDGE.

LISA PETERSON: I DON'T RECALL WHICH ONE EXACTLY, BUT WE -- I KNOW WE TALKED ABOUT IT AT LENGTH IN THE MEETING ON THE 14TH.

MR. WADE: OKAY. SO TO THE EXTENT THAT THERE ARE LANGUAGE SIMILARITIES BETWEEN THESE TWO PARAGRAPHS, THAT'S JUST A COINCIDENCE? OR DID YOU LIFT IT FROM THE "FORTUNE" ARTICLE?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. LET'S FOCUS ON THAT MILITARY SENTENCE THAT MAKES IT -- LET'S HIGHLIGHT THE SENTENCE ON THE RIGHT THAT SAYS "THAT MAKES IT POSSIBLE TO IMAGINE ONE DAY." LET'S HIGHLIGHT THE REST OF THAT. DO YOU SEE THAT?

MR. WADE: THAT, THAT DOESN'T SAY THAT THEY'RE DOING IT RIGHT NOW; CORRECT?

MR. WADE: OKAY. IT SAYS IT MAKES IT POSSIBLE TO DO IT; CORRECT?

MR. WADE: AND THEY WERE DOING A LOT OF RESEARCH AND HAVING A LOT OF MEETINGS AND TRYING TO DO THAT, WEREN'T THEY?

LISA PETERSON: CORRECT. BUT THAT'S WHY WE ASKED ABOUT IT WHEN WE WENT THERE ON THE 14TH OF WHAT IS GOING ON? WHERE ARE YOU USING IT? AND WE TALKED ABOUT IT BEING USED WITH THE GOVERNMENT.

MR. WADE: RIGHT. I -- IT WASN'T -- I THOUGHT YOU SAID IT WAS IN THE OCTOBER 3RD CALL?

MR. WADE: IT WAS IN BOTH?

LISA PETERSON: WE DEFINITELY TALKED ABOUT -- WE DEFINITELY ASKED THE QUESTION WHEN WE WERE THERE AROUND THIS WHOLE CONVERSATION WHETHER IT WAS BEING USED. WE WERE ASKING ABOUT WHETHER THAT WAS TRUE OR NOT.

LISA PETERSON: ON THE 14TH.

MR. WADE: AND THEY SAID IT WAS POSSIBLE IN THE ARTICLE; CORRECT?

LISA PETERSON: CORRECT. AND THAT'S WHAT IT SAYS. IT SAYS MAKING IT POSSIBLE TO PLACE A THERANOS LAB. I DIDN'T SAY THAT THEY WERE.

MR. WADE: RIGHT. AND, IN FACT --

LISA PETERSON: BUT THIS WAS SOMETHING THAT WE ASKED ABOUT.

MR. WADE: MY APOLOGIES FOR INTERRUPTING. I BELIEVE IN YOUR DIRECT TESTIMONY YOU DID SAY THAT THEY WERE, BUT THAT'S NOT WHAT THE ARTICLE SAYS; RIGHT?

LISA PETERSON: I'M MAYBE MIXING THE CALL WITH THE MEETING.

MR. WADE: OKAY. THE ARTICLE DOES NOT SAY THAT; CORRECT? IT SAYS IT'S POSSIBLE; RIGHT?

LISA PETERSON: CORRECT, AND SO DO MY NOTES.

MR. WADE: AND YOUR STATEMENT SAYS THAT IT'S POSSIBLE; CORRECT?

MR. WADE: OKAY. AND, IN FACT, THEY TOLD YOU IN THE MEETING THAT THEY WERE PAUSING THEIR WORK WITH THE MILITARY AND PHARMA AND FOCUSSING ALL OF THEIR EFFORTS ON RETAIL; CORRECT?

LISA PETERSON: I DON'T RECALL THEM SAYING THAT THEY PAUSED IT.

MR. WADE: YOU DON'T REMEMBER WRITING THAT IN YOUR MEMO?

LISA PETERSON: I DON'T RECALL THEM SAYING THAT THEY PAUSED DOING THAT. THEY WERE FOCUSSING THEIR EFFORTS ON WALGREENS AND MOVING FORWARD. THAT WAS THE DIRECTION THAT THEY WERE GOING TO TAKE. BUT IT WAS IMPORTANT TO US WHAT THEY WERE DOING HISTORICALLY, WHICH WAS WORKING WITH THE MILITARY AND WORKING WITH PHARMACEUTICAL COMPANIES. THAT WAS IMPORTANT TO VALIDATE THE ACCURACY OF THE MACHINE AND THEIR TESTING. ALL OF THAT WAS IMPORTANT.

MR. WADE: UNDERSTOOD. LET ME GO TO THE NEXT BULLET POINT. THIS PARAGRAPH IS FROM THE "FORTUNE" ARTICLE AS WELL; CORRECT?

MR. WADE: OKAY. ON YOUR DIRECT TESTIMONY YOU SAID IT WAS FROM MS. HOLMES AND IN THE MEETING, RIGHT? BUT IT WAS ACTUALLY ALMOST VERBATIM FROM THE "FORTUNE" ARTICLE; RIGHT?

LISA PETERSON: NO. I SAID THAT SOME OF THE SKEPTICISM I PULLED FROM OUT OF THE INTERNET, AND THAT'S WHAT THIS IS, INCUMBENT PLAYERS CRITICIZED THERANOS. THIS DIDN'T COME FROM THERANOS SAYING THIS. I WAS TRYING TO GIVE THE FAMILY MEMBERS AN IDEA OF WHAT THE MARKET WAS SAYING ABOUT THEM, WHICH PART OF IT DID COME FROM ARTICLES THAT I HAD READ.

LISA PETERSON: MORE THAN JUST THIS ONE.

MR. WADE: AND, IN FACT, IT'S IN THIS, IN THIS PARAGRAPH RIGHT HERE IN THE ARTICLE; CORRECT?

MR. WADE: AND THE NEXT PARAGRAPH IS FROM THE "FORTUNE" ARTICLE THAT YOU GOT FROM MR. MOSLEY AS WELL; CORRECT?

MR. WADE: OKAY. YOU RECALL THAT ONE?

LISA PETERSON: I DO RECALL THE BOTTOM PART OF THAT AND I -- WE DID NOT HEAR FROM HER WHAT HER SKEPTICS WERE. YOU KNOW, THAT WAS STUFF THAT I WAS PULLING OUT OF THE INTERNET IN CERTAIN THINGS LIKE THIS AND OTHER THINGS THAT I HAD READ, YES.

MR. WADE: OKAY. AND YOU MENTIONED THE -- YOU MENTIONED THAT THE WALGREENS RELATIONSHIP WAS IMPORTANT TO --

MR. WADE: -- YOU, OR RELEVANT TO YOU; CORRECT?

MR. WADE: LET'S GO TO PAGE 5 OF YOUR MEMO AND HIGHLIGHT THE FIRST HALF OF THAT DOWN TO "ALLIANCE BOOTS." YOU SEE THAT'S FROM YOUR MEMO; RIGHT?

MR. WADE: EXHIBIT 5; RIGHT?

MR. WADE: PAGE 2 OF THE MEMO?

MR. WADE: AND YOU MENTION BEFORE 44 LOCATIONS, BUT HERE YOU HAVE 22 LOCATIONS; RIGHT?

MR. WADE: AND THAT'S BECAUSE YOU GOT THE WALGREENS INFORMATION FROM THE "FORTUNE" ARTICLE; RIGHT?

LISA PETERSON: IT COULD BE, YES. THE 40 CAME FROM THE MEETING TOGETHER.

MR. WADE: AND IF WE JUST GO DOWN TO THE KEY OBJECTIVES, IF WE JUST GO BACK TO YOUR MEMO, THE BOTTOM, WE CAN BRING THE "FORTUNE" ARTICLE DOWN. THESE WERE WHAT YOU IDENTIFIED AS THE KEY OBJECTIVES FOR THE MEETING IN YOUR MEMO?

MR. WADE: YEAH. AND WAS THAT ACCURATE AT THE TIME TO THE BEST OF YOUR KNOWLEDGE?

MR. WADE: OKAY. AND YOU ASKED MR. TUBERGEN --

LISA PETERSON: CAN I SAY ONE OTHER THING? THIS IS THERANOS --

MR. WADE: THERE'S NO QUESTION PENDING. SO THE WAY THIS GENERALLY WORKS IS THAT THE GOVERNMENT CAN DO FOLLOWUP WITH YOU, BUT --

JUDGE DAVILA: HE'LL ASK YOU ANOTHER QUESTION.

MR. WADE: YEAH, I'LL ASK YOU ANOTHER QUESTION.

BY MR. WADE:

MR. WADE: THE -- MR. TUBERGEN -- YOU ASKED MR. TUBERGEN IN ADVANCE WHETHER THERE WAS ANY SORT OF MODELING OR ANYTHING THAT SHOULD BE DONE IN CONNECTION WITH THE THERANOS INVESTMENT; CORRECT?

MR. WADE: AND HE TOLD YOU NO; RIGHT?

LISA PETERSON: HE JUST SAID THAT IT WASN'T NECESSARY FOR THIS.

MR. WADE: OKAY. BUT FINANCIAL MODELING IS SOMETHING THAT IS FREQUENTLY DONE IN DUE DILIGENCE; RIGHT?

LISA PETERSON: IT'S -- YES.

MR. WADE: OKAY. BUT MR. TUBERGEN TOLD YOU NOT TO DO IT IN THIS CASE; RIGHT?

LISA PETERSON: HE SAID WE WERE RELYING ON WHAT WE WERE GIVEN BY THE COMPANY.

MR. WADE: RIGHT. AND YOU ACTUALLY RAISED A COUPLE OF POTENTIAL TECHNICAL PEOPLE THAT YOU COULD TALK TO AS WELL. DO YOU RECALL THAT?

LISA PETERSON: I DON'T RECALL WHAT YOU MEAN.

MR. WADE: WERE YOU AWARE THAT MEMBERS OF THE DEVOS FAMILY RAISED WITH MR. TUBERGEN THAT THERE MIGHT BE SOME TECHNICAL PEOPLE WHO COULD BE USED TO CONSULT ON THIS RELATIONSHIP?

LISA PETERSON: I DON'T --

MR. WADE: YOU DON'T?

LISA PETERSON: -- KNOW WHAT YOU'RE REFERRING TO.

MR. WADE: I'M JUST WONDERING IF YOU RECALL THAT COMING UP IN ADVANCE OF THE MEETING.

MR. WADE: OKAY. YOU MENTIONED THAT YOU DID LOOK AT THE TWO BINDERS OF MATERIALS; RIGHT?

MR. WADE: AND MR. LEACH SHOWED YOU, I DON'T KNOW, TWO INCHES OF THEM MAYBE? IS THAT FAIR?

MR. WADE: IS IT --

MR. WADE: OKAY. I BELIEVE IN YOUR PRIOR TESTIMONY YOU SAID THERE WERE ABOUT A FOOT OF MATERIALS.

MR. WADE: AND WHAT WERE THE OTHER MATERIALS IN THE BINDER?

LISA PETERSON: I CAN'T RECALL ALL OF THE SPECIFICS OF THAT, BUT IT WAS VERY MUCH -- ONE BINDER WAS VERY MUCH THERANOS AND THE COMPANY AND WHAT IT DOES AND WHAT IT HAD TO OFFER, AND THE SECOND BINDER WAS VERY CLINICAL.

MR. WADE: VERY CLINICAL. WAS IT DATA?

MR. WADE: OKAY. SO THEY SENT YOU -- DID THEY SEND YOU LIKE A REAM OF DATA BASICALLY?

MR. WADE: OKAY. DID YOU ASK ANYONE TO LOOK AT THAT?

MR. WADE: OKAY. SO THERE'S DATA. WHAT ELSE DO YOU RECALL ABOUT WHAT THEY SENT?

LISA PETERSON: THAT'S WHAT I RECALL.

MR. WADE: OKAY. DID YOU REVIEW THE DATA YOURSELF, OR TRY TO REVIEW THE DATA?

LISA PETERSON: I FLIPPED THROUGH ALL OF THE PAGES OF BOTH BINDERS AND THE KEY THINGS THAT WERE IMPORTANT TO US WAS THE WORK WITH THE PHARMACEUTICAL COMPANIES AND THE FINANCIALS AND THE CONTRACTS AND THE MANY TIMES THAT IT STATED THAT -- THE ACCURACY OF THE TEST.

MR. WADE: YEAH, I UNDERSTAND YOUR TESTIMONY. BUT YOU ACTUALLY DIDN'T MAKE THE INVESTMENT DECISION; RIGHT?

MR. WADE: OKAY. THE -- LET'S LOOK AT THE MATERIALS YOU WERE SENT. IT'S 4858. AND YOU'RE THE ONLY PERSON AT RDV WHO LOOKED AT THESE MATERIALS; RIGHT?

LISA PETERSON: I DON'T KNOW.

MR. WADE: OKAY. YOU'RE NOT AWARE OF ANYONE ELSE LOOKING AT THOSE?

LISA PETERSON: I'M NOT AWARE, NO.

MR. WADE: AND WHEN MR. TUBERGEN GOT THEM, HE ASKED YOU TO LOOK AT THEM; RIGHT?

MR. WADE: OKAY. AND DO YOU RECALL PREVIOUSLY MAKING STATEMENTS TO THE EFFECT OF YOU'RE THE ONLY ONE WHO DID A DETAILED REVIEW OF THE BINDERS?

MR. WADE: OKAY. THAT'S BECAUSE YOU DON'T KNOW OF ANYONE ELSE DOING IT; RIGHT?

MR. WADE: OKAY. AND WITHIN THESE MATERIALS -- SO THEY SENT THE TWO BINDERS. DID YOU ASK IN FOLLOWUP FOR ANY ADDITIONAL INFORMATION IN WRITING?

MR. WADE: OKAY. AND --

LISA PETERSON: WE WERE GOING TO GO AND VISIT THEM, SO WE DIDN'T THINK IT WAS NECESSARY TO ASK FOR MORE.

MR. WADE: I UNDERSTAND. BUT MY QUESTION WAS WHETHER -- YOU UNDERSTAND THAT IN A TYPICAL DUE DILIGENCE PROCESS, FREQUENTLY THERE ARE LISTS OF REQUESTS; RIGHT?

MR. WADE: OKAY. AND THEN YOU SEND THAT TO THE OTHER SIDE, RIGHT, IN A TYPICAL DUE DILIGENCE PROCESS; RIGHT?

MR. WADE: AND THEN THEY SEND YOU BACK MATERIALS; RIGHT?

MR. WADE: AND YOU DIDN'T DO THAT IN THIS CASE?

LISA PETERSON: WE WERE GOING TO SEE THEM PERSONALLY AND SPEND A DAY THERE, SO WE WERE GOING TO HANDLE IT THEN.

MR. WADE: I UNDERSTAND. BUT WITH RESPECT TO WRITTEN MATERIALS OR MORE DETAILED INFORMATION --

LISA PETERSON: NO, WE DID NOT ASK FOR MORE.

MR. WADE: OKAY. AND IS IT YOUR TESTIMONY THAT YOU DID REVIEW IN DETAIL ALL OF THE MATERIAL WITHIN THE SUBGROUP?

MR. WADE: WITHIN TWO -- 4858, DID YOU LOOK CAREFULLY AND REVIEW ALL OF THIS MATERIAL?

LISA PETERSON: I HAVE A 4859 AND 4734.

MR. WADE: I'M SORRY. IT'S IN THE WHITE BINDER BECAUSE MR. LEACH REFERRED TO IT EARLIER.

LISA PETERSON: WHAT NUMBER?

LISA PETERSON: YES. AND ALL OF THE HIGHLIGHTING WAS DONE EARLY.

MR. WADE: OKAY. SO YOU'VE REVIEWED EVERYTHING IN THIS EXHIBIT IN DETAIL?

MR. WADE: OKAY. DO YOU SEE IN THE BACK THERE'S A VERY DETAILED LIST OF INTELLECTUAL PROPERTY MATERIALS?

LISA PETERSON: YOU'LL HAVE TO GIVE ME A PAGE NUMBER.

MR. WADE: SURE. I BELIEVE IT'S 12805 IN THE BOTTOM RIGHT CORNER, OR ON THE EXHIBIT IN THE MIDDLE IT'S 133.

MR. WADE: OKAY. AND IN CONNECTION WITH THIS, THE GOVERNMENT -- OR, I'M SORRY -- THE COMPANY SENT YOU A LIST OF ALL OF THEIR INTELLECTUAL PROPERTY MATERIALS; CORRECT?

MR. WADE: AND DID YOU DO -- DID YOU REVIEW THIS AND LOOK AT THE PATENTS THAT THE COMPANY HAD FILED?

LISA PETERSON: WE, WE KNEW THAT THEY HAD PATENTS. I CAN'T SAY THAT I REVIEWED THEM OR KNEW WHAT THE PATENTS WERE.

MR. WADE: OKAY. SO THIS WASN'T REVIEWED IN DETAIL?

LISA PETERSON: THIS LENDS CREDIBILITY TO THE FACT THAT IT WORKS. YES, I FLIPPED THROUGH EVERYTHING.

LISA PETERSON: BUT I'M NOT A SCIENTIST, SO I DON'T KNOW EXACTLY WHAT SOME OF THESE ARE SAYING. BUT I DO -- I CAN FIGURE OUT WHETHER THINGS ARE LENDING CREDIBILITY TO WHAT THEY WERE TELLING US.

MR. WADE: NO, I UNDERSTAND. I JUST -- YOU UNDERSTAND THAT OFTEN IN DUE DILIGENCE ON TECHNOLOGY COMPANIES THAT PEOPLE DO PRETTY DETAILED REVIEWS OF INTELLECTUAL PROPERTY PORTFOLIOS; RIGHT?

MR. WADE: THEY'LL HIRE EXPERTS. ARE YOU AWARE OF THAT?

MR. WADE: AND DID YOU DO THAT?

MR. WADE: AND YOU DIDN'T HIRE AN EXPERT; CORRECT?

MR. WADE: AND YOU DIDN'T, BY YOURSELF, LOOK UP ANY OF THESE MATERIALS IN A PUBLIC RECORD OR ASK FOR ANY INFORMATION RELATING TO THESE MATERIALS?

LISA PETERSON: NO. WE TRUSTED WHAT WE READ.

MR. WADE: WELL, BUT DID YOU WANT ANY MORE INFORMATION? FOR EXAMPLE, A LOT OF THESE --

MR. WADE: -- SOME OF THESE PATENTS AND APPLICATIONS RELATE TO THE USE OF SMALL SAMPLES ON COMMERCIAL DEVICES.

MR. WADE: DID YOU LOOK INTO THAT AT ALL?

LISA PETERSON: NO. WHAT WAS RELEVANT TO US WAS THAT THEY SAID THAT'S WHAT THEY WERE DOING. AGAIN, IT GOES BACK TO THE KEY THINGS OF WHAT WE WERE UNDERWRITING, WHICH WERE THE FINANCIALS, THE CONTRACTS, AND THE VALIDITY OF THE ANALYZER WORKING BY ALL THE PHARMACEUTICAL COMPANIES AND THE GOVERNMENT.

MR. WADE: I'M GLAD YOU BROUGHT UP THE CONTRACTS. WHAT WAS YOUR UNDERSTANDING OF THE WALGREENS CONTRACT?

LISA PETERSON: THAT IT WAS BEGINNING TO LAUNCH AND ROLL OUT IN ADDITIONAL LOCATIONS. THERE WAS NO SUGGESTION THAT THERE WAS ANYTHING WRONG WITH THE WALGREENS CONTRACTS.

MR. WADE: DID YOU LOOK --

LISA PETERSON: AND THAT SAFEWAY WAS GOING TO ROLL OUT AS WELL.

MR. WADE: DID YOU LOOK AT THE CONTRACTS?

MR. WADE: OKAY. YOU UNDERSTAND THAT'S A PRETTY TYPICAL THING TO REQUEST IN DUE DILIGENCE?

MR. WADE: MATERIAL CONTRACTS? YOU DIDN'T ASK FOR THEM?

MR. WADE: DID YOU ASK FOR A SUMMARY OF THE RELATIONSHIP?

LISA PETERSON: WE TALKED ABOUT THE WALGREENS RELATIONSHIP AND IT WAS ALL VERY POSITIVE.

MR. WADE: AND THEY TOLD YOU ABOUT THE PHASE I AND PHASE II OF THE WALGREENS RELATIONSHIP?

LISA PETERSON: I DON'T RECALL THAT SPECIFICALLY.

MR. WADE: DO YOU RECALL IT GENERALLY?

LISA PETERSON: IN GENERAL. I MEAN, WE TALKED ABOUT, WE ASKED ABOUT WHAT -- AGAIN, AT THE MEETING, WE WANTED TO KNOW WHERE THEY WERE GOING TO GO NEXT, WHAT -- WERE THEY GOING TO BIG CITIES AND HOW MANY CITIES AND HOW MANY LOCATIONS WERE THEY GOING TO OPEN IN THE NEXT YEAR OR TWO? AND THAT'S WHAT THE DISCUSSION WAS AROUND.

MR. WADE: WHAT WAS YOUR UNDERSTANDING OF THE PHASE I AND PHASE II OF THE WALGREENS RELATIONSHIP?

LISA PETERSON: I DON'T KNOW WHAT YOU MEAN BY PHASE I AND PHASE II OF THE WALGREENS RELATIONSHIP. THEY WERE IN 40 STORES AT THE TIME, AND THEY WERE GOING TO ROLL OUT TO 900 THE FOLLOWING YEAR.

LISA PETERSON: AND THEY WERE GOING TO ROLL INTO I WANT TO SAY FOUR METROPOLITAN AREAS FIRST, AND THEY WERE VERY SPECIFIC ABOUT HOW MANY LOCATIONS -- HOW MANY METROPOLITAN AREAS THEY WERE GOING TO GO IN EACH YEAR.

MR. WADE: RIGHT. THEY HAD A PLAN --

MR. WADE: -- THAT THEY WERE GOING TO IMPLEMENT; RIGHT?

MR. WADE: THEY HAD THE EXECUTION LIST, BUT THEY HAD --

LISA PETERSON: THEY HAD A ROLLOUT PLAN.

MR. WADE: THEY HAD A ROLLOUT PLAN?

MR. WADE: BUT MY QUESTION WAS MORE, DO YOU RECALL ANY DISCUSSION OR ASKING ANY QUESTIONS ABOUT TWO DIFFERENT PHASES OF THE WALGREENS RELATIONSHIP THAT WAS SET FORTH IN WALGREENS CONTRACTS?

LISA PETERSON: THAT'S NOT HOW IT WAS CHARACTERIZED TO US.

MR. WADE: OKAY. THE DOCUMENT JUST PRIOR TO THIS IS THE PFIZER THERANOS DOCUMENT THAT IF YOU LOOK ON PAGE --

MR. WADE: -- 104. ACTUALLY, IF YOU CAN BRING UP 109, 109 OF THE EXHIBIT, WHICH IS PAGE 6 OF THIS DOCUMENT.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: DO YOU SEE THIS DOCUMENT?

MR. WADE: OKAY. AND THIS SETS FORTH THE DETAILS OF THE RELATIONSHIP, DO YOU SEE THAT, OF THE PROJECT THAT THEY WERE DOING?

LISA PETERSON: WHERE ARE YOU LOOKING?

MR. WADE: I'M JUST LOOKING AT PAGE 109.

LISA PETERSON: YES, ON THE PAGE.

MR. WADE: AND DO YOU SEE -- IF YOU LOOK UP ON THE SCREEN, DO YOU SEE THIS?

MR. WADE: IT SAYS "FOR THIS STUDY, AN INSTRUMENT WAS DEPLOYED IN THE HOME OF EACH PATIENT."

MR. WADE: "FOUR OTHERS WERE INSTALLED AT THE CANCER CENTER." DO YOU SEE THAT?

MR. WADE: OKAY. AND DO YOU UNDERSTAND THAT THIS WAS A THERANOS DEVICE?

MR. WADE: AND IT THEN TALKS ABOUT HOW THREE ASSAYS WERE PERFORMED SIMULTANEOUSLY IN MULTIPLEX. DO YOU SEE THAT?

MR. WADE: AND DO YOU KNOW WHAT THAT MEANS?

MR. WADE: IT MEANS THAT AT THE TIME THEY ARE RUNNING THE TESTS, THAT THEY'RE RUNNING THREE DIFFERENT TESTS AT THE SAME TIME. DID YOU UNDERSTAND THAT AT THE TIME?

MR. WADE: AND WAS THERE ANY DISCUSSION OF EXACTLY WHAT HAPPENED IN CONNECTION WITH THIS?

LISA PETERSON: NO. THE PAGES THAT WE WERE FOCUSSED IN ON ARE THE ONES THAT SAY THAT THE THERANOS SYSTEM PERFORMED WITH SUPERIOR PERFORMANCE TO REFERENCE ASSAYS WHILE RUNNING IN A COMPLEX AMBULATORY ENVIRONMENT AND THINGS LIKE THAT. WE WERE MUCH MORE AT THE SUMMARY LEVEL THAN GOING THROUGH AND MAKING SURE THAT THE PROCESS THAT THEY USED OR WHAT THEY WERE DOING WAS -- WE DIDN'T NEED TO UNDERSTAND THE PROCESS THAT THEY WERE USING, JUST THE OUTCOME.

MR. WADE: OKAY. MY QUESTION THEN IS THIS: WHAT DID THEY DO IN THIS? WHAT WAS THIS REPORT?

LISA PETERSON: THIS, THIS WAS -- THIS DEFINITELY TOLD US THAT, THAT PFIZER WAS USING THEIR MACHINES AND IT WAS PERFORMING EXCEPTIONALLY WELL IN THEIR TESTS.

MR. WADE: DID YOU UNDERSTAND THAT PFIZER -- THAT THE MACHINES WERE DEPLOYED IN THE HOME OF A NUMBER OF PATIENTS?

LISA PETERSON: I DON'T RECALL THAT. IT WAS A LONG TIME AGO.

LISA PETERSON: THE SPECIFICS OF THE REPORT.

MR. WADE: RIGHT. YOU JUST RECALL THE SPECIFIC PARTS THAT THE GOVERNMENT POINTED YOU TO? IS THAT THE LIMIT OF YOUR RECOLLECTION?

LISA PETERSON: NO, NO. I COMPLETELY REMEMBER WHEN WE WERE DOING THIS THAT THAT -- THE TAKE AWAY FROM THIS IS THAT LARGE PHARMACEUTICAL BUSINESSES, COMPANIES, WERE USING THEIR ANALYZER AND THEY WEREN'T HAVING ANY ISSUES WITH IT.

MR. WADE: RIGHT. NO. I UNDERSTAND THAT POINT.

LISA PETERSON: THAT WAS THE TAKE AWAY.

MR. WADE: I UNDERSTAND. BUT YOU TALKED ABOUT HOW IT VALIDATED THE TECHNOLOGY, AND TO VALIDATE THE TECHNOLOGY, YOU KIND OF NEED TO KNOW WHAT HAPPENED AND HOW IT WORKED; RIGHT?

LISA PETERSON: NO. I JUST NEED TO KNOW THAT THEY SAID IT WORKED.

MR. WADE: OKAY. AND YOU UNDERSTOOD THAT THEY WERE TESTING THIS IN CONNECTION WITH THE USE OF -- THAT THIS WAS A THERANOS DEVICE; RIGHT?

MR. WADE: AND THAT THIS WAS TESTED IN CONNECTION WITH A PFIZER DRUG; RIGHT?

MR. WADE: OKAY. THAT BOTH COMPANIES WERE INVOLVED IN THIS; RIGHT? YOU KNEW THAT?

LISA PETERSON: THAT -- I DON'T RECALL THAT. I DON'T RECALL EXACTLY. I JUST KNOW THAT THEY WERE USING THEIR ANALYZERS IN CLINICAL TRIALS.

MR. WADE: OKAY. AND IF YOU GO TO PAGE 8 -- I'M SORRY, ONE MORE PAGE. DO YOU HAVE ANY FAMILIARITY WITH CHARTS OF THIS KIND?

MR. WADE: OKAY. THIS IS A MEASURE OF ACCURACY. DO YOU HAVE ANY -- WAS THERE ANY DISCUSSION OF THE R SQUARED OF THIS PARTICULAR ASSAY?

MR. WADE: OKAY. LET'S GO BACK TO THE START OF THE DOCUMENT. IF WE GO TO -- LET'S GO TO PAGE 3. OKAY. HERE -- DO YOU SEE THE REFERENCE TO THERANOS'S PROPRIETARY PATENTED TECHNOLOGY?

MR. WADE: OKAY. AND THEY ATTENDED -- APPENDED ALL OF THE PATENTS TO THIS PRESENTATION; RIGHT?

LISA PETERSON: THEY -- I'M SORRY?

MR. WADE: THEY APPENDED A LIST OF ALL OF THEIR PATENTS? DO YOU RECALL THAT?

MR. WADE: OKAY. WHAT DO YOU UNDERSTAND TO BE THE BREADTH OF THERANOS'S PROPRIETARY PATENTED TECHNOLOGY AS REFERENCED IN THIS STATEMENT?

LISA PETERSON: THAT IT WAS CAPABLE OF DOING FINGERSTICK BLOOD TESTING --

MR. WADE: AND WHAT IS "IT"?

LISA PETERSON: -- ON THEIR ANALYZER.

MR. WADE: I'M SORRY, I THOUGHT YOU WERE DONE. WHAT IS "IT"?

MR. WADE: YEAH, YOU SAID "IT IS CAPABLE." WHAT IS "IT"?

LISA PETERSON: THAT THE ANALYZER IS CAPABLE OF DOING FINGERSTICK TECHNOLOGY BECAUSE OF ITS IP --

MR. WADE: NO. MY QUESTION IS --

LISA PETERSON: -- AND IS DOING IT ACCURATELY.

MR. WADE: MY QUESTION WAS, WHAT DOES THERANOS PROPRIETARY PATENTED TECHNOLOGY REFER TO? WHAT IS THE BREADTH OF THE TECHNOLOGY?

LISA PETERSON: THE WAY THAT THE ANALYZER WORKS AND RUNS FINGERSTICK BLOOD TESTING ON IT.

MR. WADE: SO IS IT YOUR TESTIMONY THAT THERANOS PROPRIETARY PATENTED TECHNOLOGY REFERS TO JUST THE DEVICE?

LISA PETERSON: AND HOW IT DOES -- HOW IT DOES THE BLOOD TESTING WITHIN THE DEVICE, YES.

LISA PETERSON: WITH THE ASSAYS.

MR. WADE: OKAY. IT DOESN'T SAY "DEVICE" THERE? YOU'LL AGREE WITH ME; RIGHT?

LISA PETERSON: I THINK IT'S IMPLIED.

MR. WADE: OKAY. AND THAT WAS YOUR UNDERSTANDING AT THE TIME; CORRECT?

MR. WADE: OKAY. YOU UNDERSTOOD THAT A LOT OF THESE SLIDES WERE FORWARD LOOKING; RIGHT?

MR. WADE: YOU DIDN'T UNDERSTAND THAT?

MR. WADE: YOU THOUGHT THEY WERE ALL PRESENT?

MR. WADE: OKAY. SO LET'S LOOK AT -- I KNOW MR. LEACH SHOWED YOU SOME. LET'S LOOK AT -- LET'S GO TO 19, WHICH IS -- YEAH, 19. IT'S 19 ON BOTH DOCUMENTS. DO YOU SEE THAT?

MR. WADE: NOW, THIS IS FORWARD LOOKING; RIGHT?

MR. WADE: AND THIS IS TALKING ABOUT THE FUTURE; RIGHT?

LISA PETERSON: WITH HOW IT'S GOING TO SAVE THE GOVERNMENT MONEY.

MR. WADE: RIGHT. AND THIS IS A GOAL; RIGHT?

MR. WADE: THIS IS IN PART THE VISION THAT MS. HOLMES HAD WAS TO TRY TO CHANGE HEALTH CARE IN A WAY WHERE THERE WERE SAVINGS TO THE WHOLE SYSTEM; RIGHT?

MR. WADE: OKAY. AND IF YOU LOOK AT THE NEXT SLIDE, IT'S SIMILAR; RIGHT?

MR. WADE: AND IF YOU LOOK AT THE NEXT SLIDE, IT'S SIMILAR?

MR. WADE: AND IF WE CAN CLICK THROUGH A COUPLE MORE. THESE ARE FORWARD LOOKING ITEMS; RIGHT?

MR. WADE: OKAY. IF YOU WOULD LOOK AT 40, WHICH MR. LEACH TALKED TO YOU ABOUT THIS. THIS IS FORWARD LOOKING; RIGHT?

MR. WADE: AND THEY WEREN'T NATIONALLY DEPLOYED AT THIS TIME?

MR. WADE: THEY WERE TALKING ABOUT THE VISION THAT THEY HAD FOR THE COMPANY; RIGHT?

LISA PETERSON: NO. BUT IT WAS VERY CLEAR THAT THEY WERE GOING TO DO 900 THE NEXT YEAR.

MR. WADE: AND THIS TALKS ABOUT 8,000; RIGHT?

MR. WADE: OKAY. AND THAT HAD NOT HAPPENED YET; RIGHT?

MR. WADE: AND MOST OF THE DOTS ON THIS WERE NOT THERE?

MR. WADE: OKAY. AND IF YOU LOOK AT THE NEXT SLIDE, THAT, TOO, THAT TALKS ABOUT THE PROXIMITY OF THERANOS TO PATIENTS; RIGHT?

MR. WADE: AND HOW IT COMPARES TO OTHER LABS; RIGHT?

MR. WADE: BUT THAT WASN'T -- THAT DIDN'T HAPPEN YET; RIGHT?

LISA PETERSON: NO. THAT WAS --

MR. WADE: FORWARD LOOKING; RIGHT?

LISA PETERSON: THAT WAS HER VISION, YES.

MR. WADE: ALL RIGHT. AND IF YOU GO TO, IF YOU GO TO SLIDE 28, DO YOU SEE THAT? YOU WERE ASKED ABOUT THAT?

MR. WADE: YOU HIGHLIGHTED THAT?

MR. WADE: AND DO YOU SEE WHERE IT SAYS, "PROCESSES ALL SAMPLE TYPES"?

MR. WADE: AND WHAT DID YOU UNDERSTAND THAT TO MEAN?

LISA PETERSON: I'M FOCUSSED IN ON "THERANOS RUNS ANY TEST AVAILABLE IN CENTER LABORATORIES," AND WE WERE TOLD THAT THEY COULD DO HUNDREDS OF THEM, 2- TO 300 OF THEM.

MR. WADE: MY QUESTION WAS ABOUT THE LANGUAGE "AND PROCESSES ALL SAMPLE TYPES." DO YOU SEE THAT?

MR. WADE: WHAT DOES THAT REFER TO?

LISA PETERSON: I DON'T KNOW WHAT THEY MEANT BY THAT.

MR. WADE: DOES IT REFER TO VENOUS DRAWS?

LISA PETERSON: I DON'T KNOW.

LISA PETERSON: IT'S NOT IN THE PICTURE.

MR. WADE: AND AGAIN, I BELIEVE IT WAS YOUR TESTIMONY THERE WERE NO SLIDES AT THE MEETING THAT YOU WENT TO --

MR. WADE: -- IN CALIFORNIA; CORRECT? THESE WERE SENT TO YOU IN ADVANCE; RIGHT?

MR. WADE: AND YOU DIDN'T BRING THESE SLIDES AND GO THROUGH A LIST OF QUESTIONS ITEM BY ITEM; RIGHT?

MR. WADE: AND IN FACT, YOU DIDN'T TAKE ANY NOTES, OTHER THAN ON THE FINANCIAL DOCUMENT, AT THE MEETING; RIGHT?

LISA PETERSON: NO, I TOOK NOTES.

MR. WADE: DO YOU RECALL PREVIOUSLY TESTIFYING THAT YOU TOOK NO NOTES BECAUSE IT WAS A HIGH LEVEL MEETING?

LISA PETERSON: I TOOK ENOUGH NOTES TO WRITE THE MEMO AFTERWARDS, YES.

MR. WADE: AND SO IF YOU TESTIFIED PREVIOUSLY, THAT WAS MISTAKEN?

MR. LEACH: OBJECTION. ARGUMENTATIVE.

JUDGE DAVILA: OVERRULED. YOU CAN ANSWER THE QUESTION.

LISA PETERSON: YES, MY MAIN JOB WAS TO SIT AND LISTEN. BUT I WAS TAKING NOTES, YES.

BY MR. WADE:

MR. WADE: OKAY. BUT AGAIN, NOT WITH RESPECT TO THIS POWERPOINT BECAUSE IT WASN'T DISCUSSED; CORRECT?

LISA PETERSON: CORRECT. THE PAGES THAT WERE PRESENTED WERE THE FINANCIALS IN THE MEETING.

MR. WADE: LET'S -- SINCE YOU BROUGHT IT UP, WHY DON'T WE TALK ABOUT THE FINANCIALS. I BELIEVE THAT'S ITEM 1853. DO YOU SEE THAT?

LISA PETERSON: WHICH BINDER?

MR. WADE: I'M SORRY. THE WHITE BINDER, 1853.

MR. WADE: YOU WERE ASKED QUESTIONS ABOUT THIS DOCUMENT. DO YOU RECALL THAT?

MR. WADE: AND YOU UNDERSTOOD -- JUST HIGHLIGHT THE LANGUAGE IN THE UPPER LEFT-HAND CORNER. AGAIN, YOU UNDERSTOOD THAT THESE WERE PROJECTIONS; RIGHT?

MR. WADE: AND IF YOU GO -- MR. LEACH DIDN'T FOCUS YOU I DON'T THINK ON THE SECOND PAGE. LET'S TAKE A LOOK AT THAT. OKAY. AND YOU SEE THIS WAS INCLUDED WITHIN THE MATERIALS AS WELL. DO YOU RECALL THAT?

MR. WADE: OKAY. AND IT IDENTIFIES THAT THERE'S ALMOST $163 MILLION IN CASH AT THE TIME. DO YOU SEE THAT?

MR. WADE: AND YOU CIRCLED THAT; RIGHT?

MR. WADE: AND THEN DOWN BELOW THERE'S $168 MILLION IN -- ALMOST $169 MILLION IN DEFERRED REVENUE AND CUSTOMER'S DEPOSITS; RIGHT?

MR. WADE: AND YOU CIRCLED THAT; RIGHT?

MR. WADE: OKAY. AND YOU SEE IN THE UPPER LEFT-HAND CORNER THAT THESE FINANCIALS THAT YOU WERE PROVIDED WERE PREPARED FOR THE PERIOD ENDING JULY 14TH, 2014?

LISA PETERSON: UH-HUH, YES.

MR. WADE: AND DID YOU ASK FOR UPDATED FINANCIALS OR PROJECTIONS THAT WERE BEYOND THAT DATE?

LISA PETERSON: WHAT, WHAT WE HAD IN THE BINDERS, THESE TWO PAGES IS WHAT WE WERE GIVEN.

MR. WADE: RIGHT. SO AS OF JULY 14TH, 2014?

MR. WADE: MY QUESTION IS, DID YOU ASK FOR AN UPDATE IN OCTOBER?

LISA PETERSON: I DON'T RECALL IF WE ASKED FOR A SPECIFIC UPDATE.

MR. WADE: OKAY. I'M DONE WITH THE FINANCIAL DOCUMENT. DID YOU ASK, DURING YOUR MEETING, WHETHER THE COMPANY USED CASH OR ACCRUAL ACCOUNTING?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. IS THAT SOMETHING THAT YOU THINK YOU WOULD HAVE NOTED IN YOUR MEMO IF YOU HAD?

LISA PETERSON: I DON'T RECALL ASKING OR TALKING ABOUT THAT.

MR. WADE: YOU TALKED A FAIR AMOUNT ABOUT THE "FORTUNE" ARTICLE; RIGHT?

MR. WADE: AND THAT WAS -- THOSE WERE THE MATERIALS THAT MR. TUBERGEN CAME BACK WITH; RIGHT?

MR. WADE: AND HE WAS VERY EXCITED; RIGHT?

MR. WADE: OKAY. DID YOU READ THE WHOLE ARTICLE?

LISA PETERSON: I BELIEVE SO.

MR. WADE: OKAY. WE'LL COME BACK TO THAT IN A SECOND. IN ADVANCE OF THE MEETING OUT THERE, OR IN THE MEETING OUT THERE, DO YOU RECALL MAKING THE STATEMENT THAT THIS WAS NOT A DUE DILIGENCE MEETING?

LISA PETERSON: I DON'T RECALL THAT.

MR. WADE: OKAY. DID YOU -- IN YOUR MIND THIS WAS NOT A DUE DILIGENCE MEETING; CORRECT?

LISA PETERSON: THIS WAS AN OPPORTUNITY TO ASK QUESTIONS, YES. WE WERE -- IT WAS AN ON SITE VISIT.

MR. WADE: OKAY. DO YOU RECALL TELLING THE GOVERNMENT THAT IN YOUR VIEW THIS WAS NOT A DUE DILIGENCE MEETING?

LISA PETERSON: I DON'T RECALL SAYING THAT.

MR. WADE: WHY DON'T YOU TAKE A LOOK AT EXHIBIT 11249 AT PAGE 6.

MR. WADE: DO YOU HAVE THAT IN FRONT OF YOU?

MR. WADE: IF YOU LOOK AT THE BOTTOM OF 6, DO YOU SEE THE LAST SENTENCE ON THE PAGE?

LISA PETERSON: WHERE ARE THE PAGE NUMBERS?

MR. WADE: GOOD QUESTION. IN THE UPPER RIGHT-HAND CORNER. AGAIN, THIS IS ONE OF THOSE DOCUMENTS WHERE YOU SHOULD READ IT TO YOURSELF AND THEN I'LL ASK A QUESTION. IF YOU COULD READ THE LAST SENTENCE THERE.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: DO YOU SEE THAT LAST SENTENCE?

LISA PETERSON: I'M STILL READING HERE.

(PAUSE IN PROCEEDINGS.)

LISA PETERSON: I DON'T RECALL -- I DIDN'T SAY THAT.

BY MR. WADE:

MR. WADE: HERE'S MY QUESTION. DOES THAT REFRESH YOUR RECOLLECTION THAT YOU TOLD THE GOVERNMENT THAT YOU DID NOT VIEW THE MEETING IN PALO ALTO AS A DUE DILIGENCE MEETING?

LISA PETERSON: I DON'T RECALL SAYING THAT.

MR. WADE: OKAY. DO YOU RECALL DURING THE MEETING THAT THERE WAS A SIGNIFICANT AMOUNT OF DISCUSSION ABOUT MS. HOLMES'S VISION IN THE MEETING?

LISA PETERSON: THERE WAS A LOT OF DISCUSSION ABOUT A LOT OF THINGS. THERE WAS A LOT --

MR. WADE: THAT WASN'T MY QUESTION. MY QUESTION WAS, DO YOU RECALL THAT THERE WAS A SIGNIFICANT AMOUNT OF DISCUSSION ABOUT MS. HOLMES'S VISION IN THE MEETING?

MR. WADE: OKAY. I BELIEVE YOU TESTIFIED ON CROSS BEFORE WE TOOK OUR BREAK THAT YOU DIDN'T KNOW WHETHER THE WALTONS INVESTED?

LISA PETERSON: AT THE TIME OF THE INVESTMENT.

MR. WADE: CAN I DRAW YOUR ATTENTION TO 14089?

MR. WADE: DO YOU HAVE THAT IN FRONT OF YOU?

MR. WADE: AND THAT WAS AN EMAIL BETWEEN YOU AND MR. TUBERGEN AND THE DEVOSES?

MR. WADE: ABOUT THE THERANOS INVESTMENT?

MR. WADE: I MOVE THE ADMISSION OF 14089.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 14089 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: AND IF WE CAN JUST BLOW UP -- DO YOU SEE AT THE TOP THIS IS AN EMAIL ON 10-24-2014?

MR. WADE: OKAY. AND IF YOU GO TO THAT FIRST SENTENCE, DO YOU SEE THAT?

MR. WADE: DO YOU SEE MR. TUBERGEN REPORTING THAT THE WALTON FAMILY FOR SURE IS INVESTING?

LISA PETERSON: YES. I DON'T REMEMBER THIS.

MR. WADE: WERE YOU A PART OF THE DISCUSSIONS THAT HE WAS HAVING WITH REPRESENTATIVES OF THE WALTON FAMILY?

MR. WADE: WERE YOU A PART OF ANY DISCUSSIONS AFTER THE MEETING AT THERANOS WITH MR. MOSLEY?

LISA PETERSON: SAY AGAIN. I'M SORRY.

MR. WADE: WITH MR. MOSLEY? WERE YOU PART OF ANY DISCUSSIONS WITH MR. MOSLEY?

MR. WADE: IN THAT FOLLOWING MONTH?

MR. WADE: AND WERE YOU INVOLVED IN ANY DISCUSSIONS AFTER THE VISIT TO THERANOS WITH MR. TROTT?

LISA PETERSON: MY BOSS WAS.

MR. WADE: MR. DAMSTRA?

MR. WADE: AND ARE YOU AWARE THAT MR. TUBERGEN WAS TALKING WITH MR. TROTT AS WELL?

LISA PETERSON: I ONLY HAD DISCUSSIONS WITH MR. DAMSTRA AROUND BDT. I KNEW THAT THEY WERE POTENTIALLY GOING TO LOOK AT THE INVESTMENT AND MAYBE INVEST.

MR. WADE: OKAY. I THINK ON YOUR DIRECTION TESTIMONY YOU MADE A LOT OF STATEMENTS RELATING TO INFORMATION THAT YOU LEARNED IN THAT MEETING. DO YOU RECALL THAT?

LISA PETERSON: WHICH MEETING?

MR. WADE: IN THE MEETING IN PALO ALTO.

MR. WADE: HADN'T YOU PREVIOUSLY TESTIFIED THAT YOU DIDN'T RECALL THE SPECIFICS OF THAT MEETING?

LISA PETERSON: I -- WE'VE HAD A LOT OF TIME TO THINK ABOUT IT. WE'VE TALKED ABOUT A LOT OF THINGS AND I HAD THE OPPORTUNITY TO READ THROUGH ALL OF THE MEMOS THAT I DID, AND THERE'S -- AND WE DID TALK ABOUT A LOT OF THINGS.

MR. WADE: OKAY. AND, AND YOU GAVE THAT DEPOSITION THAT WE TALKED ABOUT BEFORE IN MARCH OF 2019; RIGHT?

LISA PETERSON: MARCH OF 2019? OKAY, YES.

MR. WADE: THAT'S WHEN YOU GAVE THE DEPOSITION. THAT WAS A COUPLE YEARS AGO, TWO AND A HALF YEARS AGO; RIGHT?

MR. WADE: THAT WAS CLOSER IN TIME TO THE MEETING; RIGHT?

MR. WADE: AND IN THE DEPOSITION YOU WERE SHOWN A LOT OF THE SAME DOCUMENTS THAT YOU'VE LOOKED AT TODAY; RIGHT?

LISA PETERSON: YES, BUT I'VE HAD A LOT OF TIME TO REFLECT AND READ THROUGH A LOT OF THINGS THAT WAS GOING ON AT THAT POINT IN TIME.

MR. WADE: OKAY. AND SO YOU'RE NOT DISPUTING THAT YOU SAID THAT YOU DON'T RECALL THE SPECIFICS IN THAT DEPOSITION?

LISA PETERSON: NOT AT THAT TIME, NO.

MR. WADE: OKAY. SO YOUR MEMORY HAS IMPROVED OVER TIME; IS THAT YOUR TESTIMONY?

LISA PETERSON: I'VE, I'VE RECOLLECTED A LOT OF THINGS FROM WHAT I'VE READ, YES. I HAVE A TENDENCY TO WRITE A LOT DOWN.

MR. WADE: OKAY. THE RECOLLECTION THAT YOU GOT FROM REVIEWING A LOT OF THINGS, IS THAT REVIEWING IT IN CONNECTION WITH YOUR TESTIMONY HERE TODAY?

LISA PETERSON: YEAH. I'VE REVIEWED ALL OF MY NOTES, YES.

MR. WADE: AND YOU WERE ACTUALLY SHOWN ALL OF YOUR NOTES IN THAT DEPOSITION; RIGHT?

LISA PETERSON: THERE WASN'T ANYTHING THAT HASN'T BEEN IN THESE BINDERS.

MR. WADE: RIGHT. AND MY POINT IS THAT IN THAT DEPOSITION YOU WERE ACTUALLY SHOWN YOUR NOTES; RIGHT?

LISA PETERSON: I WAS TOLD NOT TO PREPARE AT ALL FOR ANY OF THOSE DEPOSITIONS, TO WHICH I DIDN'T. I DIDN'T GO BACK AND READ ANY OF MY NOTES FROM BEFORE.

MR. WADE: NOW, YOU ALSO TOLD THE GOVERNMENT IN 2017 THAT YOU DIDN'T TAKE ANY NOTES DURING THAT MEETING. WAS THAT -- ARE YOU -- DO YOU BELIEVE THAT YOU DID NOT SAY THAT?

MR. LEACH: OBJECTION, YOUR HONOR. CALLS FOR HEARSAY.

LISA PETERSON: YEAH, I --

JUDGE DAVILA: EXCUSE ME. EXCUSE ME, MA'AM.

LISA PETERSON: I DON'T RECALL SAYING THAT.

JUDGE DAVILA: HANG ON A SECOND. ARE YOU ABOUT DONE WITH THIS AREA, OR?

MR. WADE: I'VE GOT A LITTLE MORE.

JUDGE DAVILA: OKAY. SUSTAINED.

BY MR. WADE:

MR. WADE: WELL, WHY DON'T YOU LOOK AT 11249, PAGE 7.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: AND DOES THAT REFRESH YOUR RECOLLECTION WHETHER YOU TOOK ANY NOTES?

LISA PETERSON: I'M SORRY. IT'S A LONG MEMO. WHAT AM I LOOKING AT?

MR. WADE: PAGE 7. PAGE 7.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: IF YOU LOOK AT THE FIRST FULL PARAGRAPH.

LISA PETERSON: I DON'T RECALL SAYING THAT.

MR. WADE: AND DO YOU RECALL THAT -- TELLING THE GOVERNMENT THAT IT ONLY CONTAINED HIGH LEVEL INFORMATION?

LISA PETERSON: I DO RECALL THAT, AND I DO RECALL -- IT SAYS PETERSON DID NOT HEAR ANYTHING AT THE MEETING THAT CHANGED HER UNDERSTANDING OF THERANOS.

MR. WADE: OKAY. SO YOU RECALL THAT THE DISCUSSION FOCUSSED ON HIGH LEVEL INFORMATION?

LISA PETERSON: THE DISCUSSION FOCUSSED AROUND EVERYTHING THAT WE HAD READ IN THE BINDERS AND QUESTIONS AROUND THE CONTRACTS AND THE FINANCIALS AND WHERE THEY HAD DONE WORK PREVIOUSLY WITH THE ANALYZER AND WHERE THEY WERE GOING TO ROLL OUT AND THE VISION OF THE COMPANY, YES.

MR. WADE: OKAY. THAT WASN'T MY QUESTION. MY QUESTION WAS, DO YOU RECALL THAT THE MEETING FOCUSSED ON HIGH LEVEL INFORMATION? YES OR NO?

LISA PETERSON: IT DEPENDS ON THE DEFINITION OF "HIGH LEVEL." THOSE WERE THE TOPICS THAT WE DISCUSSED THAT I JUST LISTED.

MR. WADE: DO YOU RECALL ON DIRECT YOU GAVE TESTIMONY ABOUT THE FACT THAT THE SIZE OF THE INVESTMENT INCREASED ON SITE?

MR. WADE: ISN'T IT THE CASE THAT ACTUALLY BEFORE THE DEVOSES AND MR. TUBERGEN AND YOU WENT OUT THERE THAT THERE WAS DISCUSSION AND A BELIEF THAT THEY SHOULD INCREASE THE INVESTMENT TO $100 MILLION?

LISA PETERSON: NOT THAT I RECALL.

MR. WADE: TAKE A LOOK AT 14106.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: DO YOU HAVE 14106 IN FRONT OF YOU?

MR. WADE: AND AGAIN, MR. SCHIERBEEK IS THE CONUMBER 2 PERSON WITHIN THE RDV OFFICE; IS THAT RIGHT?

MR. WADE: OKAY. MOVE THE ADMISSION OF 14106.

MR. LEACH: OBJECTION. HEARSAY, FOUNDATION. SHE'S NOT ON THIS.

MR. WADE: WE'VE LET IN MANY DOCUMENTS THAT SHE'S NOT ON.

JUDGE DAVILA: OKAY. GIVE ME JUST A MOMENT, PLEASE.

(PAUSE IN PROCEEDINGS.)

MR. WADE: AND FOR THE BENEFIT OF THE COURT, I'M FOCUSSED ON NUMBER 2 WITHIN THAT COMMUNICATION.

MR. WADE: FOR THE JUDGE'S BENEFIT. WE'LL WAIT FOR HIM.

(PAUSE IN PROCEEDINGS.)

JUDGE DAVILA: DO YOU WANT TO JUST PROBE THIS THEN? IS THAT WHAT YOU WANT TO DO IS PROBE THIS? OR DID YOU --

BY MR. WADE:

MR. WADE: ARE YOU AWARE THAT THERE WAS ACTUALLY DISCUSSION AND A BELIEF GOING INTO THE TRIP TO CALIFORNIA THAT MR. TUBERGEN WAS VERY BULLISH ON THE POTENTIAL INVESTMENT AND THAT THEY PROBABLY WOULD MAKE $100 MILLION INVESTMENT?

LISA PETERSON: HE WAS VERY BULLISH ON THE OPPORTUNITY. I DON'T RECALL CONVERSATION AROUND 100 MILLION UNTIL AFTER THE MEETING, AND BOB DIDN'T -- MR. SCHIERBEEK DIDN'T HAVE ANYTHING REALLY TO DO WITH THIS DEAL.

MR. WADE: BUT HE'S A SENIOR OFFICER IN THE COMPANY; RIGHT?

LISA PETERSON: YES, BUT HE'S ON THE FAMILY SERVICES SIDE. HE'S NOT PART OF THE INVESTMENT GROUP.

MR. WADE: I UNDERSTAND YOUR VIEW. BUT YOU WERE NOT A PART OF EVERY CONVERSATION THAT MR. TUBERGEN HAD WITH MR. SCHIERBEEK; RIGHT?

LISA PETERSON: CORRECT. BUT I DON'T KNOW -- I DON'T KNOW WHERE HE WOULD HAVE GOTTEN THAT PROBABLY 100 MILLION INVESTMENT. THAT WASN'T THE DISCUSSION THAT WE HAD HAD ON THE PLANE.

MR. WADE: BUT YOU UNDERSTAND HE WAS OF THE VIEW THAT IT WAS PROBABLY A $100 MILLION INVESTMENT?

LISA PETERSON: HE WAS, RIGHT, BUT HE WASN'T WORKING ON THIS DEAL.

MR. WADE: YOU UNDERSTOOD THAT HE COMMUNICATED WITH MR. TUBERGEN ABOUT THE THERANOS TRANSACTION; RIGHT?

LISA PETERSON: SURE. THEY COMMUNICATED. I DON'T KNOW IF THEY TALKED ABOUT THERANOS.

MR. WADE: HE'S ULTIMATELY THE GUY WHO SIGNED THE AGREEMENT; RIGHT?

MR. WADE: HE'S THE GUY WHO AUTHORIZED THE WIRE; RIGHT?

LISA PETERSON: YES. BUT HE WASN'T PART OF THE INVESTMENT COMMITTEE AND HE'S NOT IN THE INVESTMENT GROUP. HE CONTROLS THE CASH.

MR. WADE: I MOVE THE ADMISSION OF THE DOCUMENT.

JUDGE DAVILA: WELL, THERE'S SOME OTHER INFORMATION ON HERE -- THAT'S WHY I ALLOWED YOU TO PROBE.

MR. WADE: I COULD REDACT -- I'D BE WILLING TO REDACT EVERYTHING BUT THAT PARAGRAPH.

JUDGE DAVILA: OKAY. I'LL ALLOW IT IN, JUST THAT NUMBER 2 PARAGRAPH, AND I'M SURE YOUR TEAM CAN REDACT THAT.

(DEFENDANT'S EXHIBIT 14106, PARAGRAPH 2, REDACTED, WAS RECEIVED IN EVIDENCE.)

MR. WADE: YEAH. CAN YOU GIVE ME ONE SECOND SO I CAN LET MY COLLEAGUE WORK?

MR. WADE: OKAY. LET ME KNOW WHEN YOU'RE READY, MR. BENNETT.

JUDGE DAVILA: OKAY. AND WHY DON'T YOU TAKE A LOOK AT IT TO MAKE SURE THAT IT CONFORMS. THAT WOULD PROBABLY BE A GOOD IDEA.

MR. WADE: THANK YOU, YOUR HONOR.

JUDGE DAVILA: FOLKS, WHY DON'T YOU STAND UP AND STRETCH IF YOU WOULD LIKE.

(STRETCHING.)

MR. WADE: JUST TO MAKE SURE WE'RE ON THE SAME PAGE, WE'RE GOING TO INCLUDE THE HEADER AND THAT PARAGRAPH.

JUDGE DAVILA: RIGHT, UP TO SUBJECT AND NUMBER 2.

MR. WADE: RIGHT. EVERYTHING ELSE WILL BE REDACTED.

JUDGE DAVILA: GREAT. WHILE THAT HAPPENING, CAN I JUST ASK A TIME ESTIMATE FOR THIS WITNESS? WILL WE CONCLUDE THIS WITNESS TODAY?

MR. WADE: PROBABLY NOT.

MR. WADE: WE HAVE ANOTHER 30 MINUTES?

JUDGE DAVILA: THAT'S WHAT WE HAVE. THAT'S WHAT I TOLD THE JURY.

MR. WADE: I DON'T THINK SO.

BY MR. WADE:

MR. WADE: OKAY. DO YOU SEE THAT IN FRONT OF YOU ON THE SCREEN NOW?

MR. WADE: AND THIS IS -- 10-14, AGAIN, IS A COUPLE OF DAYS BEFORE YOU, OR MAYBE THE DAY THAT YOU WERE HEADED OUT TO PALO ALTO; CORRECT?

MR. WADE: OKAY. AND IN THIS EMAIL THEY TALK ABOUT JERRY, AND THAT'S JERRY TUBERGEN; RIGHT?

MR. WADE: AND HE'S TRAVELLING OUT TO MEET WITH THE FOUNDER, ELIZABETH HOLMES. DO YOU SEE THAT?

MR. WADE: AND HE'S BEEN VERY BULLISH ON THIS POTENTIAL RELATIONSHIP/INVESTMENT. DO YOU SEE THAT?

MR. WADE: AND THE FAMILY WAS TRAVELLING WITH HIM AND THAT IT WAS PROBABLY A $100 MILLION INVESTMENT; CORRECT? THAT'S WHAT HE SAYS THERE?

MR. WADE: OKAY. AND THE INVESTMENT -- THE DECISION TO -- OR THE COMMITMENT TO INVEST WAS MADE ACTUALLY IN THE ROOM AT THERANOS; CORRECT?

LISA PETERSON: WE TALKED ABOUT SIZING, AND ALONG WITH WHAT SOME OF THE OTHER INVESTORS WERE GOING TO INVEST AT, AND, YES, WE DISCUSSED LOOKING AT IT, OR CONSIDERING THE 100 MILLION INSTEAD OF THE 50 MILLION.

MR. WADE: WELL, ACTUALLY, THERE WAS AN ACTUAL COMMITMENT MADE BY MR. TUBERGEN AND MR. DEVOS TO A $100 MILLION COMMITMENT IN THE MEETING WITH THERANOS; CORRECT?

LISA PETERSON: THERE WASN'T A COMMITMENT, NO. THAT'S NOT HOW IT WORKS. IT HAS TO GO THROUGH OUR INVESTMENT COMMITTEE PROCESS. THEY MAY HAVE SAID THAT THEY WOULD LOOK AT 100 MILLION OR WERE WILLING TO DO 100 MILLION, BUT IT STILL HAD TO BE -- IT STILL HAD TO GO THROUGH THE PROCESS. THERE WERE A NUMBER OF PEOPLE NOT THERE THAT WERE ON THE INVESTMENT COMMITTEE, AND JERRY IS NOT ON OUR INVESTMENT COMMITTEE.

MR. WADE: DO YOU RECALL PREVIOUSLY TESTIFYING THAT THE COMMITMENT WAS MADE IN THE ROOM?

LISA PETERSON: I DON'T RECALL.

MR. WADE: OKAY. WE'LL GO THROUGH THAT IN A SECOND, BUT BEFORE I DO, LET'S LOOK AT THE -- LET'S LOOK AT 204 -- I'M SORRY, 2097. DO YOU SEE THAT IN FRONT OF YOU?

MR. WADE: OKAY. AND THAT'S AN EMAIL BETWEEN YOU AND ONE OF YOUR COLLEAGUES THAT DISCUSSES THE THERANOS INVESTMENT. DO YOU SEE THAT?

LISA PETERSON: YEAH, SHE'S A COWORKER, FRIEND.

MR. WADE: OKAY. MOVE THE ADMISSION OF 2097.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(GOVERNMENT'S EXHIBIT 2097 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: LET ME BLOW UP THE MIDDLE EMAIL. THIS IS AN EMAIL THAT YOU WROTE ON OCTOBER 20TH, 2014; RIGHT?

MR. WADE: THAT'S LESS THAN A WEEK AFTER THE DATE OF THE MEETING; CORRECT?

MR. WADE: AND DO YOU SEE DOWN BELOW WHERE IT SAYS, "JERRY COMMITTED ON THE SPOT $100 MILLION WITH DOUG AND CHERI IN COMPLETE AGREEMENT"? DO YOU SEE THAT?

MR. WADE: AND WAS THAT TRUE AT THE TIME?

LISA PETERSON: IT DOESN'T WORK THAT WAY. I THINK THAT HE HAD SIGNALLED AND DOUG AND CHERI WERE IN AGREEMENT TO DO THE 100 AND WE TALKED ABOUT THE 100 AFTERWARD. BUT IT STILL HAS TO GO THROUGH THE PROCESS OF GOING THROUGH INVESTMENT COMMITTEE. THAT'S JUST MY CHARACTERIZATION TO A FRIEND AND A COWORKER.

MR. WADE: OKAY. SO YOU DON'T RECALL THEM COMMITTING IN THE ROOM TO THE $100 MILLION INVESTMENT?

LISA PETERSON: WE TALKED ABOUT IT. I DON'T -- THERE'S, THERE'S NOT A COMMITMENT BECAUSE IT HAS TO GO THROUGH INVESTMENT COMMITTEE.

MR. WADE: LET ME JUST ASK IF THE LANGUAGE -- IF THAT IS AN ACCURATE STATEMENT AT THE TIME THAT YOU MADE IT.

LISA PETERSON: IT WAS MY CHARACTERIZATION OF WHAT I SAW GOING ON, YES.

MR. WADE: AND LET ME GO TO 2098.

MR. WADE: OKAY. THIS IS AN EMAIL RELATING TO THE THERANOS INVESTMENT THAT YOU ARE ON; CORRECT?

LISA PETERSON: IT'S -- WHICH PART ARE YOU ON? IT'S A FEW PAGES LONG.

MR. WADE: THE BOTTOM PART OF THE EMAIL IS AN EMAIL BETWEEN MR. TUBERGEN, MS. HOLMES, MR. BALWANI, AND MR. DEVOS, CORRECT, THE LATER PART OF THE EMAIL? AND THEN IT'S FORWARDED TO YOU; CORRECT?

MR. WADE: I MOVE THE ADMISSION OF 2098.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(GOVERNMENT'S EXHIBIT 2098 WAS RECEIVED IN EVIDENCE.)

MR. WADE: IF WE CAN GO TO THE SECOND PAGE AND BLOW UP THE BOTTOM EMAIL. I'M SORRY. ACTUALLY, LET'S GO TO THE THIRD PAGE AND GET MR. TUBERGEN'S EMAIL.

MR. WADE: DO YOU SEE THIS IS AN EMAIL FROM MR. TUBERGEN?

MR. WADE: TO MS. HOLMES AND MR. BALWANI COPYING DOUG DEVOS? DO YOU SEE THAT?

MR. WADE: OKAY. AND DO YOU SEE IN THE MIDDLE PARAGRAPH WHERE IT SAYS, "WE WOULD LOVE TO MOVE FORWARD AND BE A PART OF THE NEW SHAREHOLDER BASE YOU ARE ASSEMBLING. AS WE DISCUSSED, AN INVESTMENT OF $100 MILLION SEEMS TO FIT, IF THAT WORKS FOR YOU AND THE COMPANY." RIGHT?

LISA PETERSON: YES, THAT'S PRETTY MUCH HOW IT WAS DISCUSSED IN THE MEETING.

MR. WADE: RIGHT. AND THAT'S FOUR DAYS AFTER THE MEETING THEY'RE SAYING THEY MADE THE COMMITMENT; CORRECT?

LISA PETERSON: IT DOESN'T NECESSARILY SAY THEY MADE THE COMMITMENT, BUT YES.

MR. WADE: ALL RIGHT. LET'S GO FORWARD AND LOOK AT MS. HOLMES'S EMAIL. DO YOU SEE THAT? AND SHE SAYS, "WE HAVE RESERVED THE $100 MILLION ALLOCATION FOR YOU AND THE FAMILY." DO YOU SEE THAT?

MR. WADE: AND THEN THIS IS LATER FORWARDED TO YOU SO THAT SUNNY CAN BE IN TOUCH ON THE DOCUMENTATION; RIGHT?

MR. WADE: OKAY. LET'S GO TO 12856. DO YOU SEE THAT?

LISA PETERSON: WHERE? I'M SORRY?

MR. WADE: DO YOU HAVE 12856 IN FRONT OF YOU, THAT EMAIL?

LISA PETERSON: THERE'S NOTHING ON MY SCREEN. IS THERE SUPPOSED TO BE?

MR. WADE: NO, NOT YET.

MR. WADE: I'M SORRY. THE WAY IT WORKS IS THAT ONCE WE INTRODUCE IT, WE CAN PUT IT UP ON THE SCREEN. BUT UNTIL IT IS IN EVIDENCE, WE CAN'T PUT IT UP ON THE SCREEN. MY APOLOGIES.

LISA PETERSON: I DON'T -- I'M NOT SEEING 12856. I'M SORRY.

MR. WADE: YOU DON'T HAVE THAT IN THE BLACK BINDER?

LISA PETERSON: WHERE AM I LOOKING?

MR. WADE: DO YOU SEE A TAB WITH 12856?

LISA PETERSON: I THOUGHT WE WERE STILL ON THAT SERIES OF EMAILS. I'M SORRY.

MR. WADE: I'M SORRY IF I --

MR. LEACH: YOUR HONOR, I HAVE NO OBJECTION TO THIS EXHIBIT IF YOU WANT TO JUST DISPLAY IT.

JUDGE DAVILA: DO YOU WANT TO INTRODUCE IT?

MR. WADE: YES, PLEASE.

JUDGE DAVILA: ALL RIGHT. IT'S ADMITTED, AND IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 12856 WAS RECEIVED IN EVIDENCE.)

MR. WADE: IF WE CAN BLOW UP THE THIRD EMAIL DOWN. YEAH, THE --

MR. WADE: DO YOU SEE THAT THIS IS THAT EMAIL THAT WE WERE JUST TALKING ABOUT WHERE MS. HOLMES RESPONDED IN THE SEPARATE CHAIN THAT WAS FORWARDED TO YOU?

MR. WADE: OKAY. NOW, LET'S JUST GO UP THE CHAIN AND LOOK AT THE NEXT EMAIL. MR. TUBERGEN SAYS, "THANKS VERY MUCH." AND THEN WE'LL KEEP WORKING UP. THIS IS FOR -- HE THEN FORWARDS IT TO DOUG DEVOS?

MR. WADE: AND THERE'S A SEPARATE COMMUNICATION BETWEEN MR. DEVOS AND MR. TUBERGEN. DO YOU SEE THAT?

MR. WADE: AND HE SAYS, "WELL DONE, IT LOOKS LIKE WE'RE THERE." DO YOU SEE THAT?

MR. WADE: "EXCITING TO BE A PART OF THIS TREMENDOUS EFFORT TO CHANGE THE WORLD FOR THE BETTER." DO YOU SEE THAT?

MR. WADE: THE LAST LANGUAGE WE REFLECTED WAS THE FORWARD LONG-TERM FOCUS THAT THE DEVOS FAMILY HAD; CORRECT?

MR. WADE: OKAY. LET'S LOOK UP THE CHAIN. MR. TUBERGEN CONFIRMS, "THANKS, DOUG. YUP, WE'RE THERE." RIGHT? DO YOU SEE THAT?

MR. WADE: THE -- YOU'VE TALKED A LITTLE BIT ABOUT THE MEMO THAT YOU PREPARED. DO YOU RECALL THAT?

LISA PETERSON: YES. THE MEMO SUMMARIZED WHAT WAS DISCUSSED AT THE MEETING --

LISA PETERSON: -- ALONG WITH EVERYTHING ELSE.

MR. WADE: I UNDERSTAND. BUT THE INVESTMENT DECISION WAS PREPARED BEFORE THE MEMO --

JUDGE DAVILA: LET HIM FINISH.

BY MR. WADE:

MR. WADE: I APOLOGIZE. NORMALLY WE HAVE CONVERSATIONS, BUT WE HAVE TO LET ME FINISH, AND THEN I'LL TRY NOT TO INTERRUPT YOU, TOO. I THINK I'VE DONE THAT A FEW TIMES. I'M SORRY.

MR. WADE: THE INVESTMENT DECISION WAS MADE BEFORE THE MEMO WAS PREPARED; CORRECT?

LISA PETERSON: IT STILL HAS TO GO TO INVESTMENT COMMITTEE, SO IN MY -- IN MY FINISHING OF THIS, THE ONLY WAY THAT WE CAN FINALIZE EVERYTHING IS IT HAS TO -- THE MEMO HAS TO GO OUT AND BE SIGNED AND APPROVED THROUGH THE INVESTMENT COMMITTEE, BUT JERRY AND DOUG WERE EMAILING THAT THEY WERE THERE. SO YES.

MR. WADE: SO THE -- AGAIN, I UNDERSTAND THAT YOU HAD SOME -- ON YOUR END, YOU HAD SOME PROCESSING THAT YOU NEEDING TO PERFORM --

MR. WADE: -- AND SOME LOGISTICAL ISSUES, BUT THE INVESTMENT WAS DONE BEFORE THE MEMO WAS PREPARED; CORRECT?

LISA PETERSON: HMM -- THEY STILL -- WE STILL DIDN'T WIRE THE MONEY UNTIL AFTER OUR PROCESS WAS COMPLETED.

MR. WADE: BUT YOU SEE HERE THE COMMITMENT IS MADE; RIGHT?

LISA PETERSON: IT'S NOT REALLY A COMMITMENT UNTIL YOU SEND THE DOCUMENTS.

MR. WADE: OKAY. LET'S KEEP GOING. 2139. DO YOU HAVE THAT DOCUMENT IN FRONT OF YOU?

MR. WADE: AND THIS IS A COMMUNICATION -- MOVE THE ADMISSION OF 2139.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(GOVERNMENT'S EXHIBIT 2139 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: THIS IS A COMMUNICATION BETWEEN YOU AND MR. BALWANI WHERE YOU'RE WORKING TO PAPER THE DEAL AND GET SIGNATURES AND THE LIKE; RIGHT?

MR. WADE: OKAY. AND THEN DO YOU RECALL THERE BEING WORD THAT THEY WANTED TO FUND IT PRETTY QUICKLY AND IT WAS FUNDED WITHIN A COUPLE OF DAYS AFTER THAT?

LISA PETERSON: AFTER THIS MEMO, OR AFTER WHAT?

MR. WADE: AFTER THIS EMAIL.

MR. WADE: OKAY. AND IF WE GO TO 14080.

LISA PETERSON: 14080. OKAY. OKAY.

MR. WADE: THIS IS A DOCUMENT CONFIRMING RECEIPT OF THE SIGNATURE PAGE ON OCTOBER 31ST; CORRECT?

MR. WADE: MOVE THE ADMISSION OF 14080.

MR. LEACH: NO OBJECTION, YOUR HONOR.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 14080 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: I JUST WANT TO FOCUS ON THE DATE. THAT'S 10-31; CORRECT?

MR. WADE: EXECUTED DOCUMENTS?

MR. WADE: OKAY. NOW LET'S GO TO 13987.

MR. WADE: OKAY. AND DO YOU SEE THIS IS AN EMAIL ABOUT THE THERANOS INVESTMENT THAT YOU'RE ON?

MR. WADE: I MOVE THE ADMISSION OF 13987.

MR. LEACH: NO OBJECTION.

JUDGE DAVILA: IT'S ADMITTED. IT MAY BE PUBLISHED.

(DEFENDANT'S EXHIBIT 13987 WAS RECEIVED IN EVIDENCE.)

BY MR. WADE:

MR. WADE: AND IF YOU LOOK AT THE BOTTOM, YOU SEE THERE'S AN EMAIL FROM YOU TO A GROUP OF PEOPLE WITHIN RDV?

MR. WADE: DO YOU SEE THAT? ARE THOSE SORT OF ACCOUNTING AND FINANCIAL PEOPLE?

LISA PETERSON: YES, INTERNAL.

MR. WADE: OKAY. AND THERE IT SAYS, "JERRY WANTS TO BRING THERANOS TO IC. NOT SURE WHEN THAT WILL BE, NOR IS IT RELEVANT GIVEN WE'VE FUNDED, BUT FYI I WON'T HAVE A SIGNATURE ON APPROVAL DOC FOR A BIT." DO YOU SEE THAT?

MR. WADE: OKAY. AND THIS IS FIVE OR SIX DAYS AFTER THE MONEY WAS WIRED AND THE DOCUMENTS WERE SIGNED; RIGHT?

LISA PETERSON: BUT THE MEMO HAD GONE OUT ON THE 23RD OF OCTOBER.

MR. WADE: RIGHT. DO YOU KNOW WHEN IT WAS SIGNED? IT WASN'T SIGNED AS OF NOVEMBER 5TH; RIGHT?

MR. WADE: AND DO YOU KNOW WHEN THE INVESTMENT COMMITTEE GOT IT?

LISA PETERSON: ON THE 20 -- IT WAS DONE ON THE 23RD AND SENT TO JERRY.

MR. WADE: RIGHT. DO YOU KNOW WHEN THE INVESTMENT COMMITTEE GOT IT?

LISA PETERSON: I BELIEVE THEY GOT IT THEN. I DON'T KNOW EXACTLY.

MR. WADE: OKAY. DO YOU KNOW WHEN THE NEXT INVESTMENT COMMITTEE MEETING WAS?

LISA PETERSON: IN DECEMBER.

MR. WADE: OKAY. LET'S LOOK AT 14081. IT WAS DECEMBER 17TH; CORRECT?

MR. WADE: AND THESE ARE THE DEVOS FAMILY COUNCIL MINUTES; CORRECT?

MR. WADE: AND I'D MOVE THE ADMISSION. I THINK THEY'RE APPROPRIATELY REDACTED ALREADY, YOUR HONOR. MAYBE WE CAN REDACT THE -- AFTER PETER EVANS NAMES.

JUDGE DAVILA: ON THE FRONT PAGE?

MR. WADE: YES, IF THAT --

JUDGE DAVILA: MR. LEACH?

MR. LEACH: I DON'T OBJECT TO THE EXHIBIT, YOUR HONOR. THE REDACTIONS SOUND APPROPRIATE.

JUDGE DAVILA: WITH THOSE REDACTIONS, THEN IT WILL BE ADMITTED. MR. LEACH, YOU HAVE NO OBJECTION?

MR. LEACH: NO OBJECTION.

JUDGE DAVILA: ALL RIGHT.

(DEFENDANT'S EXHIBIT 14081 WAS RECEIVED IN EVIDENCE.)

MS. TREFZ: MR. WADE, CAN YOU JUST COME AND SEE? SORRY.

BY MR. WADE:

MR. WADE: OKAY. THIS IS THE DEVOS -- THESE ARE MINUTES OF THE DEVOS FAMILY COUNCIL MEETING; CORRECT?

MR. WADE: AND THAT'S WHERE THEY ACT ON A VARIETY OF CORPORATE MATTERS; CORRECT?

LISA PETERSON: YES. THIS ISN'T THE INVESTMENT COMMITTEE.

MR. WADE: RIGHT, I UNDERSTAND. BUT FOR THE FAMILY OFFICE, THEY -- THEY'LL ACT OFTEN AT THESE MEETINGS; CORRECT?

LISA PETERSON: THEY WHAT?

MR. WADE: THEY'LL ACT OFTEN AT THESE MEETINGS; IS THAT RIGHT?

LISA PETERSON: ACT OFTEN? I'M NOT SURE I'M FOLLOWING.

MR. WADE: OKAY. LET ME TRY AGAIN. LIKE A CORPORATION SOMETIMES ACTS THROUGH ITS BOARD OF DIRECTORS, THE DEVOS FAMILY WILL TAKE CORPORATE ACTIONS AT MEETINGS OF THIS KIND; IS THAT RIGHT?

LISA PETERSON: FAMILY COUNCIL IS DIFFERENT THAN INVESTMENT COMMITTEE. OFTENTIMES THERE WILL BE AN UPDATE ON THINGS, BUT IT'S NOT A FORMAL INVESTMENT COMMITTEE MEETING.

MR. WADE: OKAY. SO DO YOU -- I'M SORRY. I DIDN'T MEAN TO INTERRUPT.

LISA PETERSON: THOSE, THOSE CAN OFTEN BE DONE VIA TELEPHONE, AND WE DO HAVE TWO OR THREE A YEAR, FORMAL ONES.

MR. WADE: OKAY. AS YOU SIT HERE TODAY, DO YOU KNOW THE DATE ON WHICH THE INVESTMENT COMMITTEE ACTED, OR IF THEY ACTED?

LISA PETERSON: IT WAS MY UNDERSTANDING THAT THERE WAS A PHONE CALL OR DISCUSSION RIGHT AFTER -- BETWEEN THE 23RD AND THE 30TH, 31ST WHEN WE WIRED THE MONEY, THAT ALL WAS GREEN LIGHTED TO GO.

MR. WADE: AND HAVE YOU SEEN ANY DOCUMENTS TO THAT EFFECT?

LISA PETERSON: IT'S JUST JERRY TELLING ME.

MR. WADE: OKAY. JERRY TOLD YOU THAT?

MR. WADE: OKAY. WERE YOU PRESENT FOR THE MEETING?

MR. WADE: OKAY. IF I CAN PULL UP 13987, AND BRING UP THAT BOTTOM EMAIL AGAIN. IF YOUR RECOLLECTION IS RIGHT, WHY IS IT THAT THE DOCUMENT WASN'T SIGNED ON NOVEMBER 5TH, 2014?

LISA PETERSON: I DON'T KNOW IF HE JUST HADN'T SIGNED IT YET. BUT THERE HAD TO HAVE BEEN A DISCUSSION AROUND IT WITH THE OTHER MEMBERS OF THE INVESTMENT COMMITTEE. IT COULD HAVE HAPPENED ON THE PLANE AS WELL. I DON'T KNOW HOW MANY PEOPLE HAD TO -- ON THE WAY HOME. I DON'T KNOW HOW MANY HAD TO OKAY THE INVESTMENT --

LISA PETERSON: -- AS PART OF THE INVESTMENT COMMITTEE.

(PAUSE IN PROCEEDINGS.)

BY MR. WADE:

MR. WADE: AFTER YOUR INTERACTIONS IN THE MEETING WITH MS. HOLMES, WERE YOUR NEXT INTERACTIONS WITH PEOPLE FROM THERANOS THE INTERACTIONS WITH MR. BALWANI?

LISA PETERSON: THROUGH THE EMAILS AND A CONVERSATION ON THE TELEPHONE?

MR. WADE: AND WERE THOSE THE LAST COMMUNICATIONS THAT YOU HAD IN 2014 AND '15?

MR. WADE: OKAY. AND COMMUNICATIONS THAT HAPPENED THEREAFTER WERE COMMUNICATIONS THAT HAPPENED AFTER "THE WALL STREET JOURNAL"?

MR. WADE: OKAY. AND YOU TESTIFIED ON DIRECT THAT -- OR YOU WERE SHOWN THE JIM CRAMER CLIP. DO YOU RECALL THAT?

MR. WADE: AND WERE YOU SHOWN -- DID YOU WATCH THAT AT THE TIME?

MR. WADE: OKAY. DO YOU RECALL OTHER -- YOU HAD OTHER INTERACTIONS WITH MS. HOLMES IN THE PERIOD FOLLOWING THAT CLIP? YOU TALKED ABOUT SOME OF THEM. DO YOU RECALL THAT?

LISA PETERSON: I DON'T RECALL THE EXACT DATE OF THAT CLIP. THE NEXT TIME THAT WE SAW ELIZABETH WAS APRIL -- LATE APRIL OF 2016.

MR. WADE: AND THAT WAS THE MEETING THAT -- THAT WAS THE MEETING THAT MR. LEACH ASKED YOU ABOUT?

MR. WADE: OKAY. AND THAT WAS ATTENDED BY, I THINK YOU SAID, MR. MOSLEY, MR. TUBERGEN, AND SOME OTHERS AT THERANOS? DO YOU RECALL THAT?

LISA PETERSON: MYSELF AND LEGAL COUNSEL, HEATHER KING, AND DAN EDLIN, AND ELIZABETH.

MR. WADE: OKAY. AND DO YOU RECALL THAT THEY GAVE YOU AN UPDATE ON THE REGULATORY ISSUES AT THAT MEETING?

MR. WADE: AND THEY GAVE YOU AN UPDATE ON SOME CHANGES THAT WERE BEING MADE WITHIN MANAGEMENT? DO YOU RECALL THAT?

MR. WADE: AND THEY GAVE YOU AN UPDATE ABOUT CHANGES THAT WERE MADE IN THE BOARD?

MR. WADE: AND SET FORTH WHAT THEY THOUGHT WAS THEIR STRATEGY GOING FORWARD TO TRY TO REGAIN CREDIBILITY IN THE MARKETPLACE? DO YOU RECALL THAT?

MR. WADE: AND ONE OF THOSE WAS TO TRY TO FOCUS ON, TRY TO WORK TO GET SOME PEER REVIEW PUBLICATIONS. DO YOU RECALL THAT?

MR. WADE: AND THERE WAS ALSO A PLAN TO FORM SOME COMMITTEES TO GIVE SCIENTIFIC AND TECHNICAL ADVICE TO THE COMPANY? DO YOU RECALL THAT?

MR. WADE: AND THEY ALSO GAVE YOU A REPORT ON THE FINANCIAL STATE OF THE COMPANY AT THAT TIME?

MR. WADE: YOU DON'T BELIEVE THEY DID?

LISA PETERSON: THEY DIDN'T GIVE US ANY PAPER AT THAT MEETING.

MR. WADE: DID YOU --

LISA PETERSON: WE DIDN'T LEAVE WITH ANYTHING. THERE MIGHT HAVE BEEN SOME VERBAL AROUND WHERE THE CASH WAS OF THE COMPANY, BUT I DON'T RECALL SPECIFICALLY.

MR. WADE: OKAY. DO YOU RECALL THAT THERE WAS DISCUSSION ABOUT HOW THEY HAD ABOUT $375 MILLION IN CASH AT THAT TIME?

LISA PETERSON: I DON'T RECALL THE EXACT NUMBERS.

LISA PETERSON: YES, WE WERE TALKING ABOUT THE CASH POSITION OF THE COMPANY.

LISA PETERSON: BUT THERE WERE NO FINANCIALS SHOWN.

MR. WADE: UNDERSTOOD. AND DID THEY TELL YOU THAT THEY WERE ACTUALLY IN THE PROCESS OF TRYING TO IMPROVE THE FINANCIALS OF THE COMPANY IN THAT TIME?

LISA PETERSON: I DON'T RECALL THAT PART OF THE CONVERSATION.

MR. WADE: DO YOU RECALL THAT THEY WERE BRINGING IN NEW PEOPLE INTO THE FINANCIAL OPERATIONS TO TRY TO IMPROVE THE ACCOUNTING FUNCTION?

LISA PETERSON: I RECALL WE SENT AHEAD A LIST OF QUESTIONS THAT WE HAD, AND A LOT OF IT WAS AROUND THE FINANCIALS AND EVERYTHING, AND WE DIDN'T RECEIVE ANY HARD CORE -- ANYTHING TO TAKE BACK WITH US. THAT IS WHAT I REMEMBER.

MR. WADE: OKAY. DO YOU REMEMBER THAT, AS PART OF THAT, THE COMPANY TOLD YOU THAT THEY -- PART OF THEIR STRATEGY FOR MOVING FORWARD WAS TO INCREASE ENGAGEMENT WITH THE SCIENTIFIC COMMUNITY? DO YOU RECALL THAT?

MR. WADE: AND TO BE MORE TRANSPARENT?

MR. WADE: OKAY. AND THAT THEY WERE WORKING, THAT THEY HAD PLANNED TO GIVE A PRESENTATION ABOUT THE TECHNOLOGY, THEIR TECHNOLOGY AT THE AACC --

MR. WADE: -- MEETING? DO YOU RECALL BEING TOLD THAT IN THAT APRIL MEETING?

LISA PETERSON: YES. BUT WE WERE ALSO TOLD IN THAT MEETING -- MUCH OF WHAT YOU HEARD IN THE TWO CLIPS THAT WERE SHOWN IS THE SAME THING THAT SHE WAS SAYING IN THAT MEETING, THAT A LOT OF IT WAS ERRONEOUS AND UNFOUNDED AND DONE BY A VERY OVERZEALOUS REPORTER WHO WANTED TO WIN A PULITZER. THERE WAS A LOT OF CONVERSATION AROUND WE WERE TRYING TO UNDERSTAND WHAT WAS GOING ON IN THE NEWSPAPER AND TRYING TO GET HER TO EXPLAIN A LOT OF IS IT TRUE OR IS IT NOT TRUE? AND SHE DOWNPLAYED A LOT OF IT. AND THAT WAS MUCH OF THE CONVERSATION, MUCH MORE SO AROUND THAT NOT BEING BASED ON FACT OF WHAT WAS BEING WRITTEN IN THE NEWSPAPER THAN THE CHANGING OF THE PEOPLE.

MR. WADE: YOUR HONOR, I WOULD MOVE TO STRIKE EVERYTHING AFTER THE IMMEDIATE ANSWER TO MY QUESTION.

(PAUSE IN PROCEEDINGS.)

JUDGE DAVILA: ALL RIGHT. I'LL STRIKE -- EVERYTHING AFTER "YES" IS STRICKEN AS NONRESPONSIVE.

BY MR. WADE:

MR. WADE: AND ONE OF THE THINGS THAT YOU CAME AWAY FROM THAT MEETING WAS A REQUEST TO GET -- YOU WANTED TO GET AN INVITE TO THE AACC PRESENTATION?

MR. WADE: AND DID YOU GET SUCH AN INVITE?

MR. WADE: AND DID YOU GO TO THE PRESENTATION?

MR. WADE: AND THE AACC IS A PROFESSIONAL ORGANIZATION OF PEOPLE WHO WORK IN CLINICAL CHEMISTRY?

MR. WADE: AND THERE WERE APPROXIMATELY 2500 PEOPLE AT THAT CONFERENCE?

MR. WADE: DO YOU RECALL THAT?

MR. WADE: AND IT WAS A PRETTY HOSTILE ENVIRONMENT; RIGHT?

MR. WADE: AND THEY WERE VERY SKEPTICAL OF THERANOS GOING IN; RIGHT?

LISA PETERSON: YES. THAT WAS MY VIEW OF THINGS, YES.

MR. WADE: BUT THERANOS WENT IN AND GAVE -- A NUMBER OF PEOPLE GAVE A PRESENTATION AND PARTICIPATED IN THE Q AND A WITH RESPECT TO THEIR TECHNOLOGY; CORRECT?

LISA PETERSON: A NUMBER OF -- I'M SORRY, SAY AGAIN.

MR. WADE: LET ME TAKE IT IN TWO STEPS. DO YOU RECALL THAT THERE WERE SEVERAL PEOPLE FROM THERANOS AT THAT MEETING, AT THAT CONFERENCE?

LISA PETERSON: I ONLY RECALL ELIZABETH TALKING.

MR. WADE: OKAY. YOU RECALL MS. HOLMES WAS THERE?

MR. WADE: AND SHE GAVE PART OF A PRESENTATION; RIGHT?

MR. WADE: OKAY. AND DO YOU RECALL THAT AFTER HER PRESENTATION THERE WAS A Q AND A WITH A PANEL OF PEOPLE?

LISA PETERSON: YES -- I DON'T RECALL EXACTLY, NO.

MR. WADE: AND DO YOU RECALL THAT THERE WERE THREE PEOPLE FROM AACC REPRESENTATIVES AND ABOUT FOUR PEOPLE FROM THERANOS?

LISA PETERSON: I DON'T REMEMBER THAT, NO.

MR. WADE: OKAY. DO YOU RECALL -- LET ME GIVE YOU NAMES AND SEE IF YOU REMEMBER THAT. DO YOU RECALL THAT DR. YOUNG WAS THERE?

MR. WADE: DO YOU RECALL THAT DR. PANGARKAR WAS THERE?

MR. WADE: DO YOU RECALL THAT DR. ANEKAL WAS THERE?

MR. WADE: OKAY. AND YOU OBSERVED THE WHOLE PRESENTATION IN THE Q AND A?

LISA PETERSON: I DON'T RECALL OBSERVING THAT PART OF IT. I REMEMBER HER PRESENTING, YES.

MR. WADE: OKAY. AND YOU PREPARED A SUMMARY OF THAT PRESENTATION; CORRECT?

LISA PETERSON: I JUST PREPARED A SUMMARY OF WHAT I OBSERVED.

MR. WADE: AND YOU --

LISA PETERSON: I DIDN'T, I DIDN'T TRY TO SUMMARIZE WHAT SHE WAS TRYING TO SAY.

LISA PETERSON: THE WHOLE PURPOSE OF GOING WAS TO TRY TO FIGURE OUT WHETHER THE TECHNOLOGY WORKED OR NOT. WE WERE STILL TRYING TO FIGURE OUT WHAT WAS GOING ON.

MR. WADE: I UNDERSTAND. MY QUESTION WAS, YOU PREPARED A SUMMARY --

MR. WADE: -- OF WHAT YOU OBSERVED IN THAT MEETING; CORRECT?

MR. WADE: CAN YOU LOOK AT 5273.

MR. WADE: AND IS THIS THE SUMMARY THAT YOU PREPARED OF THAT MEETING?

MR. WADE: MOVE THE ADMISSION OF 5273.

MR. LEACH: YOUR HONOR, RELEVANCE AND HEARSAY, 403.

(PAUSE IN PROCEEDINGS.)

JUDGE DAVILA: I'M JUST CURIOUS HERE ABOUT THE TIME DIFFERENCE AND THE RELEVANCE.

MR. WADE: WELL, I WONDER IF, GIVEN THE HOUR, MAYBE WE CAN BREAK HERE AND THEN DISCUSS THIS WITHOUT BURDENING THE JURY AND START BACK WITH THIS TOMORROW?

JUDGE DAVILA: LET'S DO THAT THEN. LADIES AND GENTLEMEN, LET'S TAKE OUR RECESS FOR THE DAY. WE'LL RESUME TOMORROW AT 9:00 O'CLOCK. AGAIN, LET ME ADMONISH YOU TO CONTINUE YOUR VIGILANCE NOT TO READ, LISTEN, OR DISCUSS THIS CASE IN ANY WAY WITH ANYONE OR TO FORM ANY OPINIONS ABOUT THIS CASE UNTIL THE CASE HAS BEEN DELIVERED TO YOU FOR YOUR DELIBERATIONS. PLEASE CONTINUE TO DO THAT. I'LL ASK YOU TOMORROW IF ANY OF YOU HAVE INADVERTENTLY COME ACROSS ANY SUBJECT MATTER. LET ME ALSO TELL YOU ANOTHER SCHEDULING ISSUE. NOVEMBER 4TH WE'RE IN SESSION, THAT'S NEXT THURSDAY, BUT WE WON'T START UNTIL 9:30. 9:30 THAT MORNING I EXPECT IS WHEN OUR START TIME WILL BE. I JUST WANT TO LET YOU KNOW THAT FOR PLANNING PURPOSES. TOMORROW WE'LL GO UNTIL 4:00 O'CLOCK I HOPE. IS THAT A PROBLEM FOR ANYONE? OKAY. LET'S SHOOT FOR 4:00 O'CLOCK. OTHER THAN THAT, WE'LL BE IN RECESS FOR THE DAY. THANK YOU VERY MUCH. MS. PETERSON, YOU CAN STAND DOWN AS WELL. THANK YOU. WE'LL SEE YOU TOMORROW AT 9:00 O'CLOCK, PLEASE.